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Abstract 
It has been proposed that musculo-skeletal modelling techniques may provide new tools 
for use in clinical gait analysis to help our understanding of the role of muscles and 
tendons in movement dysfunction. Sensitivity and validity analyses are necessary and 
important steps in achieving this goal. 
 
The aim of this investigation was to evaluate SimTrack, a workflow for generating muscle 
driven simulations of movement embedded within the 3D musculo-skeletal modelling 
software package OpenSim (Delp et al., 2007). Walking in both pathological (cerebral 
palsy) and typically developing subjects was analysed. If muscle activations can be 
accurately determined using such techniques, advanced simulation methods may be used 
to determine the mechanical potential of muscles in these groups and therefore help 
identify muscles in subjects with cerebral palsy that cannot make significant contribution 
to support and progression in walking. Ten typically developing adolescents and ten 
independently ambulant adolescents with cerebral palsy were recruited and the following 
data collected: MRI of the lower-limbs; 2D-ultrasound of a number of lower limb muscles; 
3D motion, electromyography and ground-reaction-force data of the subjects’ walking 
patterns. 
 
The muscle morphology of subjects in the two groups were assessed and this data was 
used to inform 3D musculo-skeletal models. Each model’s muscle activations were 
allowed to vary to track the subject’s recorded walking pattern and the sensitivities of 
these simulated activations to changes in model muscle strength were tested over a 
normative range. The validity of the simulated activations were then determined by 
comparison with experimental electromyographic data. 
 
In the case group, muscle volumes were found to be smaller (principally in the distal 
musculature) and physiological cross-sectional areas were found to be larger in the thigh 
and smaller in the shank than the control group. The musculo-skeletal model was 
insensitive to changes in muscle strength. All simulated activations were found to be 
invalid. The results suggest that the application of SimTrack to the understanding of 
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“That’s one small step for man… 
     one giant leap for mankind” 
 
1.1. Introduction 
When Neil Armstrong spoke these words on 20th July 1969 he was making reference to 
the leap in technological and scientific achievement that had enabled him to become the 
first person to set foot on the moon. Human language has always made use of walking 
terminology to describe the concepts of advancement and progression. We refer to the 
steps of a process, we like to run with an idea, and we make leaps of understanding. 
Expressions such as these are commonplace and universally understood because of our 
innate fascination with the human ability to move. 
 
Armstrong’s analogy between walking and technology is very apt if we examine the 
development of our understanding of human walking. In his history of early gait analysis, 
Baker (2007) tells us that the earliest known work on the subject comes from Aristotle 
(384-322 BC), who amongst many observations recognised that we do not walk purely 
horizontally but rather our body rises and falls with each step. However, it was not until 
the advent of photography in the 19th Century that some of the complexities of walking 
began to be unravelled and as technology developed so instrumented gait analysis was 
born. Jules Etienne Marey (1830–1904) invented the first high-speed camera “gun” that 
could record images from the same position at 12 frames per second and the 3D motion 
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capture systems found in most modern gait analysis laboratories are still based on 
photographic techniques. 
 
Walking is an ability that many of us take for granted but an injury or disorder to the 
neural or musculo-skeletal system, such as with cerebral palsy, can make walking difficult 
or impossible. The resulting immobility may be a barrier to physical and social activity and 
consequently lead to a reduced quality of life (Jaspers et al., 2013). Modern clinical gait 
analysis centres use a variety of data such as 3D joint angles/torques and recordings of 
muscle activity combined with medical understanding of patient groups to make 
treatment recommendations in an attempt to improve an individual’s gait and mobility. 
However, despite such sophisticated measurement tools, the subsequent analysis of 
movement patterns is in the most part limited to simple descriptions of the deviations of 
the data from a normal pattern and it is left to clinicians to interpret the data to find 
clinical meaning.  
 
There is a need therefore for new tools in clinical gait analysis (Baker, 2006) and musculo-
skeletal modelling and simulation techniques may provide a solution (Delp, 1990). 
However, there is still a requirement for evaluation and validation of such methods and 
this thesis attempts to make one small step towards achieving this goal. 
 
This introductory chapter provides some background to the disabling condition of cerebral 
palsy and briefly describes how musculo-skeletal modelling may both help our 
understanding of this condition and be used to aid treatment decision making. 
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1.2. Cerebral Palsy (CP) 
Cerebral Palsy is: 
 
 “an umbrella term covering a group of non-progressive, but often changing, motor 
impairment syndromes secondary to lesions or anomalies of the brain arising in the early 
stages of development.”  (Mutch et al. 1992, p.549) 
 
Cerebral palsy is a static perinatal encephalopathy and was originally known as Little’s 
Disease after William Little linked it to difficult labours and perinatal hypoxia in 1862 
(Jones et al., 2007). Since then, advances in the understanding of early life brain injury 
mechanisms have led to more specific ideas of cerebral palsy aetiology which, as du 
Plessis (2009) explains, include hypoxic, ischemic, haemorrhagic and inflammatory brain 
lesions to the ante-, peri- and post-natal child. Other proposed pre-natal causes of 
cerebral palsy include genetic abnormalities, congenital brain malformation and in utero 
infections. 
 
Whatever the cause, this non-progressive neuropathy leads to a complex variety of 
primary abnormalities dependent on both the location of the brain lesion(s) and the stage 
of brain development in which it occurred. Primary abnormalities can include both 
sensory and motor elements such as cognitive difficulties, epilepsy, behavioural disorders 
and dysarthria (motor speech disorder) as well as balance difficulties, the loss of selective 
motor control, and abnormal muscle tone (Fowler & Goldberg, 2009; Gormley, 2001; 
Jones et al., 2007; Stackhouse et al., 2005). As individuals with cerebral palsy grow they 
will also develop progressive secondary abnormalities such as anomalies of muscle and 
bone growth due to the influence of loading and activation patterns on the development 
of the musculo-skeletal system (Gage & Schwartz, 2009a). 
 
Muscles can become short and stiff (a muscle contracture) which limits the range of 
movement of the joint (Barber et al., 2011), and a number of studies (Brown et al., 1991; 
Wiley & Damiano, 1998) have shown that the muscles of children with spastic cerebral 
15 
palsy are weak. The term cerebral palsy means weakness originating from the brain 
(Damiano et al., 2002). There are a number of recognised causes for this weakness: 
subjects with spastic cerebral palsy have smaller muscle volumes (Barber et al., 2011; Fry 
et al., 2007; Malaiya et al., 2007; Oberhofer et al., 2010), they have incomplete muscle 
activation and/or increased co-activation (Elder et al., 2003; Stackhouse et al., 2005; 
Tammik et al., 2008) and there are myopathic changes in muscle microstructure including 
increased fat and connective tissue content (Booth et al., 2001; Castle et al., 1979; 
Johnson et al., 2009), and changes in muscle fibre stiffness (Lieber et al., 2003; Smith et 
al., 2011). These changes have a direct effect on the active and passive mechanics of 
muscle and so, if measured, it should be possible to incorporate them into a musculo-
skeletal model and so analyse their influence on a walking pattern. 
 
Bone abnormalities that often occur in the lower limbs of children and adults with 
cerebral palsy include torsion of the long bones (tibial torsion, femoral anteversion), hip 
dislocation and a number of foot deformities (Gage & Schwartz, 2009a). Many of these 
abnormalities lead to the problem of lever-arm dysfunction where the change in skeletal 
geometry affects the line of action of the muscles and hence alters their rotational action 
on the related joint. For someone with cerebral palsy, the progressive nature of these 
secondary abnormalities typically leads to a decline in mobility during adulthood (Strauss 
et al., 2004). 
 
Various classifications of cerebral palsy have been proposed (SCPE, 2000) including a 
topographical classification:  
 
 diplegia – legs more affected than arms 
 hemiplegia – one side only (usually arm more than leg) 
 quadriplegia – all four limbs affected (legs more than arms) 
 double hemiplegia – all four limbs affected (arms more than legs) 
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and a motor classification: 
 
 dyskinetic/choreo-athetoid – loss of postural control with unwanted movements 
 ataxic – poor balance and coordination, often with shaky hand movements 
 spastic – hyper-excitability of the muscle/tendon stretch reflex 
 
The different types of cerebral palsy can be explained in terms of the location of the brain 
lesion. As explained by Peacock (2009) and Albright (2009a) human movement begins 
with a thought in the cerebral cortex and, after interaction with various other motor 
control centres, a nerve impulse is passed via the brainstem and down the spinal cord 
through the corticospinal tract (also known as the pyramidal tract) to synapse with a lower 
motor neuron and hence onto the appropriate muscle. Originally it was thought that 
damage to the pyramidal tract was the principal cause of spasticity and hence the terms 
pyramidal and extrapyramidal were commonly used to describe lesion location. However, 
this is incorrect and it is now accepted that it is disruption to the inhibitory influence of 
the neighbouring reticulospinal and vestibulospinal tracts which is important and 
therefore any lesions affecting the reticular and vestibular midbrain nuclei or their 
cortical/spinal connections can result in spasticity. Non-spastic cerebral palsy is caused by 
damage to the basal ganglia, cerebellum or their cortical connections. However, due to 
the variation in the extent and severity of these injuries, it is often difficult to fit a patient 
with cerebral palsy into a particular classification. A collaboration of cerebral palsy surveys 
and registers in Europe (SCPE, 2000) revealed that between two and three children per 
1000 live births were diagnosed as having cerebral palsy with spastic cerebral palsy being 
the most common type. 
 
Cerebral palsy cannot, at present, be cured and so the principal aims of intervention are to 
prolong functional mobility and reduce pain. There are a number of current techniques 
used by clinicians to achieve these goals including physiotherapy, pharmacological 
treatments, the use of orthoses and orthopaedic surgery (Gage et al., 2009). 
Physiotherapy is typically used to try and maintain joint range of motion, to improve 
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strength and to facilitate mobility (Damiano et al., 2002, 1995; Darrah et al., 1997; Haney, 
1998; Murr & Walt, 2009).  
 
There are many pharmacological treatments used in the management of cerebral palsy, all 
principally dealing with the reduction of abnormal muscle tone. The mechanisms of each 
drug are different and these complexities are outside the scope of this thesis. However, 
two of the more commonly used treatments are the systemic action of intrathecal 
Baclofen (Krach, 2009) which reduces both dystonia and spasticity, and the action of 
Botulinum toxin type A injections (Molenaers & Desloovere, 2009) which can reduce local 
spasticity. Two operative treatments are also used to address the problem of abnormal 
muscle tone. Selective dorsal rhizotomy is a technique to reduce spasticity that involves 
the selective cutting of dorsal spine (sensory) nerve rootlets between the levels of the 
sacral and first lumbar vertebrae with selection based on a rootlet’s abnormal response to 
electrode stimulation (Trost et al., 2009). Deep brain stimulation is a technique in which 
electric pulses are delivered via electrodes placed in the basal ganglia to reduce dystonia 
(Albright, 2009b). 
 
Orthoses can include a variety of foot splints (e.g. supra-malleolar orthosis - SMO), foot 
and ankle splints (e.g. ankle-foot orthosis - AFO), and less commonly, foot, ankle and knee 
splints, all of which are typically manufactured from moulded plastic and worn to 
compensate for neuro-motor deficiencies. The stiffness and contact region(s) can be 
varied in order to achieve the required support and they can be used to address both 
structural and functional impairments. Some common requirements of an orthosis include 
the prevention of drop-foot, the reduction of crouch gait or the elimination of the 
excessive knee stresses caused by recurvatum (Novacheck et al., 2009).  
 
There are too many orthopaedic procedures used in the treatment of cerebral palsy to be 
described here but they can be summarised into a number of groups. Soft tissue surgery 
can be used to reduce muscle contracture via lengthening techniques, or to transfer 
tendons to change a muscle’s line of action in order to regain function, and bony surgery 
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can be carried out to reduce torsion of the long bones or to correct specific deformities of 
the foot (Gage et al., 2009). 
 
It is important to be able to measure the functional changes that occur as a result of these 
interventions in order to inform and improve treatment. The International Classification of 
Functioning, Disability and Health (ICF; WHO, 2001) provide a framework and common 
language for the discussion of health issues (Figure 1.1). The ICF terminology defines an 
individual with two medical domains, body functions (physiology) and body structures 
(anatomy), and two social domains, activity (day-to-day tasks) and participation (social 
involvement), which are measured in terms of performance (current ability) and capacity 
(possible ability with aid). The framework also includes additional contextual influences 
such as personal or environmental factors that can act as barriers or facilitators to any of 
the four domains. 
 
 
Figure 1.1 – The International Classification of Functioning, Disability and Health 
framework for measuring health and disability (ICF; WHO, 2001) 
 
It is important to consider this framework in healthcare provision (Rauch et al., 2008) as it 
promotes a more global assessment of the individual and in this context, as regards 
cerebral palsy, tools such as the Gross Motor Function Classification System (GMFCS; 
Palisano et al., 1997), the Gillette Functional Assessment Questionnaire (GFAQ; Novacheck 
et al., 2000) and the Gross Motor Function Measure-66 (GMFM-66; (Russell et al., 2002) 
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have been shown to be good predictors of mobility and functionality in daily life, 
measures that can be used to monitor the efficacy of treatment. 
 
1.3. Cerebral Palsy Assessment 
An individual with cerebral palsy will experience a combination of the primary and 
secondary abnormalities described above which is likely to have a detrimental effect on 
their ability to carry out motor tasks, and specifically within the context of this work, on 
their ability to walk. For example, bony deformities and short/stiff muscles may lead to 
limitations in the range of movement at the joints, and the lack of selective motor control, 
muscle weakness and/or abnormal muscle tone including co-contraction and spasticity 
may make balance and coordination of the lower limbs more difficult. These factors will 
inevitably result in a walking pattern that is different to that of typically developing 
individuals. Such deviations from normal walking are known as pathological gait and the 
prevalence study of Wren et al. (2005) describes typical gait pathologies seen in subjects 
with cerebral palsy: 
 
 equinus gait – increased ankle plantarflexion in the stance phase 
 crouch gait – increased knee flexion in the stance phase 
 recurvatum – hyperextension of the knee in the stance phase 
 stiff knee gait – decreased range of knee motion 
 
A subject’s walking pattern can be defined by their kinematics (joint angles), kinetics (joint 
torques) and/or other gait data such as spatio-temporal parameters (walking speed, step 
length etc.) which can be measured using gait analysis techniques (section 2.3.2). 
Distinctions between normal and pathological gait are then limited to the comparison of a 
patient’s gait data, such as joint angle and joint torque graphs, with previously collected 
normal data from unaffected individuals. This can be done visually using the graphical 
data or by using a number of quantitative measures of gait deviation such as the Gillette 
Gait Index (GGI) by Schutte et al. (2000), the Gait Deviation Index (GDI) by Schwartz & 
Rozumalski (2008), or the more recent Gait Profile Score (GPS) from Baker et al. (2009) but 
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it is ultimately left to clinicians to interpret the data to find clinical meaning. The quality of 
treatment decision making is therefore heavily dependent upon the experience of the 
interpreting clinician(s) and the gait impairments identified by these techniques do not 
explain much of the variance in functional capacity or performance in children with 
cerebral palsy (Ostensjø et al., 2004). In addition, the use of clinical gait analysis in the 
evaluation of treatment efficacy is usually restricted to the same global measures of gait 
deviation gathered from retrospective pre/post-intervention studies. 
 
There is a clear need therefore for new tools in the field of clinical gait analysis (Baker, 
2006); tools which it is hoped will better identify the underlying pathology and true 
functional limitations of the individual and hence have a more direct input to treatment 
decision making and the improved efficacy of intervention. Musculo-skeletal modelling 
and simulation techniques may provide a solution (Delp, 1990) and access to sophisticated 
musculo-skeletal modelling software packages has become more available in recent years 
(Delp et al., 2007) leading to a number of cerebral palsy studies in the literature based on 
simulated data. Some of these studies evaluate the contribution of individual muscles to 
supporting the body against gravity and to progressing the body forwards. Subject-specific 
identification of individual muscle contributions and potential deficits in this way may help 
our understanding of a condition and be used to aid treatment decision making. These 
techniques have already been used to analyse muscle contributions in gait pathologies 
such as crouch gait (Arnold & Delp, 2005; Arnold et al., 2007; Hicks et al., 2008), stiff-knee 
gait (Anderson & Pandy, 2003) and equinus foot posture (Higginson et al., 2006), as well as 
in investigations into the effects of bony deformities on muscle capacity (Hicks et al., 
2007). 
 
However, there are currently a number of limitations to these techniques which have 
prevented their adoption into standard gait analysis protocols. Firstly, these studies made 
use of generic musculo-skeletal models that were scaled to match subject size. Arnold et 
al. (2001) and Scheys et al. (2008a, 2008b) however have shown that using models with 
bespoke musculo-skeletal geometry (usually obtained from MRI) result in significant 
differences in muscle moment-arm lengths and muscle-tendon lengths. It is likely 
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therefore that subject-specific models will be necessary if such techniques are to provide 
effective targeting of an individual’s treatment or give reliable predictions of intervention 
outcomes. Current methods of creating subject-specific models however are too 
expensive and time-consuming to be carried out in routine clinical practice. Secondly, 
these techniques usually involve optimisation algorithms (to minimise a cost function) to 
overcome the static indeterminacy problem (section 2.1.3) when calculating muscle 
activations from experimental joint torques. Various cost functions have been proposed, 
often focusing on a global measure of muscle activation. These cost functions may well 
prove valid in the simulation of muscle activation in typically developing subjects but they 
lack any element of neurological control which is likely to have a strong influence on the 
walking patterns of subjects with neurological conditions such as cerebral palsy. 
 
1.4. Problem Statement 
Musculo-skeletal modelling techniques may provide a useful tool in the analysis and 
treatment of individuals with cerebral palsy but there is still a need for evaluation and 
validation of such methods (Baker, 2006). 
 
1.5. Project Scope 
This work includes a validity analysis of simulated muscle activations generated using 
SimTrack (section 2.2.3) which is a workflow for generating muscle driven simulations of 
movement embedded within the 3D musculo-skeletal modelling software package 
OpenSim (Delp et al., 2007). This method is fast becoming accepted as an industry 
standard approach due to interest from leading international centres and an increasing 
number of OpenSim human simulation studies appearing in the literature (as detailed in 
section 1.3). 
 
The sensitivity of the simulated muscle activations to changes in muscle strength is 
assessed for typically developing adolescents and the validity of the activations compared 
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to experimental electromyographic data is assessed for both typically developing 
adolescents and for ambulant adolescents with cerebral palsy. 
 
1.6. Thesis Overview 
 
 Chapter 2: description of current musculo-skeletal modelling methods and 
research including the algorithms utilised in this work - SimTrack. Later sections 
provide an overview of gait analysis methods and our current understanding of 
human gait followed by an outline of the equipment and methodology used in the 
principal data collection. 
 
 Chapter 3: description of the differences in muscle size and morphology between 
the two subject cohorts using data collected from both magnetic resonance and 
ultrasound imaging and comparison to the literature. 
 
 Chapter 4: evaluation of the sensitivity of simulated muscle activations in the 
control group to changes in muscle strength. 
 
 Chapter 5: calculation of the validity of the simulated muscle activations in both 
subject groups by comparison to electromyographic data. 
 





This chapter begins with in-depth description of current musculo-skeletal modelling 
methods and research with specific focus on SimTrack – the OpenSim workflow for 
generating muscle driven simulations of movement. Later sections provide an overview of 
gait analysis methods and our current understanding of human gait. The final sections 
outline the equipment and methodology used in the principal data collection of this work. 
 
2.1. Musculo-skeletal Modelling 
2.1.1. Introduction to musculo-skeletal modelling 
The term model in the context of computer modelling refers to a mathematical construct 
used to represent a system of interest – in this case the human musculo-skeletal system. 
This system is a complex, three dimensional, mechanical linkage of interconnected bodies 
including bones, muscles, tendons and ligaments. It is logical therefore for a model of this 
system also to be based around a mechanical linkage of segments. However, the level of 
complexity of such a model should be chosen as appropriate for the parameters under 
investigation. For example, for the analysis of a single joint torque and ground-foot 
interaction forces (ground-reaction-forces), a simple 2D, two segment model (Figure 2.1a) 
may suffice, whereas using a more complex 3D, multi-segment model enables the 
calculation of multiple joint torques and bone-on-bone forces. Typically segments are 
modelled as rigid bodies with appropriate joint constraints chosen for inter-segment 
connections, e.g. ball, hinge joints. The contribution of active elements can also be added 
into the system (Figure 2.1b) using appropriate muscle models to allow calculation of 





Figure 2.1– (a) 2D, two segment reciprocating model (b) 3D multi-segment model 
 
However, despite their difference in complexity, the techniques and equations of motion 
used to analyse these types of models are based on the same geometric and mechanical 
principles. Rigid body translation and rotation mathematics can track segment movement 
and the subsequent accelerations can be linked to forces by the appropriate inertial 
parameters (e.g. mass). The Newton-Euler equations (Equation 2.1 & Equation 2.2) 
provide an intuitive understanding of the method but techniques such as Lagrangian 
mechanics, which make use of energy calculations to simplify and reduce the number of 
necessary equations, and matrix algebra are more efficient and are typically used in 




F  m a  Newton’s 2nd Law 
 
where: F is the net force on an object (N) 
 m is the mass of the object (kg) 




T  I     Euler equation 
 
where: T  is the net torque on an object (Nm) 
 I  is the moment of inertia of an object (kgm2) 
 α  is the resulting angular acceleration of the object (rads-2) 
 
This provides the mathematical link between the model kinematics (position, velocity, 
acceleration) and the model kinetics (forces and resultant energetics) and gives rise to the 
two main approaches of dynamic model analysis. 
 
 Forward dynamics – the kinetics are known and used to calculate the kinematics 
 Inverse dynamics – the kinematics are known and used to calculate the kinetics 
 
Direct measurement of muscle force is possible via surgically implanted transducers but 
the invasive nature of such techniques prohibits their use in human studies. A workflow to 
achieve a full forward dynamic simulation of human gait (Figure 2.2) would therefore 




(a) EMG to muscle activations 
(b) Activations to muscle forces 
Step 2 
Muscle forces to 
joint torques 
Step 3 




to joint velocities 
Step 5 
Joint velocities 
to joint angles 
 
Figure 2.2 – Forward dynamic workflow from EMG signals to model joint angles. 
EMG = electromyogram, m = muscles, n =joints, T = torques 
 
26 
 Step 1 – (a) Muscle activation states are determined from electromyographic 
(EMG) recordings of the muscle action during the motion of interest. (b) Musculo-
tendon dynamics defined by the chosen muscle model (e.g. a spring/damper 
complex) are used to convert the muscle activations into muscle forces. 
 Step 2 – Muscle forces and external forces (e.g. ground-reaction-forces) are 
combined with joint geometry (force moment-arms) to convert the forces into 
joint torques. 
 Step 3 – The Newton-Euler equations or Lagrangian mechanics are employed to 
convert joint torques into joint angular accelerations and resultant forces into 
linear accelerations. 
 Step 4 – Accelerations are integrated to give joint angular velocities and the global 
translational velocities of the model. 
 Step 5 – Velocities are integrated to give joint angles and the global translational 
position of the model. 
 
This workflow requires feedback elements as can be seen in Figure 2.2. The musculo-
tendon dynamics has dependencies on both joint angles and velocities, the joint geometry 
is a function of joint angle and the centripetal effects from angular velocities must be 
included in step three when calculating accelerations. An inverse dynamics analysis would 
run the steps in reverse beginning with joint angle data (e.g. from a motion capture 
system). An estimation procedure will be necessary however to calculate individual 
muscle forces from joint torques due to the problem of static indeterminacy (section 
2.1.3).  
 
The implementation of steps 2-5 is straightforward using standard mechanics and 
equations of motion and is often summarised using a matrix equation similar to Equation 
2.3. 
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q  is the coordinate positions (e.g. joint angles, global position) in a 
system of n kinematic degrees of freedom 
 q  is the coordinate velocities 
 q  is the coordinate accelerations 
 M is the system mass matrix (n x n) 
 C is the centripetal and Coriolis effects (n x 1) 
 G is the gravitation effects (n x 1) 
 R is a matrix of muscular moment-arms (n x m) where m is the 
number of muscles 
 FMT is the forces of the muscles (m x 1)  
 E is the external forces applied to the system 
 
However, the relationships between muscle excitation and activation (activation 
dynamics) and between activation and the resulting force (contraction dynamics), Figure 
2.2 step 1(a) and (b) respectively, are more complex. Activation dynamics is discussed in 
more detail in section 5.2.2. To parameterise contraction dynamics the construction of a 
muscle model is necessary. 
 
2.1.2. Muscle Modelling 
Skeletal muscles are responsible for the generation of active musculo-skeletal movement 
in the human body. These muscles are complex structures able to produce powerful and 
sustained contractions that work on the mechanical levers of the skeleton to induce 
rotational movement of the joints. The physiology and detailed structure of muscle tissue 
is beyond the scope of this thesis but some of the elements of structure and function that 
are pertinent to the construction of a muscle model are described below. 
 
Each muscle is a separate organ composed of hundreds to thousands of long, cylindrical 
cells known as muscle fibres held together with a series of layers of connective tissue that 
join together at the ends of the muscle to produce the tendons that attach on to bone 
(Purslow, 2008). There are a number of subunits within a muscle fibre including parallel 
protein filament elements and it is here, driven by a chemical mechanism involving 
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calcium ions and adenosine triphosphate, that the sliding filament mechanism takes place 
that is the source of muscle contraction force. A variety of fibre types exist, dependent on 
the way that adenosine triphosphate is generated, which can be crudely classified as slow 
or fast in relation to their contraction speed and speed to fatigue. Typical skeletal muscles 
contain a combination of fibre types but this can change depending on disease, genetic 
factors or by following specific exercise regimes (Tortora & Derrickson, 2007). 
 
Groups of muscle fibres, known as a motor unit, are innervated by a single motor neuron. 
The resultant electrical signal, known as a motor unit action potential, travels along the 
membranes of all the corresponding muscle fibres simultaneously triggering the 
contraction mechanism (Winter, 2005). Muscles that control large, powerful movements 
of the body therefore contain motor units made up of thousands of fibres and muscles 
that control small, precise movements will contain motor units of tens of fibres. It is the 
combined electrical signal from many neighbouring motor unit action potentials that can 
be detected in EMG. 
 
In addition, different muscles in the human body adopt different muscle fibre alignments 
determined by the muscle pennation angle: the angle between the line of the muscle 
fibres and the line of force that the muscle exerts upon contraction. At this stage it 
becomes convenient to use the term fascicle (bundles of fibres), rather than fibre, as the 
base unit of contraction in the muscle model. This is for two reasons: firstly, fascicle 
lengths are more typically reported in the literature as they are more easily identifiable 
using conventional imaging techniques; and secondly, muscle fibres do not run the full 
width of the muscle to connect internal tendon to internal tendon but a number of fibres 
may be joined end to end along the length of a fascicle. However, for the purposes of 
large scale muscle models, the terms fibre and fascicle are used interchangeably and refer 




Figure 2.3 – Simplified muscle morphology. The muscle originates and inserts at the ends of the 
external tendons giving a horizontal muscle line of action. Muscle fascicles run in parallel between 
the two internal tendons (aponeuroses) at a pennation angle α to the muscle line of action. 
 
Each alignment gives a different contraction characteristic to the muscle. Typically, the 
smaller the pennation angle, the longer the fascicles and hence the greater number of 
fibres that are in series which increases both the maximum possible change in length of a 
muscle belly (the excursion) and the contractile velocity of the muscle. Due to volumetric 
constraint, muscles with large pennation angles have short fibres but have space to pack 
more side by side. This gives a reduced excursion range but with more fibres able to 
contract in parallel the muscle is able to exert a much greater force. The physiological 
cross-sectional area of a muscle, a combination of muscle size with architectural 
alignment (Equation 2.4), is therefore the only muscle parameter that is directly 










where:     PCSA is physiological cross-sectional area 
      Vm is muscle volume 
     θ is pennation 
     Lf is fascicle length 
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Finally, it is necessary to consider the passive stretch of the tendons to which the muscles 
are connected in series. These are usually modelled as a series spring-type element in a 
muscle model. The resultant mechanical behaviour of human muscle is therefore driven 
by the sliding filament contraction mechanism and influenced by a combination of muscle 
architecture, fibre type and the passive mechanical response of the tendons. In order to 
analyse and simulate models of the musculo-skeletal system it is therefore necessary to 
construct a mathematical representation of this muscular-tendinous contraction unit 
which, as the name suggests, is made up of two constituent parts: the muscle belly is 
solely responsible for the active component of muscle action as well as contributing to the 
passive stretch; and the tendon is only a passive structure. 
 
Most modern muscle models are variations on the classic Hill-type model first proposed in 
a number of publications by Hill, Wilkie and Ritchie in the 1930-50s and conveniently 




Figure 2.4 – Hill-type muscle model. LMT is the musculo-tendinous unit length. The muscle belly is 
represented by a contractile element (CE) that is a function of activation (a), fibre length (L
M
) and 
fibre contraction velocity (V
M
), and a passive elastic element (PEE). The tendon is represented by a 
series elastic element (SEE) of length L
T
. α is the pennation angle, the angle between the contractile 
element of the muscle and the line of action of the musculo-tendinous unit. F
T
 is tendon force which 
is equal to the net force of the musculo-tendinous unit. 
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The muscle belly is modelled by two elements in parallel. The contractile element (CE) 
represents the active component of the musculo-tendinous unit and the passive elastic 
element (PEE) represents the muscle belly’s resistance to passive stretch. These elements 
both act at an angle α (the pennation angle) to the line of action of the whole musculo-
tendinous unit. The series elastic element (SEE) represents the tendon’s resistance to 
passive stretch and this acts in parallel to the line of action of the whole musculo-
tendinous unit. As the force generated by the contractile component is a function of 
fascicle contraction velocity (as well as activation and fascicle length), the passive 
component of the CE/PEE complex is sometimes represented by a spring/damper 
mechanism. Figure 2.5 shows a typical parameterisation method often used to represent 




Contractile Element (CE) 
Force-Length Curve 
 
A series of isometric force 
curves (FA) for each 
activation over a range of 
muscle lengths (LM) 
(b) 
Contractile Element (CE) 
Force-Velocity Curve 
 
A force curve (FV) for a 
single muscle activation 
(FA) over a range of muscle 
contraction velocities (VM) 
 
(c) 
Passive Elastic Element (PEE) 
Force-Length Curve 
 
Muscle belly passive 
stretch force curve (FP) 
over a range of muscle 
lengths (LM) 
(d) 
Series Elastic Element (SEE) 
Force Length Curve 
 
Tendon passive stretch 
force curve (FT) over a 
range of tendon lengths 
(LT) 
Figure 2.5 – Hill-type muscle model curves. 
Parameters: 
F0 maximum isometric force of the muscle    Vs maximum muscle shortening velocity 
LMo optimal (resting) muscle length     LTS tendon slack length (Hoy et al., 1990) 
 
The parameters and shape factors chosen to represent these curves determine the 




2.1.3. Calculating Muscle Forces 
If reliable measures of muscle activations can be obtained and muscle morphology is 





F  a PCSA T  
 
where:   F is muscle force (N) 
   a is muscle activation  
   PCSA is muscle physiological cross-sectional area 
   T is specific muscle tension of human skeletal muscle tissue 
      (typically 22.5N/cm2 – Lieber & Fridén, 2000) 
 
However, there are two principal obstacles that prevent the calculation of muscle 
activations from EMG (step 1, Figure 2.2). Firstly, for a complex model such as that shown 
in Figure 2.1(b) it is not possible to obtain EMG from all the muscles. This is because there 
are too many muscles for this to be a practical task and the electrical signals of some 
muscles can only be detected with needle electrodes which are undesirable in movement 
studies. Secondly, even if it were possible to obtain EMG from all the muscles there is also 
a problem of processing these signals to give a quantitative value of muscle activation 
(zero = no activation, 1 = maximum activation) or force. This is often achieved by 
normalising the signal amplitude to previously collected maximum voluntary contraction 
levels (Lloyd & Besier, 2003; Potvin & Brown, 2004) but such methods can be unreliable 
for subjects with upper motor neurone problems, such as cerebral palsy, for whom a 
maximum voluntary contraction may produce sub-maximal muscle contractions and/or 
force measurements may be confounded by co-contraction of neighbouring muscles 
(Stackhouse et al., 2005). 
 
In reality, even if muscle forces are calculated accurately from EMG signals, the model 
kinematics produced from a forward dynamic simulation are unlikely to match the original 
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movement due to the cumulative errors generated from measurement inaccuracies, signal 
processing errors, rounding effects and the difficulty of double integration of potentially 
noisy data. For this reason full forward dynamic simulations are rarely carried out, but 
instead elements of forward dynamics, inverse dynamics and additional techniques are 
employed to calculate the parameters of interest. For example, as gait pathology in 
subjects with cerebral palsy can be caused by weak muscles and malformation of joint 
geometry, it is of interest to calculate and analyse the muscle forces and moments arms of 
this population. 
 
Joint angles and ground-reaction-forces can be measured using the motion capture and 
force-plate equipment of a gait laboratory (sections 2.4.1, 2.4.2), and inverse dynamics 
carried out to calculate the joint torques necessary for the movement of interest (steps 3, 
4, 5 in reverse, Figure 2.2, p.25). Working step 2 backwards to calculate muscle forces 
from joint torques however introduces the problem of static indeterminacy. The multiple 
muscles spanning each joint give rise to a large number of different muscle-force 
combinations that can produce the same overall joint torque and hence there can be 
more than one numerical solution. This can be overcome by employing iterative 
optimisation algorithms that converge to a single solution by maximising or minimising a 
specified cost function. One such algorithm, since termed Static Optimisation, was 
developed by Hardt (1978) – the name denoting the fact that each time frame is 
considered separately and so the movement is treated as a series of consecutive static 
poses (and hence musculo-tendon dynamics are ignored). One cost function (J) proposed 
by Crowninshield & Brand (1981) is based on the minimisation of muscle stress and is 




























where:    J is the cost function to be minimised 
    M is the total number of muscles 
    fm  is the force of muscle m    
    Am is the cross-sectional area of muscle m 
 
Davy & Audu (1987) proposed another algorithm called Dynamic Optimisation. Here the 
cost function to be minimised combines both a kinematic tracking error (the difference 
between the recorded motion and the motion generated by model muscle action) and the 
energy expenditure over the whole motion. Muscle energy expenditure is calculated by 
including a muscle model (a spring/damper complex) and hence musculo-tendon 
dynamics are included within the algorithm which has the advantage of ensuring that 
rates of change of muscle activation and hence force are limited to physiologically realistic 
levels. The disadvantage of the Dynamic Optimisation algorithm however is that, as each 
iteration is carried out over the entire motion rather than a single time frame, the 
computation time is significantly increased. Thelen et al. (2003) compared their computed 
muscle control algorithm (based on Static Optimisation) against Dynamic Optimisation for 
a three degree of freedom pedalling model and found the respective computation times 
were 10 minutes verses 120 hours. 
 
Static and dynamic optimisation algorithms may overcome the problem of static 
indeterminacy but they are only as good as the cost functions that they use. Davy & Audu 
(1987) described the cost function of Crowninshield & Brand (1981), shown in 
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Equation 2.6, as having one of the more realistic physiological justifications. Minimising 
energy expenditure is a likely analogue of the way a typically developing person may 
activate their muscles to coordinate complex movements. However, confidence in how 
appropriate these functions are for determining human muscle forces is lacking and 
validations for both typically developing and pathological individuals are needed. 
Modenese et al. (2011) investigated the change in muscle activation that resulted from a 
cost function (Equation 2.7) similar to Equation 2.6. 
 
















where:    J is the cost function to be minimised  
    M is the total number of muscles 
    fm  is the force of muscle m 
    fm,max  is the maximum potential force of muscle m 
    p is the user defined power of the cost function 
 
Within this mathematical construct, the parameter p can be considered as a synergism 
factor, for higher values of p will penalise high muscle activations and hence promote 
sharing of activation across all muscles. Modenese et al. (2011) carried out a series of 
musculo-skeletal simulations using a six segment, 3D, single lower limb model using the 
open source modelling software OpenSim (Delp et al., 2007). The simulation was driven by 
published kinematics and ground-reaction-forces during walking from a study of four 
arthroplasty patients with instrumented prostheses. A number of muscle force sets were 
calculated using Equation 2.7, varying the power p from 1 to 15. The hip contact forces 
that resulted from each force set were calculated and compared to the published 
experimental hip contact forces measured from the instrumented prostheses. Muscle 
forces were also compared to published EMG. Their results showed the best agreement 
between simulated hip contact forces and experimental data was found using linear 
optimisation (p=1) but the best qualitative agreement between simulated muscle force 
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and EMG required a quadratic synergism factor (p=2). Higher values of p produced over-
estimates of the hip contact forces due to increased antagonistic action promoted by 
higher muscle activation synergy. 
 
An alternative technique proposed by Kepple et al. (1997) allows some degree of muscle 
analysis without the need for individual muscle force data. Induced acceleration analysis 
involves calculating the instantaneous acceleration of model segments for a unit force 




Figure 2.6 – Induced acceleration analysis: (a) a unit force input to the gastrocnemius 
muscle of a 2D, four segment model: (b) typical instantaneous accelerations induced in the 
four segments of foot, shank, thigh, pelvis. 
 
Gmax = gluteus maximus, Hams = hamstrings, RF = rectus femoris 
Gas = gastrocnemius, TA = tibialis anterior 
 
The magnitudes of the resulting accelerations are arbitrary as the input is an arbitrary unit 
force rather than a proportionate value of a known muscle force and the body’s 
mechanical impedances to movement (e.g. other active/passive structures) are ignored. 
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However, it is the relative directions of the accelerations that are of interest as they can 
provide information about the contributions of each muscle for support and progression 
of the model. If the input forces are scaled to muscle physiological cross-sectional area 
then the relative magnitudes of the induced accelerations can also be compared. This 
process can be repeated for different muscles and for various times (different model 
poses) during the movement of interest. Many such analyses have been carried out which 
include investigations into normal walking (Hof & Otten, 2005; Kepple et al., 1997), 
cerebral palsy crouch gait (Arnold & Delp, 2005; Hicks et al., 2008) and tibial torsion (Hicks 
et al., 2007). Chen (2006) however showed that induced acceleration analysis can produce 
a variety of results depending on the degrees of freedom used in the model and hence 
called for the re-evaluation of this method in the analysis of muscle function in 
locomotion. However, this argument also implies that such an analysis will produce 
meaningful results if used on a model that matches the degrees of freedom of the real 
system under investigation. 
 
If the muscle forces necessary for a specific motion have been calculated by one of the 
optimisation methods described above then a technique known as perturbation analysis 
(Liu et al., 2006) can be used, like induced acceleration analysis, to determine the muscle 
contributions to support and progression. A unit force perturbation is applied to a single 
muscle and the forward dynamics simulation progressed for a small time period to 
calculate the accelerations on the body segments. This technique has the advantage over 
induced acceleration analysis that, as external and other muscle forces (both active and 
passive) are included in the simulation, the magnitudes of the accelerations actually 
describe the true accelerations of the model. However, this process is still reliant on the 
validity of the muscle forces used as input to the forward dynamic simulation. If the 
effects of muscle action on a specific kinematic parameter are of interest then an 
alternative perturbation analysis can be carried out where the force of a specific muscle is 
changed over a more prolonged time period during a forward dynamic simulation and the 
system response observed. Goldberg et al. (2004) used this technique to investigate stiff-
knee gait. They looked at the change in knee flexion velocity after each muscle of the 
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lower limb was given incremental strengthening and weakening perturbations during the 
double support phase of the gait cycle. 
 
There are currently a number of commercially available musculo-skeletal software 
packages – these include: the LifeMODTM system from The Biomechanics Research Group 
Inc., California; the AnyBody Modeling SystemTM from AnyBody Technology, Denmark; and 
SIMM (Software for Interactive Musculo-skeletal Modelling) from Musculographics Inc., 
California (Delp & Loan, 1995). However, in 2007, Simbios, the National Institutes of 
Health Centre for Biomedical Computation at Stanford University, released the open-
source software package OpenSim (Delp et al., 2007) which uses SIMM models for the 
analysis of dynamic simulations of movement. Simbios also hosts a web-based file 
exchange and discussion forum known as SimTK (tool kit) that allows the sharing of 
models, analyses and code. 
 
Due to the free, open-source nature of OpenSim its use has become widespread across 
the globe with interest from a number of leading international centres. For this reason 
there have been an increasing number of OpenSim human simulation studies appearing in 
the literature (as detailed in section 1.3) and SimTrack, the OpenSim workflow for 
generating muscle driven simulations of movement, is fast becoming accepted as an 
industry standard approach. However, there is little or no validation of the muscle 




2.2.1. OpenSim Introduction 
OpenSim is a freely available, user extensible software system that lets users develop 3D 
models of musculo-skeletal structures and create dynamic simulations of movement (Delp 




OpenSim uses a plug-in architecture that allows open-source third party tools to be used 
for some functionality and computational components such as dynamics engines, 
integrators, and optimisers to be updated as appropriate without extensive restructuring. 
The plug-in capability also allows users to extend the functionality by developing their 
own musculo-skeletal models, contact models, controllers, and analyses.  
 
 
Figure 2.7 – OpenSim graphical user interface. A number of musculo-skeletal 
models are shown: lower extremity, full body, neck, and upper extremity. 
 
OpenSim musculo-skeletal models are coded in Extensible Markup Language (XML). The 
models are built up from a number of rigid skeletal bodies, each assigned with appropriate 
inertial properties and degrees of freedom (DoFs) of movement to mimic the system 
under investigation (in this case, the human musculo-skeletal system). The inter-body 
joint constraints are therefore set by the degrees of freedom and each degree of freedom 
gives rise to a model coordinate parameter. Some joints can be highly constrained with 
only a single coordinate, for example a simple hinge ankle joint limited solely to 
flexion/extension, whilst others can be less constrained and therefore capable of more 
complex movements, such as a ball and socket hip joint being allowed to rotate around all 
three orthogonal axes giving flexion/extension, abduction/adduction and long axis 
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rotation. Usually, there are no translational degrees of freedom between body segments 
but one body (typically the pelvis) is given universal freedom relative to the ground to 
control the model’s global position and orientation. Muscles are then represented by 
actuator elements attached to specified points on the body elements and controlled by 
appropriate muscle models. 
 
A number of models have been published and are shared on the SimTK forum, four of 
which were suitable for use in this work as they were designed for the analysis of gait 
(Figure 2.8).  
 
    
(a) LEM (b) gait2354 (c) gait2392 (d) LLM10 
Figure 2.8 – Four OpenSim, lower extremity, human musculo-skeletal models. 
(a) LEM = lower extremity model - 20 DoFs, 88 Schutte actuators  
(b) gait2354 - 23 DoFs, 54 Thelen actuators 
(c) gait2392 - 23 DoFs, 92 Thelen actuators 
(d) LLM10 = lower limb model 2010 
      23 DoFs, 90 Schutte actuators and 6 Thelen actuators 
 
DoFs = degrees of freedom 
Schutte actuator = muscle model from Schutte et al. (1993) 
Thelen actuator = muscle model from Thelen (2003) 
(a-c) Delp et al. (1990), (d) (Arnold et al., 2010) 
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The lower extremity model, gait2354 and gait2392 were created by Darryl Thelen 
(University of Wisconsin-Madison) and Ajay Seth, Frank Anderson, and Scott Delp 
(Stanford University). The models feature lower extremity joint definitions taken from 
Delp (1990), low back joint and anthropometry from Anderson & Pandy (1999), and a 
planar knee model taken from Yamaguchi & Zajac (1989). The muscle models were 
parameterised using data collected from five cadaveric specimens from two studies 
(Friederich & Brand, 1990; Wickiewicz et al., 1983). These studies are described in more 
detail in section 3.2. Muscle strengths were determined using physiological cross-sectional 
area measurements from these studies but they were found to be weak when compared 
to the experimental data of Anderson & Pandy (1999). An inflated value of specific tension 
(61N/cm2) compared to the commonly accepted value for mammalian muscle (23N/cm2; 
Spector et al., 1980) was therefore used to compensate. However, this does raise 
questions over the validity of the other muscle data. More recently, in recognition of the 
limited sample size of these older studies, the Lower Limb Model (Arnold et al., 2010) was 
created to update the gait2392 model using anatomical data from the newer, 21 cadaver 
study of Ward et al. (2009). All four models have the same rigid body segments and 
degrees of freedom listed in Table 2.1 except the lower extremity model which has no 
torso body. 
 
It was necessary to choose one of these models for use in this work. The lower extremity 
model was not chosen because it lacked a torso segment and the inertial properties of a 
segment of high mass would have significant influence on the ground-reaction-force. 
 
The gait2354 model was not chosen as it was designed as a simpler version on the 
gait2392 model to reduce simulation time for teaching and presentation purposes and, 
with fewer muscle actuators than either the gait2392 or LLM10 models, the origins, 
insertions and moment-arms of true human musculature would be less closely matched. 
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12 Bodies 12 Joints 23 Degrees of Freedom 23 Coordinates 
torso back 
ball & socket joint 
with pelvis 






universal joint with 
external environment 
3 orthogonal translations 
3 orthogonal rotations 
model global position X, 
Y, Z, pelvic tilt, obliquity, 
rotation 
femur (L&R) hip 
ball & socket joint 
with pelvis (L&R) 
3 orthogonal rotations (L) 
3 orthogonal rotations (R) 





complex hinge type 
joint with femur (L&R) 
1 rotation/translation (L) 
1 rotation/translation (R) 
knee flexion (L&R) 
talus (L&R) ankle 
hinge joint with 
tibia/fibula (L&R) 
1 rotation (L) 
1 rotation (R) 




*hinge joint with 
  talus (L&R) 
*1 rotation (L) 
*1 rotation (R) 
*subtalar in/eversion 
(L&R) 
toes (L&R) MTP 
*hinge joint with 
  calcaneum (L&R) 
*1 rotation (L) 
*1 rotation (R) 
*toe flexion (L&R) 
Table 2.1 – OpenSim model degrees of freedom. Bodies, joints, degrees of freedom and corresponding 
coordinates for the OpenSim gait models listed in Figure 2.8. The complex hinge joint of the knee consists of 
both rotational and translational elements and is defined by Yamaguchi & Zajac (1989). L&R = exists for both left 
and right legs. MTP = metatarsal-phalangeal joint. 
 
* the OpenSim User Guide recommends that these joints are locked at neutral for simulations involving the 
Computed Muscle Control tool as there is not enough musculature in the model to adequately control their 
movement. This reduces the number of joints from 12 to 9 and the number of DoFs/coordinates from 23 to 19. 
 
It would have been preferable to use the LLM10 model over gait2392 as it was based on 
newer anatomical data from a larger study of cadavers, but LLM10 performed poorly in 
initial tests of computational time for calculating muscle forces over a single gait cycle. 
Using the same machine, the LLM10 simulation took 4.7 hours to run, whereas the 
gait2392 simulation took only 30 minutes. The difference in simulation time between 
these two similar models is likely to have been caused by the different muscle models that 
each one incorporated (as detailed in Figure 2.8). Longer processing time made the LLM10 
model impractical to use for multiple simulations and so the gait2392 model was selected 
for use in this work. 
 
 
2.2.2. The Gait2392 Model 
The gait2392 model has a mass of 75.16kg and a height of 1.8m. In addition to the 12 
body segment and 23 degrees of freedom listed in Table 2.1 the model also contained 92 
muscle actuators based on the Thelen (2003) model. Six actuators control torso 
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movement relative to the pelvis, and the remaining 86 are assigned to the lower limbs (43 
each side). The muscle actuators are string elements and typically a single actuator is used 
to represent each anatomical muscle; however, multiple actuators are used for the glutei 
and adductor magnus muscles to more accurately characterise their broad origins. 
Actuators for the right lower limb are listed below in Table 2.2 and a matching set also 
exists for the left side. 
 
 
muscle actuator corresponding muscle  muscle actuator corresponding muscle 
glut_max1_r   iliacus_r iliacus 
glut_max2_r gluteus maximus  psoas_r psoas 
glut_max3_r   quad_fem_r quadratus femoris 
glut_med1_r   gem_r sup/inferior gemellus 
glut_med2_r gluteus medius  peri_r piriformis 
glut_med3_r   rect_fem_r rectus femoris 
glut_min1_r   vas_med_r vastus medialis 
glut_min2_r gluteus minimus  vas_int_r vastus intermedius 
glut_min3_r   vas_lat_r vastus lateralis 
semimem_r semimembranosus  med_gas_r medial gastrocnemius 
semiten_r semitendinosus  lat_gas_r lateral gastrocnemius 
bifemlh_r biceps femoris long head  soleus_r soleus 
bifemsh_r biceps femoris short head  tib_post_r tibialis posterior 
sar_r sartorius  flex_dig_r flexor digitorum longus 
add_long_r adductor longus  flex_hal_r flexor hallucis longus 
add_brev_r adductor brevis  tib_ant_r tibialis anterior 
add_mag1_r   per_brev_r peroneus brevis 
add_mag2_r adductor magnus  per_long_r peroneus longus 
add_mag3_r   per_tert_r peroneus tertius 
tfl_r tensor fasciae latae  ext_dig_r extensor digitorum brevis/longus 
pect_r pectineus  ext_hal_r extensor hallucis longus 
grac_r gracilis    
Table 2.2 – 43 muscle actuators for the right lower limb in the gait2393 model 
 
 
The Thelen (2003) muscle model characterises the muscle response curves outlined in 
section 2.1.2 using the following equations. 
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where:  a is muscle activation 
  t is time 
  u is the idealised muscle excitation (ranging from 0-1) 
 

a (a,u) is an activation time constant that varies with activation 
 

act  is the activation time constant 
 

deact  is the deactivation time constant 
 
Three equations are used to characterize the muscle and tendon properties. The passive 
component of the muscle belly force-length relationship (the parallel elastic element) is 
represented by the exponential function Equation 2.9. 
 




















F PE  is the normalised passive muscle force  
 

kPE  is the exponential shape factor 
 











act(0.51.5a);        u  a
deact
(0.51.5a);     u  a
 ),( uaa  
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The active component of the muscle belly force-length relationship (the contractile 
element) is represented by the Gaussian function Equation 2.10. 
Equation 2.10  

f l  e







f l   is the active force-length scale factor 
 

L M  is the normalised muscle fibre length 
 

  is a shape factor 
 
The force-length relationship of the tendon (the series elastic element) is characterised by 
an exponential function for an initial non-linear toe region and a linear function at higher 















 is the transition tendon force between toe and linear regions = 0.33 
 

ktoe  is an exponential shape factor = 3 
 






 is the minimum tendon strain for linear behaviour 
 

klin  is a linear shape factor  
 














































T  F toeT ;     T   toeT
 





The muscle-tendon contraction dynamics are characterised by the force-velocity curve 
defined by Equation 2.12a,b. Parameter b varies dependent on whether the active muscle 




V M  (0.250.75a) Vmax
M F 



















 is the maximum muscle fibre contraction velocity 
  a is activation 
 

F M is the active muscle force 
 

f l   is the active force-length scale factor 
 






 is the maximum normalised muscle force for eccentric action 
 
During a simulation, these equations are numerically integrated alongside the equations 
of motion to calculate time varying actuator activations and fibre lengths. 
 
Finally, the pennation angle of the fibres in each muscle are incorporated within the 
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L T  is the normalised tendon length 
 

L MT  is the normalised musculo-tendinous unit length 
 

L M  is the normalised muscle fibre length 
 

M  is the muscle fibre pennation angle 
 
A graphical representation of these equations is shown in Figure 2.9. 
 
 
Figure 2.9 – Example Thelen (2003) muscle model curves 
(a) The active (contractile element) and passive (parallel elastic element) forces-length relationship of the 
muscle belly component of the muscle model. The active curve represents the response for a single 
level of activation. Total muscle belly force is given by combination of both the active and passive 
components. max_iso_force is the maximum isometric force of the muscle 
(b) The muscle belly force-velocity relationship for a single level of muscle activation. Shortening velocities 
(concentric action) are negative. 
(c) The passive (series elastic element) force-length relationship of the tendon component of the muscle 
model. The non-linear, toe region extends to a strain of 0.02 and a linear relationship continues at 
higher strains 
 
16 muscle parameters are used to fully characterise the Thelen (2003) muscle model in 
the gait2392 model. 12 of these parameters are common to all 92 actuators and four 
parameters are muscle specific (Table 2.3). 
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gait2392 model parameter Description Value Thelen Model  
max_isometric_force 
max. isometric muscle force 
used for normalisation 
m.s. n/a 
optimal_fiber_length 




resting tendon length used for 
normalisation 
m.s. n/a 
pennation_angle muscle fibre pennation angle m.s. 

M  
activation_time_constant activation time constant 0.01 

act  












max. muscle fibre contraction 
velocity at full activation 
10 n/a 
Vmax0 
max. muscle fibre contraction 
velocity at low activation 
5 n/a 
FmaxTendonStrain 



















passive muscle belly 





passive damping in the force-
velocity relationship 
0.05 n/a 
Af force-velocity shape factor 0.3 

A f  
Flen 
max. normalised muscle force 






Table 2.3 – Gait2392 muscle actuator parameter names, descriptions, values and their 
Thelen (2003) muscle model equivalents. m.s. = muscle specific 
 
 
2.2.3. SimTrack - Calculating Muscle Activations in OpenSim 
SimTrack (Delp et al., 2007) is the OpenSim tool for generating muscle driven simulations 
of movement. It is a four step process (Figure 2.10) that requires a musculo-skeletal model 
(e.g. gait2392), experimental kinematics and experimental ground-reaction-force data as 
inputs. These datasets are usually obtained from a motion capture system following a 





Figure 2.10 – SimTrack: the four step process in OpenSim for generating a muscle driven simulation 
from motion capture data. 
 
There are two ways in which movement data from a motion capture system can be 
imported into OpenSim. Firstly the joint coordinate data for each time frame can be 
supplied directly as an input to the model. However, as these joint coordinates are 
calculated from biomechanical models run within third party software, incompatibilities 
may exist between these models and the model being used within OpenSim, resulting in 
an incomplete or erroneous set of coordinates. 
 
The second method requires the OpenSim Inverse Kinematics tool to calculate the 
necessary joint coordinates using the trajectories of the motion capture markers. For 
clarity, the markers used in motion capture will be referred to as experimental markers 
and the markers attached to the OpenSim model will be referred to as virtual markers. 
This technique avoids the problem of incompatibility of models but it is reliant on a 
carefully chosen marker set and weightings to ensure that the Inverse Kinematics tool is 
able to accurately reconstruct the original movement. For this project, motion capture 
was performed using a combination of the standard gait2392 marker set and the Vicon 
Plug-in-Gait marker set, as described in section 2.4.1. This allowed the experimental 
marker trajectories to be directly compatible with the virtual markers attached to the 
gait2392 model and also allowed kinematics and kinetics to be calculated independently 
by running the standard Plug-in-Gait model in the motion capture software. The 
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kinematics generated by the OpenSim Inverse Kinematics tool could then be checked by 
comparison. 
 
OpenSim is not able to read the binary C3D data file format output by the motion capture 
system and so file conversion was necessary before running SimTrack. A number of 
Matlab scripts (The MathworksTM, MA, USA) are available for download from the online 
SimTK resources depository for this purpose. Three sets of scripts were evaluated for their 
suitability to the Guy’s Hospital Gait Laboratory setup and the Gait Extraction Toolbox 
(Dorn, 2008) was selected for use. The following binary to ASCII file conversions were 
carried out: 
 
Standing trial C3D file converted to: 
*.trc file – 3D trajectory data for the experimental markers (120Hz) 
*coordinates.mot file – Vicon model joint angles and ground-reaction-force (120Hz) 
 
Walking trial C3D file converted to: 
*.trc file – 3D trajectory data for the experimental markers (120Hz) 
*coordinates.mot file – Vicon model joint angles and ground-reaction-force (120Hz) 
*kinetics.mot file – ground-reaction-force data (1080Hz) 
*EMGSet.mot file – EMG data channels 1-16, raw and processed (1080Hz) 
 
SimTrack Step 1 – Scaling 
The Scale tool resizes the generic model to match the size of the subject. There are three 
phases in the scaling process. The first stage scales the size of each of the model’s body 
elements based on either manual scaling factors or scaling factors calculated from the 
ratio of the distances between experimental and virtual marker pairs from the static trial. 
For example, the torso body can be scaled in all three orthogonal axes by the ratio of the 
experimental sacrum-to-head marker distance to the virtual sacrum-to-head marker 
distance. The model’s mass distribution will also be scaled to the subject’s weight. In the 
second stage the Inverse Kinematics tool is run to place the scaled model in the standing 
pose (Figure 2.11) to match experimental marker positions (with user defined weightings) 
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and/or directly input coordinates. In the final stage selected virtual markers are then 
moved to match the positions of the experimental markers. This allows the position of the 
virtual markers to be corrected to the positions actually used during motion capture which 
should allow better motion tracking in the subsequent dynamic inverse kinematics. 
 
   
(a) (b) (c) 
Figure 2.11 – OpenSim SimTrack Step 1 - Scaling 
(a) markers on the subject in the standing pose 
(b) marker trajectories in motion capture software 
(c) OpenSim model standing pose after scaling but before marker adjustment 
(experimental markers blue, virtual markers pink) 
 
SimTrack Step 2 – Inverse Kinematics (IK) 
The Inverse Kinematics tool determines a set of coordinates to position the model in a 
specific pose for each time frame (Figure 2.12). The coordinates are calculated using 
weighted least squares optimisation (Equation 2.14) to minimise marker error (the 
distance between virtual and experimental markers) and/or coordinate error (difference 
between OpenSim coordinates and input coordinates) to track a set of marker trajectories 
and/or input coordinates from motion capture. The final motion can be very sensitive to 




















E sq  is the squared error 
 












 is the 3D position of the ith virtual marker 
 

















Figure 2.12 – OpenSim SimTrack Step 2 – Inverse Kinematics 
(a) marker trajectories in the motion capture software 




SimTrack Step 3 – Residual Reduction Algorithm (RRA) 
The Residual Reduction Algorithm is used to reduce the dynamic inconsistencies that 
result from the imperfect matching of the experimental kinematics and kinetics. These 
arise from inaccuracies in the measurement of size and weight of the subject, as well as 
inaccuracies and noise that arise in motion and ground-reaction-force data collection and 
processing. The dynamic inconsistency exists in the form of a mismatch (the residual force 
in Equation 2.15) between the ground-reaction force and the model inertia. An analogous 





F grf  mT g  mia i 
i1
bodies




F grf  is the measured ground-reaction-force 
 

mT  is the total mass of the subject 
 

g  is the acceleration due to gravity 
 

mi  is the mass of the i
th body segment 
 

a i  is the linear acceleration of the i
th body segment 
 

F residual is the residual force necessary to balance the equation 
 
The Residual Reduction Algorithm is a form of forward dynamic simulation which 
calculates the joint torques necessary for the model to propel itself to track the motion 
determined by Inverse Kinematics. All the muscle actuators are replaced by ideal joint 
actuators (known as reserves), one for each coordinate, and six residual actuators for the 
three global orthogonal forces and three global orthogonal moments (Fx, Fy, Fz, Mx, My, 
Mz). The forward simulation is run frame by frame optimising the reserves to produce the 
desired motion. Magnitudes of the residual actuators are then calculated to compensate 
for the difference between the inertial terms and the ground-reaction-force. After the first 
run of the algorithm the Mx and Mz residuals (anterior/posterior, medial/lateral leaning) 
are minimised by creating a new model with an adjusted torso centre of mass and the Fy 
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residual (vertical) is minimised by altering the model total mass. The algorithm can then 
be run for a second time using the new model and with limits on the magnitude of the 
residual actuators. This allows the dynamic inconsistencies to be reduced further but this 
time by forcing the kinematics to change. The limits imposed on the residuals therefore 
need to be chosen with care to ensure that kinematics do not change too severely. 
Recommended thresholds for residuals and kinematic tracking deviations to determine an 
“acceptable” walking or running simulation are provided by the OpenSim software 
developers (Table 2.4).  
 
Thresholds: Good OK Bad 
Max. residual force (N) 0-10 10-25 >25 
RMS residual force (N) 0-5 5-10 >10 
Max. residual moment (Nm) 0-50 50-75 >75 
RMS residual moment (Nm) 0-30 30-50 >50 
Max. translation error (cm) 0-2 2-5 >5 
RMS translation error (cm) 0-2 2-4 >4 
Max. rotation error (°) 0-2 2-5 >5 
RMS rotation error (°) 0-2 2-5 >5 
Table 2.4 – Acceptability thresholds after running the Residual 
Reduction Algorithm for residuals and kinematic tracking 
position errors. Data taken from the OpenSim 2012 User Guide 
 
However, from the perspective of clinical gait analysis, some of these thresholds are 
arguably too high (too lenient). Let us examine the maximum thresholds of the “Good” 
category. The peak vertical/anterior/medial ground reaction forces in normal gait for a 
typical adult (70kg) would be approximately 750N/170N/35N (1.1/0.25/0.05 x body 
weight – Wearing et al., 2000) and so a maximum residual force of 10N is small (1.3%) in 
comparison to the vertical component, but starts to become proportionally larger (5.9% 
and 28.6%) if applied in the anterior and medial directions. A maximum residual moment 
of 50Nm however is a very large turning force to be applied globally to the model. It is 
equivalent to holding a 10kg weight at arm’s length (0.5m) away from our body – a task 
few people could physically achieve. Allowing such a large correction to a simulation 




Maximum translation errors of the model are given an acceptability threshold of 2cm in 
the “Good” category. Again this limit is high compared to the acceptance limits of marker 
position error typically used for quality assurance testing of motion capture equipment in 
clinical gait laboratories (c.2mm). If the maximum joint rotation error is maintained below 
2° as advised however, then the changes in model joint kinematics that result from these 
errors may be acceptable. Error propagation into the calculation of kinetics may be more 
problematic however as a translational shift of the model will alter the point of application 
of the ground reaction force (as there will be a relative movement between the model and 
the experimental ground reaction force’s centre of pressure). There is little published 
research on the necessary accuracy of force-plate data in clinical gait analysis but some 
unpublished work by the author examined the changes to kinetic data as a result of 
artificially imposed force-plate errors. An acceptable change in kinetics was classified as a 
RMS difference less than 0.5 standard deviations of the gait laboratory’s control dataset. 
Following this criteria the limit of a force-plate’s centre of pressure error was calculated to 
be 20mm. It would appear therefore that the OpenSim User Guide recommended 2cm 
threshold for maximum translational error is appropriate, but certainly the thresholds for 
both the “OK” and “Bad” categories are likely to allow significant errors in the calculation 




SimTrack Step 4 – Static Optimisation or Computed Muscle Control 
As discussed in section 2.1.3 various techniques have been proposed to overcome the 
problem of static indeterminacy when calculating muscle forces from joint moments and 





First proposed by Hardt (1978), Static Optimisation is a technique for resolving net joint 
moments into muscle forces by considering each time frame individually. A movement is 
therefore treated as a series of consecutive static poses and hence activation dynamics 
and most elements of musculo-tendon dynamics are ignored. The Static Optimisation tool 
within OpenSim first carries out an inverse dynamics step to calculate net joint torques 
from experimental kinematics and ground-reaction-forces. A set of muscle activations, 
dependent on the muscle-activation-to-force condition, are then calculated which will 
generate these joint torques. The static indeterminacy of this calculation is overcome by 
use of a cost function (Equation 2.16) that finds a solution to minimise the sum of all 
muscle activations raised to a user defined power.  









where: J is the cost function 
 n is the total number of muscle actuators 
 am is the activation of the m
th muscle actuator 
 p is the user defined power (typically p=2) 
 
The Static Optimisation tool within OpenSim offers two alternative muscle-activation-to-
force conditions. The first condition (the “non-physiological” case: Equation 2.17) replaces 
the muscle model with unconstrained ideal force generators and so all elements of 
musculo-tendon dynamics are ignored. The second condition (the “physiological” case: 
Equation 2.18) imposes a simplified version of the muscle model (described in section 
2.2.2) by only considering the active component of this model (the tendon is made 
inextensible and the parallel elastic element is ignored). The muscle actuators are 
therefore only constrained to follow the appropriate active force-length-velocity curves.  
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where: n is the total number of muscle actuators 
 am is the activation of the m
th muscle actuator at a discrete time step 
 
0
mF  is the maximum isometric force of the m
th muscle actuator 
 lm is the length of the m
th muscle actuator 
 vm is the shortening velocity of the m
th muscle actuator 
  mmm vlFf ,,0  is the force-length-velocity surface of the mth muscle actuator 
 rm,j is the moment arm of the m
th muscle actuator about the jth joint axis 
 τj is the generalised moment acting about the j
th joint axis 
 
In the muscle model of this second condition the pennation angles of the muscles are 
constant and the tendon is fixed at the tendon slack length. Therefore, as can be seen 
from Equation 2.13, the muscle fibre length can be directly calculated from the musculo-
tendinous length, and hence from the angle(s) of the joint(s) that the muscle crosses – the 
input kinematics. No reference is made in the OpenSim user-guide however on how the 
Static Optimisation tool determines muscle fibre velocity and so it can only be assumed 
that it is calculated from the current and previous frame muscle fibre lengths. If this is 
correct then it is not truly a static process. It also follows therefore that if the Static 
Optimisation tool is run on a single frame of data alone, the fibre velocity has to be 
assumed to be zero. 
 
The suitability of such a cost function (Equation 2.16) for the predication of human muscle 
activity during gait is discussed in a number of papers. Crowninshield & Brand (1981) 
describe how early cost functions were chosen more for ease of implementation rather 
than for their physiological validity and justified their choice of cost function (similar to 
Equation 2.16) by describing it as an analogue to maximum muscle endurance. 
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A number of criticisms however, summarised succinctly by Anderson & Pandy (2001), have 
been made against the use of static optimisation algorithms for the estimation of in-vivo 
muscle forces during gait – these include: the reliance on potentially inaccurate 
experimental kinematics and, due to the time-independent nature of the technique, the 
difficulty of incorporating muscle physiological properties or muscle coordination 
principles into the algorithm. However, as the title of their article suggests, they go on to 
show that for normal gait, static and dynamic optimisation solutions are practically 
equivalent. 
 
The review article of Erdemir et al. (2007) points out that despite the use of static 
optimisation techniques in research for a number of decades, none of these methods have 
been successfully translated into clinical practice due to the ever present difficulty of 
validating these simulated muscle forces, especially in pathological populations.  
 
Computed Muscle Control 
An alternative method for calculating muscle forces from joint moments is the Computed 
Muscle Control algorithm first proposed by Thelen et al. (2003) and subsequently updated 
(Thelen & Anderson, 2006). This also makes use of the Static Optimisation algorithm to 
determine muscle activations but added into the optimisation loop is a proportional 
derivative feedback control to track experimental kinematics and a forward dynamics step 
to enable activation and contraction dynamics to be included in the calculations (Figure 





Figure 2.13 – OpenSim SimTrack Step 4 – a schematic showing the Computed Muscle Control algorithm 
applied to gait. Errors between simulated and experimental joint angles and joint angle velocities are used 
in a feedback loop in the calculation of the desired joint accelerations necessary to track the experimental 
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  is the desired jth coordinate acceleration 
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t  is the time 
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T  is the integration time step (typically 
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There are a number of distinct stages within the Computed Muscle Control optimisation 
loop that are described below: 
 
The initial states of the model (joint angles, velocities, accelerations) are set to the 
experimental kinematics. The desired accelerations are then calculated from the 
experimental accelerations modified by previous frame (t - T) simulated position and 
velocity errors (Equation 2.19). Clearly, it is not possible to calculate previous frame 
simulated data for the first frame (t = 0) and so no feedback is used for the initial state. 
For this reason, muscle states (activations and fibre-lengths) are typically out of 
equilibrium and simulated muscle forces can change dramatically during this initial time 
interval. It is therefore recommended that the Computed Muscle Control algorithm is 
started at least 0.03 seconds (3 time steps) before the interval of interest. 
 
The modification of experimental accelerations to give desired accelerations is carried out 
with a proportional derivative control (Equation 2.19), so called because the feedback is in 
proportion to the position error and the velocity error (the derivative of position). Values 
of the feedback gains are chosen to drive the errors to zero in a critically damped fashion. 
 
Static optimisation is used to overcome static indeterminacy (section 2.1.3) and to 
compute a set of muscle excitations and hence the forces that will drive the body 
segments to produce these desired accelerations. Two formulations of the static 
optimisation cost function are offered in the Computed Muscle Control tool, both similar 
to Equation 2.16. The first formulation, the “slow target” (Equation 2.20), contains two 
terms: the first is the sum of squared muscle excitations, and the second is a weighted 
sum of squared joint acceleration errors. When the cost function is minimised therefore 
the first term will minimise and distribute excitations across the muscles, and the second 
term will drive the model towards the desired accelerations.  
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where: J is the cost function 
 n is the total number of muscle actuators 
 xi is the excitation of the i
th muscle actuator 
 m is the total number of coordinates 
 wj is p is the user defined power (typically p=2) 
 
des
jq  is the desired j
th coordinate acceleration 
 jq  is the simulated j
th coordinate acceleration 
 
The second formulation of the cost function, the “fast target” (Equation 2.21), replaces 
the tracking term of the slow target with a set of equality constraints that require the 
desired accelerations to be achieved within a set tolerance. 
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where: J is the cost function 
 n is the total number of muscle actuators 
 xi is the excitation of the i
th muscle actuator 
 Cj is the equality constraint for the j
th coordinate 
 
The main difference between these two formulations therefore is that the fast target is 
faster (computationally) and will ensure good tracking except where muscles are not 
strong enough to generate an appropriate acceleration, in which case the algorithm will 
fail. The slow target on the other hand is slower, but muscle “weakness” will manifest as a 
tracking error rather than causing the algorithm to fail. 
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The OpenSim user-guide does not explicitly define the muscle-model used in the static 
optimisation stage of Computed Muscle Control. It can only be assumed therefore that it 
is the same simplified version of the muscle model as described for the Static Optimisation 
tool – with an inextensible tendon and ignoring the parallel elastic element. It is important 
to note however that the output variable in both of these formulations of static 
optimisation cost functions is muscle actuator excitation, rather than activation as used in 
the Static Optimisation tool. Inverse muscle activation dynamics (Equation 2.8) must 
therefore be included in the static optimisation stage of Computed Muscle Control. 
 
Finally, in the last stage of Computed Muscle Control, the muscle excitations calculated 
from static optimisation are used in a standard forward dynamics simulation (see section 
2.1.1). Again it is not explicitly stated in the OpenSim user-guide but it is assumed that the 
full muscle model (described in section 2.2.2) is used for this process. Once the coordinate 
accelerations are calculated from the muscle model, the equations of motion are 
integrated over a user-defined time step (typically 0.01s) using a 5th-order Runge-
Kutta-Fehlberg integrator to calculate coordinate velocities and positions. These are then 
used in the proportional derivative feedback loop to various stages within the Computed 
Muscle Control workflow. Foot-floor forces during this forward simulation are set to the 
experimental values of the ground-reaction-force.  
 
During Computed Muscle Control the same residual and reserve actuators used during the 
Residual Reduction Algorithm are added to the model in addition to the muscle actuators. 
These extra actuators enable the simulation to maintain kinematic tracking in case the 
muscle actuators have insufficient strength to generate the necessary accelerations. If the 
limits placed on the maximum magnitude of these residual/reserve actuators are too 
tight, they may not be able to make up any force/moment deficit caused by muscle 
actuator weakness and the simulation may fail to track the experimental kinematics. 
However, if the residuals/reserves are allowed to become too large then their action may 
dominate and the validity of the muscle actuator action may be reduced. 
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Once again the OpenSim software developers provide a rule of thumb guide to 
residual/reserve acceptability thresholds (Table 2.5) during walking and running 
simulations.  
 
Thresholds: Good OK Bad 
Max. residual force (N) 0-10 10-25 >25 
RMS residual force (N) 0-10 10-25 >25 
Max. residual moment (Nm) 0-50 50-75 >75 
RMS residual moment (Nm) 0-30 30-50 >50 
Max. translation error (cm) 0-1 1-2 >2 
RMS translation error (cm) 0-1 1-2 >2 
Max. rotation error (°) 0-2 2-5 >5 
RMS rotation error (°) 0-2 2-5 >5 
Max. reserve (Nm) 0-25 25-50 >50 
RMS reserve (Nm) 0-10 10-25 >25 
Table 2.5 – Acceptability thresholds after running the Computed 
Muscle Control algorithm.for residuals/reserves and kinematic tracking 
position errors. Data taken from the OpenSim 2012 User Guide 
 
Examining the maximum values in the “Good” category, many of the thresholds are the 
same as those discussed above for the Residual Reduction Algorithm tool. The maximum 
allowed translational error however has reduced from 2cm to 1cm which may be more 
appropriate when considering that a 20mm shift in the ground reaction force’s centre of 
pressure can begin to produce significant changes in joint kinetics. An additional 
parameter that requires discussion here however is the maximum threshold for a reserve 
joint actuator – a joint torque that can be applied to any model degree of freedom to 
ensure kinematic tracking. The threshold of 25Nm is a large torque to be applied to any 
joint (equivalent to holding a 5kg weight at an arm’s distance of 0.5m) and so, rather 
contradictorily, the OpenSim User Guide also recommends that peak reserve actuator 
torques should be kept below 10% of the expected peak joint torque. Example 10% 
thresholds for a 70kg adult are shown in Table 2.6 calculated from peak joint torques 
during walking for typically developing adult male subjects (Winter, 2005; p.200). These 
thresholds give a much tighter limit on acceptable peak reserve actuator torques 










hip extension 1 70 7 
hip abduction 1 70 7 
hip rotation 0.2 14 1.4 
knee extension 0.6 42 4.2 
ankle plantar-flexion 1.9 133 13.3 
Table 2.6 – Peak joint torques (normalised to body weight) 
during walking for typically developing adult males (Winter, 
2005) and the corresponding peak joint torques for a 70kg 
adult with 10% CMC reserve actuator thresholds.  
 
Judging whether or not a Computed Muscle Control simulation was “successful” (i.e. 
having confidence in the simulated muscle activations) must therefore involve a check of 
both the kinematic tracking and the magnitude of the residuals/reserves. Kinematic and 
kinetic tracking is regularly reported in the literature for studies using the Computed 
Muscle Control algorithm but there is often a lack of information regarding the associated 
residuals/reserves values. This makes it difficult for a researcher to evaluate the quality of 
published musculo-skeletal simulation data. 
 
A number of limitations in the use of the Computed Muscle Control algorithm are 
described by Thelen et al. (2003). Firstly, the authors highlight the fact that CMC can only 
optimise to performance criteria that can be evaluated in an instant of time, and not 
global measures such as metabolic energy expended over the whole task which may be 
more appropriate for investigations into pathological movement. Secondly, the authors 
acknowledge that, as Computed Muscle Control is a tracking algorithm rather than a 





2.3. Gait Analysis 
Gait analysis is the systematic study of animal locomotion and generally focuses on the 
walking of humans. The review articles of Sutherland (2001) and Baker (2007) detail the 
progression of gait analysis from the early methods (based purely on human observation 
through various ingenious photographic techniques) to the modern gait analysis 
laboratory, which typically combines digital cameras, motion capture systems, force-
plates and electromyography to record a great many different movement parameters, 
including body segment motion, joint forces and muscle activity. 
 
2.3.1. Gait Cycle 
Walking is the repetitive action of placing one foot in front of the other in order to achieve 
forward motion (and to support against gravity) and as a cyclical process analysis usually 
focuses on the gait cycle – the repeating unit within the action of walking. The gait cycle 
was first described by Gaston Carlet in 1872 (Baker, 2007) and is defined as the events 








Specific events that occur at instantaneous points during walking are used to define the 
gait cycle. It begins at 0% with initial contact of the foot with the ground and ends at 100% 
after two steps (one stride) when the same foot makes initial contact again. The period of 
time during which the limb of interest (ipsilateral limb) is in contact with the ground is 
termed the stance phase and off the ground is the swing phase. The event that divides 
these two phases is known as foot off which typically occurs at approximately 60% of the 
gait cycle. Initial contact and foot off are alternatively known as heel strike and toe off but 
these terms can be misleading when describing a non-standard gait pattern. The gait cycle 
for the other (contralateral) limb is identical but shifted in time by 50%. This gives two 
periods of double support (both limbs in contact with the ground) in the gait cycle at 
0-10% and 50-60%. The middle 40% of the stance phase is therefore the single support 
period that corresponds to the swing phase of the contralateral limb. During the stance 
phase of normal walking, the movement of the foot relative to the ground is analogous to 
a wheel-like rolling motion which Perry (1992) described in terms of three rockers. 
Additionally, Perry coined a number of more descriptive time periods that she related to 
specific changes in muscle activity. These time periods are described below in terms of the 
joint kinematics (position, velocity, acceleration) along with what is generally believed to 
be the corresponding muscle actions (Gage & Schwartz, 2009b). 
 
Loading Response (first period of double support) 
This period begins with the 1st foot rocker (the heel rocker), the motion of the foot 
immediately after initial contact when only the heel is in contact with the ground. The 
ground-reaction-force, lying posterior to the ankle, drives the mid/forefoot flat to the 
floor, controlled by the eccentric (activation whilst lengthening) action of the dorsiflexor 
muscles. During this time, body weight is transferred onto the ipsilateral limb. The knee is 
controlled by eccentric action of the vasti group and glutei/abductors are active to control 
the hip and pelvis. 
 
Mid-Stance (first half of single support) 
This period corresponds to the 2nd foot rocker (the ankle rocker) when the tibia hinges 
forward over the stationary foot controlled by eccentric action of the plantarflexors. 
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During this time the origin of the ground-reaction-force moves forwards at the foot and 
the line of action moves in front of the knee and behind the hip, stabilising both joints and 
allowing both sets of extensor muscles to relax.  
 
Terminal Stance (2nd half of single support) 
This period corresponds to the 3rd foot rocker (the forefoot rocker) when the combined 
action of the plantarflexor muscles stop the dorsiflexion movement of the tibia as it hinges 
forward over the foot and instead begins to raise the heel off the floor in concentric 
(activation whilst shortening) plantarflexion action. Tibialis posterior, peroneal and toe 
flexor action all contribute to stabilising the foot. The ground-reaction-force vector still 
runs in front of the knee and behind the hip, continuing its stabilising action on both of 
these joints. This calf muscle action in terminal stance provides a significant amount of the 
propulsive force necessary for walking (Neptune et al., 2001).  
 
Pre-Swing (2nd period of double support) 
During this period the ipsilateral limb is prepared for swing and correspondingly the 
contralateral limb responds to loading. The ground-reaction-force has moved to the 
forefoot and the vector now runs behind the knee leading to a strong external flexing 
moment. The gastrocnemius muscle now also begins to contribute to knee flexion as do 
the hip flexors through their action of flexing the hip. The knee therefore begins its rapid 
acceleration into flexion, and tibialis anterior action begins to lift the toes, both necessary 
for foot clearance in the swing phase. 
 
Initial Swing 
This period spans the time between foot off and when the ipsilateral limb has swung 
forward to pass the contralateral stance limb. At normal walking speed this pendulum-like 
movement occurs largely passively being driven by inertial forces and gravity. Tibialis 
anterior action dorsiflexes the ankle and prevents the toes catching the ground. 
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Mid Swing 
Muscle activity remains the same in this period and the ipsilateral limb swings forward 
past the contralateral stance limb. Tibialis anterior is still active but now is responsible for 
maintaining a neutral ankle posture against the external plantarflexion moment of gravity. 
 
Terminal Swing 
During this period the swinging limb is slowed down in preparation for initial contact. This 
is achieved principally by eccentric hamstring action which decelerates both hip flexion 
and knee extension. Tibialis anterior action maintains a neutral ankle posture in readiness 
for its eccentric action during loading response to prevent foot slap. 
 
However, this conventional understanding of lower-limb muscle action in normal gait has 
come under scrutiny from work using more advanced musculo-skeletal modelling 
techniques such as induced acceleration analysis. Many of these studies are summarised 
in the review article by Zajac et al. (2003). Neptune et al. (2001) recognised that 
conflicting conclusions on the role of the plantarflexors during gait were reported in the 
literature and identified three main theories: the plantarflexors (1) provide a controlled 
roll-off; (2) actively provide forward progression or push-off; and/or (3) accelerate the leg 
into swing. The authors suggested that the lack of consensus may have arisen from the 
monoarticular/biarticular mix of the triceps surae group which had not been delineated in 
these early studies as they were based on joint torques rather than individual muscle 
contributions. They therefore carried out a forward dynamics analysis using a 2D model 
with 30 muscle actuators developed in SIMM (MusculoGraphics, Inc., Illinois, USA) based 
on experimental kinematic data from five healthy male adult subjects. Their results 
showed that both the gastrocnemius and soleus support the trunk during the single-
support/pre-swing periods but contributions to forward progression were more complex. 
In early single-support the soleus and gastrocnemius both decelerate trunk progression; in 
middle single-support they have opposite effects with the soleus decelerating the leg and 
accelerating trunk progression (with the gastrocnemius opposing both); and in late single-
support/pre-swing the soleus accelerates trunk progression and the gastrocnemius 
accelerates leg progression (hence contributing to swing initiation). 
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Anderson & Pandy (2003) were interested in identifying other muscles that contributed to 
support during walking, particularly during early stance, and also to calculate the passive 
contribution made by the skeleton. Using a 3D model similar to the gait2354 model 
outlined in section 2.2.1, with additional ligament action to prevent anatomically 
unfeasible joint angles, they carried out a dynamic optimisation over a gait cycle using a 
cost function based on total metabolic energy divided by forward displacement of the 
centre of mass, and derived initial conditions from mean experimental data from five 
healthy adult male subjects. Contributions to support were then determined via 
decomposition of the resultant vertical ground-reaction-force. Muscles and ligaments of 
the ipsilateral limb were found to make the largest contribution to support accounting for 
50-95% of the vertical ground-reaction-force (with less than 15% from the contralateral 
limb). The passive transmission of force through the joints and bones in resistance to 
gravity accounted for 20-50% of support when the foot was flat on the ground but much 
less before foot flat or after heel off. A much smaller contribution to support came from 
inertial or centrifugal effects. 
 
At initial contact, support was generated by the contralateral plantarflexors and ipsilateral 
dorsiflexors but the contribution of the dorsiflexors stopped abruptly when the foot 
became flat to the floor. The first peak of the vertical ground-reaction-force was then 
principally generated by action of the gluteus maximus, the vasti, and the posterior 
gluteus medius/minimus. The force was maintained by the posterior gluteus 
medius/minimus, passive action of the skeleton and an increasing contribution from the 
anterior gluteus medius/minimus through mid-stance. This action diminished in late 
stance when support was taken over by action of the soleus and gastrocnemius to 
produce the second peak in the vertical ground-reaction-force, with the soleus action 
producing twice the support of gastrocnemius. Little contribution to support was provided 
by the hamstrings or rectus femoris. The authors acknowledge however that these results 
are only as good as the muscle forces generated by the simulation and they describe the 
simulated muscle excitation patterns as similar to those measured from the subjects 
(although no detail of EMG methodology is given). 
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Since the review article of Zajac et al. (2003), there have been many more studies in the 
literature looking at muscle coordination during walking in typically developing human 
subjects (Anderson et al., 2004; Arnold et al., 2005; Arnold et al., 2007; Hof & Otten, 2005; 
John et al., 2012; Jonkers et al., 2003; Liu et al., 2006, 2008; Neptune et al., 2004a, 2004b; 
Siegel et al., 2006; Xiao & Higginson, 2008). Other papers have focused on the muscle 
coordination involved in specific pathological gait patterns such as stiff knee gait 
(Goldberg et al., 2004), crouch gait (Correa et al., 2012; Hicks et al., 2008; Steele et al., 
2010) or jump knee gait (Correa et al., 2012). There is some agreement between the 
papers investigating muscle coordination of walking in typically developing human 
subjects (similar to the results of Anderson & Pandy, 2003) and discrepancies between 
them are a likely result of differences in modelling of the foot-ground interactions (Dorn 
et al., 2012). In terms of contributions to support, these discrepancies typically involve 
changes in the timing and relative magnitude of muscle contributions but not changes to 
the muscle function. The plantarflexor contribution to support in early stance is a good 
example: Neptune et al. (2001) showed that the soleus and gastrocnemius were the 
principal contributors to support for the whole of the single-support period and into pre-
swing, but Anderson & Pandy (2003) found that their contribution was limited to pre-
swing. Discrepancies between studies in terms of contributions to progression and 
medial/lateral accelerations can be more conflicting, with the same muscles shown to 
have opposite function in different studies. However, care must be taken in the 
interpretation of data from these techniques because, at present, few model predictions 
of muscle function have been validated as it is difficult to measure a single muscle’s 
contribution to the ground-reaction-force experimentally. Although some pioneering work 
in this area has been carried out by Stewart et al. (2007, 2008). 
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2.3.2. Gait Analysis Methods 
Many different types of gait analyses are possible. An experienced clinician may be able to 
identify gait deviations simply by watching the subject as they walk up and down – an 
observational gait analysis. 
 
This technique may be improved through the use of video which can then be slowed down 
and recorded from specific positions to give views of the motion in the anatomical planes. 
Quantitative scoring methods have also been developed for observational gait analysis 
such as the Physician’s Rating Score (Koman et al., 1993) and the Edinburgh Visual Gait 
Score (Read et al., 2003). 
 
A gait analysis will become instrumented if measurements are taken during walking. For 
example, a basic instrumented gait analysis might make use of a ruler and stop-watch to 
allow calculation of a few simple spatio-temporal parameters of the gait cycle such as 
cadence (number of steps per minute) and walking speed. 
 
Finally, with the use of more sophisticated equipment, such as force-plates, 3D motion 
tracking systems and electromyography, more advanced instrumented gait analyses are 
possible in which ground-reaction-forces, 3D joint kinematics (position, velocity, 
acceleration), 3D joint kinetics (turning moments and bone-on-bone forces) and the 
electrical activity of surface muscles can be measured. It is this type of gait data that has 
been used to inform and test the musculo-skeletal simulations performed in later 
chapters. The data was collected at the Guy’s Hospital Gait Laboratory, London. The data 
collection methodologies and equipment are described below. 
 
2.4. Data Collection Methods 
Ten adolescents with spastic diplegic cerebral palsy and ten typically developing control 
subjects were recruited following approval from the local Research Ethics Committee and 
the NHS Research & Development Office (Appendix A). The case subjects were selected 
from referrals to the Guy’s Hospital Gait Laboratory in London. Control subjects were 
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recruited from siblings of the case subjects or volunteers known to the research team. 
Example patient information sheets can be seen in Appendix B. 
 
Inclusion criteria for selection were: 
 all subjects aged between 10 and 22 years of age 
 all subjects to demonstrate an understanding of what they would be asked to do if 
they agreed to participate in the study 
 case subjects to have a diagnosis of spastic diplegic cerebral palsy 
 case subjects to be independently ambulant 
 
Exclusion criteria for selection were: 
 any subject unable to comply with the safety requirements of MRI (e.g. previous 
abdominal surgery without a post-operative x-ray or having cerebral aneurysm clips in 
place) 
 any case subject who has undergone any orthopaedic intervention to their lower limbs 
in the previous year 
 any control subject who has any known neurological condition or has had any previous 
orthopaedic intervention to their lower limbs 
 
A number of different datasets were collected in order to inform the musculo-skeletal 





Figure 2.15 – Summary of data collected in this project including dependencies between data sources. 
MRI = magnetic resonance imagery, EMG = electromyography 
 
Details of ultrasound and magnetic resonance imaging methods are described in section 
3.3. The clinical examination protocol can be seen in Appendix C. Height, knee/ankle 
widths and weight were measured using a wall-mounted stadiometer, joint callipers and a 
set of chair-scales respectively. Leg lengths were measured from the anterior superior iliac 
spine to the medial ankle malleolus using a tape measure.  
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An overview of the motion capture methodology is described here and further detail is 
given in sections 2.4.1 - 2.4.4 below. The principal pieces of equipment used during data 
collection in the gait laboratory were a 3D motion capture system, three force-plates 
embedded in the floor of a 10m walkway and a surface electromyography system. 
 
 Subjects dressed in shorts and t-shirt and were barefoot 
 Surface electromyography sensors were placed on nine muscles (Table 2.8) of one 
randomly selected leg 
 Motion capture markers were placed on the lower limbs, torso and head using a 
combined OpenSim and Helen Hayes maker set (Figure 2.19) 
 Motion capture was performed using a Vicon Nexus opto-electronic motion 
capture system (section 2.4.1) 
 A single static trail was recorded with the subjects standing stationary with both 
feet within the borders of one force-plate and with arms out-stretched to avoid 
obscuring markers 
 A number of dynamic walking trials were then collected with the subject walking 
the length of the 10m walkway. Walking was carried out at a self-selected walking 
speed and repeated until five trials with three sequential force-plate hits were 
obtained with the selected limb on the second plate. This provided full ground-
reaction-force data for an entire gait cycle for the selected limb. Joint kinematics 
and kinetics were calculated from marker trajectories using the Conventional Gait 
Model (section 2.4.1) 
 Synchronous collection of force-plate data (section 2.4.2) and electromyography 
data (section 2.4.3) was carried out during walking  
 Electromyography data was also collected during maximum voluntary contractions 
for appropriate muscles (section 2.4.4) 
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2.4.1. 3D Motion Capture 
Motion capture was carried out using a Vicon Nexus motion capture system (Oxford 
Metrics Group, Oxford, UK) with seven T-series cameras arranged around the 10m walk-
way (Figure 2.16). Vicon Nexus is an opto-electronic motion capture system that tracks the 




(c)  (b)  
Figure 2.16 – Vicon Motion Capture System 
(a) Vicon T-series motion capture camera 
(b) Calibration L-frame – five markers define two horizontal orthogonal axes (red and green) and the 
origin of the capture volume axis system. The third, vertical, axis (blue) is created orthogonal to the 
first two axes 
(c) The capture volume, as displayed in the Vicon Nexus software, showing the position of the seven T-
series cameras. The global axis system is marked in the lower left corner and the combined Helen 
Hayes and OpenSim lower limb & torso marker set can be seen in the centre (torso orange, pelvis 
blue, left leg red, right leg green) 
 
A ring of near-infra-red LEDs around each camera lens strobe synchronously at 120Hz and 
the resulting marker reflections are recorded from each camera view at this frequency. A 
calibration object (L-frame) is used to calibrate the 3D capture volume, to calculate the 
relative position and orientation of each camera, and to set the Cartesian coordinate 
origin and axis system used to describe the capture volume. With the position and 
orientation of each camera known, the location of any marker visible by a camera must lie 
on the ray projected out normal to the camera field of view. Therefore, if a marker can be 
seen by two cameras, its 3D position will be located at the intersection of the two rays. A 
marker must therefore be seen by a minimum of two, non-parallel cameras to be 
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reconstructed in three dimensions. The camera resolution, size of the capture volume 
(distance of the cameras to the markers), marker diameter and centroid identification 
algorithm combine to give approximately 1mm accuracy in marker location. 
 
Markers are attached to the surface of an object and the motion of interest is performed 
in the capture volume whilst collecting camera data. The 2D image data from all cameras 
is then combined to reconstruct 3D marker trajectories. Appropriate transformations, 
dependent on the marker set used, are then necessary to calculate the object motion 
from the trajectories of the attached markers. For this project, the Vicon Plug-in-Gait 
lower limb model and Helen Hayes marker set (Kadaba et al., 1989, 1990; Sutherland, 
2002) were used to capture the gait pattern of human walking.  
 
SACR 
SACRUM: placed mid-way between the 
posterior superior iliac spines 
 
LASI & RASI 
Placed directly over the left or right 
anterior superior iliac spine (ASIS) 
LTHI & RTHI 
Placed on the lateral surface of the 
THIGH at approximately 2/3 the 
distance from hip to knee 
LKNE & RKNE 
Placed over the lateral epicondyle of 
the left or right KNEE 
LTIB & RTIB 
TIBIA: placed on the lateral surface of 
the shank at approximately 2/3 the 
distance from knee to ankle 
LANK & RANK 
ANKLE: placed over the lateral 
malleolus along an imaginary line 
passing through the transmalleolar axis 
LTOE & RTOE 
TOE: placed between the 2
nd
 & 3rd 
metatarsal heads 
LHEE & RHEE 
HEEL: placed over the calcaneus at the 
same height above the plantar surface 
of the foot as the toe marker 
Figure 2.17 – Skin surface marker positions for the Helen Hayes lower body marker set. Left side 
markers are shown in red and right side markers in green. SACR and L/RHEE have alternate 
shading to indicate that these markers would not be visible in an anterior coronal view. 
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The Conventional Gait Model is also known as the Newington, Gage, Davis, Helen Hayes, 
Kadaba or Vicon Clinical Manager (VCM) model (Baker, 2006). For the lower limbs this is a 
seven segment model (pelvis, 2 x thigh, 2 x shank, 2 x foot) with three degrees of freedom 
at both the hip and knee and two at the ankle. It is typically implemented using the Helen 
Hayes marker set which, for the lower limbs, consists of 15 skin surface markers placed on 
bony landmarks, three around the pelvis and six on each lower limb (Figure 2.17).  
 
Surface marker positions and a number of anatomical measurements (leg length, knee 
width, ankle width) are then used to calculate joint centres and segment axes systems. 
The hip joint centres (HJC) are defined using the regression equations of Davis et al. 
(1991). The chord function (Figure 2.18) is used to define: the knee joint centres (KJC) 
using the KNE marker, HJC, THI marker and knee width; and ankle joint centres using the 
ANK marker, KJC, TIB marker and ankle width for points i, j, k and length A respectively. 
 
 
Figure 2.18 – The chord function 
This function uses three points, i, j, k (blue dots), to define 
a plane. A circle, diameter point i to point j, is drawn 
within the plane. A chord, length A, is drawn from point i 
in the direction of the required joint centre. The joint 
centre (green dot) then lies at the other end of the chord. 
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Surface marker and joint centre positions are then used to define local Cartesian 
coordinate systems for each segment using an angle sequence that attempts to match 
anatomical flexion, abduction and rotation. Joint angles can then be calculated from 
rotations between the local coordinate systems of adjoining segments. 
 
In this study, the Helen Hayes lower limb marker set was combined with a full body 
marker set recommended for use with the OpenSim gait2392 lower limb and torso model 
(Delp, 1990) to produce a 40 marker set (Figure 2.19). This enabled kinematic modelling 
using the Conventional Gait Model as well as providing marker trajectory data that could 
be imported into OpenSim. 
 






  2 = Sternum 23 = LTIB 
  3 = R.Acromium 24 = RANK 
  4 = L.Acromium 25 = R.Ankle.Med 
  5 = SACR 26 = LANK 
  6 = RASIS 27 = L.Ankle.Med 
  7 = LASIS 28 = RHEE 
  8 = R.Thigh.Upper 29 = R.Toe.Med 
  9 = R.Thigh.Front 30 = R.Midfoot.Lat 
10 = RTHI 31 = R.Midfoot.Med 
11 = L.Thigh.Upper 32 = R.Toe.Lat 
12 = LThigh.Front 33 = R.Toe.Tip 
13 = LTHI 34 = LHEE 
14 = RKNE 35 = L.Toe.Med 
15 = R.Knee.Med 36 = L.Midfoot.Lat 
16 = LKNE 37 = L.Midfoot.Med 
17 = L.Knee.Med 38 = L.Toe.Lat 
18 = R.Shank.Upper 39 = L.Toe.Tip 
19 = R.Shank.Front 40 = RTOE 
20 = RTIB 41 = LTOE 
21 = L.Shank.Upper  
Figure 2.19 - OpenSim lower limb and torso marker set combined with the Helen Hayes marker set. For 
clarity, only right side markers have been labelled. Two additional lateral pelvic markers were used in case 
the standard pelvic markers were obscured. Surface EMG sensors can also be seen on the subject secured 




Three AMTI OR6 force-plates (AMTI Inc., MA, USA) were embedded to lie flush with the 
floor in the centre of the gait laboratory walkway. The contact surface of the force-plate is 
supported at each corner by a tri-axial, strain-gauge force transducer, the signals of which 
are combined to give a six channel device output representing the three orthogonal forces 




Figure 2.20 – Force Plates (a) AMTI OR6 force-plate(b) Position of the 3 force-plates in the capture volume 
 
The force-plates were orientated in the laboratory such that the X-axes were aligned 
across the walkway, the Y-axes along the walkway and the Z-axes in the vertical direction. 
The Fz channel therefore provided the principal component of the ground-reaction force, 
with Fx and Fy representing the shear forces applied to the plate. The Mx and Mz 
moments represented the offset of the centre-of-pressure of the ground-reaction-force 
from the plate’s centre and the Mz moment represented the free moment applied by any 
twisting contact force. Assuming contact with the plate is made at the surface, simple 
processing of the six channels can provide the three components of the ground-reaction-
force vector, the two surface coordinates of the centre-of-pressure and any free moment 




Fx, Fy, Capacity (N) 2224 
Fz, Capacity (N) 4448 
Mx, My, Capacity (Nm) 1129 
Mz, Capacity (Nm) 565 
Fx, Fy, Natural Frequency, Hz 400 
Fz, Natural Frequency, Hz 1000 
Fx, Fy, Sensitivity (μV/N) 0.674 
Fz, Sensitivity (μV/N) 0.169 
Mx, My, Sensitivity (μV/Nm) 1.59 
Mz, Sensitivity (μV/Nm]) 3.37 
Table 2.7 – AMTI OR6-6 force-plate specification 
 
 
2.4.3. Surface Electromyography 
Motion capture systems and force-plates enable the measurement of spatio-temporal 
parameters, kinematics and kinetics of motion – useful information for the task of 
identifying underlying causes of motor disability. However, as many conditions will include 
an element of neurological involvement it is important to get an understanding of the 
excitatory signals that are being sent to the muscle fibres. This is done with 
electromyography (EMG). 
 
Surface EMG (sEMG) was collected using a Delsys Bagnoli-16 EMG system (Delsys Inc., MA, 
USA) (Figure 2.21). Bipolar electrodes were taped to the skin over each muscle of interest 
and secured using self-adhesive bandage (Figure 2.19). During muscle activity the 
combination of local motor unit action potentials travelling along the muscle fibres set up 
a potential difference at the skin’s surface, and hence between the two electrodes. Typical 
sEMG signals tend to be in the region of μV and have a frequency in the low hundreds of 
hertz range. The signals are amplified by a differential amplifier (gain 1000), filtered using 
a 450Hz low pass analogue filter to avoid aliasing and then sampled at 1080Hz for digital 
storage. A digital band-pass filter (20-400Hz) was then applied using Matlab (The 





Differential Amplification 1000 
Analogue Filter 450Hz low pass 
Bandwidth Roll-Off 80 dB/decade 
Overall Noise ≤1.2uV 
Saturation Error Threshold ± 4.8V (output) 
Medical Device Conformity IEC 60601-1, CE mark 
Classification Class I (93/42/EEC), Type BF 
Figure 2.21 – Delsys Bagnoli-16 bipolar surface EMG electrode and system specifications 
 
2.4.4. Maximum Voluntary Contractions 
sEMG signals are a recording of the electrical activity of motor unit action potentials as 
they manifest at the skin surface. As such, they provide an almost direct indication of the 
timing of muscle activity (ignoring the electro-mechanical delay of muscle tissue – typically 
0.1s; Buchanan et al., 2004) but not of the muscle activation level. As a muscle becomes 
more active, a larger proportion of its total motor units are recruited via action potentials 
and hence the magnitude of the sEMG signal increases. However, the absolute voltage 
“seen” by the sEMG sensor is dependent on many factors including the number and 
distribution of motor units within the muscle, the muscle size, the depth of the muscle 
beneath the skin, the subcutaneous fat thickness and the electrical impedance of the 
sensor-skin contact. 
 
Prediction of sEMG amplitudes is therefore an extremely complex task and rarely 
undertaken. Instead, the amplitude of sEMG signals are often normalised to the peak 
amplitude obtained during a maximum voluntary contraction (MVC) to give an indication 
of muscle activation levels. The MVC methodology used in this study is outlined below. A 
major limitation to this technique however is that some subjects (especially those with 
cerebral palsy) are unable to achieve maximal contraction of their muscles voluntarily 
(Stackhouse, 2005) and the pain associated with a maximal contraction obtained via 
external electrical stimulation is often prohibitive. This will need to be considered when 
comparing simulated muscle activations to normalised EMG signals. 
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Specific isometric tasks were performed to illicit the appropriate muscle activations (Table 
2.8). For some muscles, the contractions were carried out at two different joint positions 
to better represent joint ranges during walking. Tasks were carried out with the subject 
either sitting on the edge of a couch with legs hanging freely or standing. Joint movement 
was manually constrained by the examiner to ensure isometric contraction. Subjects were 
given one practice trial of each task before the task was repeated three times with verbal 
encouragement to obtain maximal contraction. The MVC for each muscle was then 
calculated from the mean peak voltage from all associated trials. 
 






knee extension at 90∘ 
knee extension at 30∘ 
Vastus Lateralis 
knee extension at 90∘ 
knee extension at 30∘ 
Tibialis Anterior ankle dorsiflexion at 0∘ (knee 90∘) 
Semimembranosus knee flexion at 30∘ 
Semitendinosus knee flexion at 30∘ 






Medial Gastrocnemius ankle plantarflexion at 0∘ (knee 0∘) 
Lateral Gastrocnemius ankle plantarflexion at 0∘ (knee 0∘) 
Soleus 
ankle plantarflexion at 0∘ (knee 0∘) 
ankle plantarflexion at 0∘ (knee 30∘) 
Table 2.8 – Maximum voluntary contraction tasks. Isometric tasks 
performed to collect maximum voluntary contraction electromyography 
data. Each task was repeated three times and the maximum voluntary 
contraction for each muscle calculated from the mean peak amplitude 
from all associated trials.  
 
Peak EMG amplitude for each task was calculated using a four step process carried out in 
Matlab (The MathworksTM Inc., MA, USA): 
 
1. standard EMG filtering was carried out as described above in section 2.4.3 
2. the signals were rectified by taking the absolute value of the signal 
3. the signal envelope was calculated using a low-pass Butterworth filter with zero 
phase shift (2nd order, cut-off 6Hz) 




Clinical gait analysis (section 2.3.2) provides a useful tool in treatment decision making for 
subjects with cerebral palsy and as an outcome measurement but its clinical power is 
limited (Baker, 2006). It is able to describe the movement of an individual but it cannot 
describe the functional contributions of individual muscles during that movement. Such 
information would be useful as pathological changes in skeletal morphology may alter the 
function of particular muscles, and changes in muscle and tendon material properties may 
alter the timing of the development of muscular force. 
 
It is hoped that more advanced techniques, such as the SimTrack method of musculo-
skeletal simulation, may be able to provide more specific information on muscle function. 
However, to date, quantitative validation of muscle activations generated by such 
techniques has been lacking despite many publications using SimTrack or similar methods 
appearing in the literature. As a result the clinical utility of this technique for typically 
developing subjects or for subjects with cerebral palsy remains in doubt. 
 
The aim of this study therefore is to validate the simulated muscle activations generated 
using the models and analysis techniques of SimTrack. This will be carried out by 
comparison to experimentally recorded electromyographic data in both typically 
developing subjects and subjects with cerebral palsy. If found valid, simulated muscle 
activations could be used in further techniques such as induced acceleration analysis to 
identify and quantify specific functional muscle contributions. For children with cerebral 
palsy this may help our understanding of the movement dysfunction associated with this 
disorder and it has the potential to provide a new tool in clinical gait analysis to assess 
how interventions alter the contributions of muscles and observe whether the 
reconfiguration of the skeletal posture results in improved muscle action. 
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3 Muscle volumes & architecture in typically developing 
adolescents & in adolescents with cerebral palsy 
 
Muscle morphological data (volume, fibre length, pennation angle) was collected using 2D 
ultrasound and magnetic resonance imaging for a number of lower limb muscles from ten 
typically developing adolescents and ten adolescents with cerebral palsy. Muscle 
physiological cross-sectional area was also calculated from these three parameters. 
Muscle volumes and fibre lengths were found to be smaller in the case group with smaller 
volumes more prominent in the distal musculature. Physiological cross-sectional area was 
found to be larger in the thigh and smaller in the shank for the case group and no 
difference between groups was found in pennation angle. A high variation in reported 
muscle pennation was noted from the literature. 
 
3.1 Introduction 
The mathematical models used to represent muscle action in musculo-skeletal simulations 
have been described in Chapter 2. The Thelen (2003) muscle model used in the gait2392 
OpenSim model uses a number of parameters (Table 2.3) to characterise muscle action. 
Muscle morphological data was collected from typically developing subjects and subjects 
with cerebral palsy in order to inform the appropriate model parameters indicated in 
Table 3.1. This data was used to examine differences between the groups and to create 
bespoke musculo-skeletal models for both a sensitivity and validity analysis described in 
Chapters 4 & 5 respectively. 
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Morphological Data  Model Parameter 
1. muscle pennation angle used to inform pennation_angle 
2. muscle fascicle length used to inform optimal_fiber_length 
3. muscle length 
used to inform tendon_slack_length 
4. tendon length 
5. muscle volume used with 1 & 2 to calculate PCSA to inform max_isometric_force 
Table 3.1 – Informing the muscle model with morphological data 
 
3.2 Altered Muscle Morphology in Cerebral Palsy 
Typically developing muscle morphology has been described in Chapter 2 and an outline 
of musculo-skeletal abnormalities found in subjects with cerebral palsy was given in 
Chapter 1. There have also been a number of studies looking in more detail at human 
muscle morphology both in typically developing subjects and in subjects with cerebral 
palsy. Wickiewicz et al. (1983) measured the muscle mass, length and physiological cross-
sectional area, the fibre length and pennation and the number of sarcomeres per fibre in 
27 lower limb muscles of three cadavers. The age and sex of the specimens are 
unfortunately not reported. They found similar fibre to muscle length ratios across the 
three subjects and generally consistent pennation angles throughout each muscle. 
 
Friederich & Brand (1990) carried out a similar study on two cadavers (37 year old male & 
63 year old female) measuring muscle length, volume, fibre length and pennation, and 
calculated physiological cross-sectional area on all the lower limb muscles. They found 
consistent fibre length within each muscle but found variation between muscles. They 
compared their data to Wickiewicz et al. (1983) and found consistency in fibre to muscle 
length ratio data. It is principally the data from these two papers that are used to inform 
the muscle model parameters in the OpenSim gait2392 model. 
 
Many musculo-skeletal simulations use the data from these two early studies to 
parameterise their muscle models but this is based on a limited sample of five cadaveric 
specimens for which the age and sex of three cadavers is unknown. With the current 
increased interest in musculo-skeletal modelling, Ward et al. (2008) recognised the need 
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for a larger cadaveric study of human muscle morphology to parameterise these muscle 
models. They therefore disassembled 27 lower limb muscles from one side of 21 cadaveric 
specimens (9 male, mean age 83 years) and measured muscle mass (and hence volume), 
muscle length, fibre length, sarcomere length, pennation angle and physiological cross 
sectional area (PCSA). The authors conceded that the mean age of their subjects, and the 
associated muscle shrinkage through sarcopenia (Dutta et al., 1997; Shortland, 2009) were 
likely to make PCSA comparisons to in vivo data problematic, but they also found large 
differences in fibre length and PCSA when comparing to the cadaveric data of Wickiewicz 
et al. (1983) and Friederich & Brand (1990). Newer musculo-skeletal models are now using 
the Ward et al. (2008) data for muscle model parameterisation as it is based on a larger 
cadaveric sample. 
 
With the advance of imaging techniques a number of more recent papers have begun to 
look at muscle morphology in vivo. Fukunaga et al. (1992) measured muscle length and 
volume in human leg muscles from T1-weighted magnetic resonance images from 12 
healthy subjects (20-49 years old, mean age 32.6) and compared the results to Wickiewicz 
et al. (1983), Friederich & Brand (1990) and a number of other papers. It is unfortunate 
however that individual fascicles cannot be delineated from magnetic resonance images 
and so it should be highlighted that the fibre lengths and physiological cross-sectional area 
data reported here were calculated using the appropriate fibre length/muscle length 
ratios and pennation angles of Wickiewicz et al. (1983). The authors justify this by stating 
that measurements of fibre length/muscle length ratios appear consistent between 
subjects and across studies. They do not comment on the consistency of pennation angles.  
 
Lampe et al. (2006) used a similar magnetic resonance technique to compare the lower 
limb muscle volumes between the paretic and non-paretic sides of 16 hemiplegic cerebral 
palsy subjects (aged 16-25). They found a mean reduction of thigh muscle volumes to 83% 
and a statistically significant mean reduction of the lower leg muscle volumes to 74% with 
the calf muscles being particularly affected. 
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Fry (2008) used T1-weighted magnetic resonance images to measure the volumes of 
eleven lower-limb muscles in nine young adults with spastic cerebral palsy (14-22 years) 
compared with nine age and sex-matched control subjects. All muscles were found to be 
smaller in the case group with an average 42% volume reduction and with the distal 
muscles more affected. Larger volume deficits were also found in biarticular compared to 
monoarticular muscles. 
 
Malaiya et al. (2007) used 3D ultrasound to compare gastrocnemius muscle morphology 
between 16 children with spastic hemiplegic cerebral palsy (mean age: 7.8 years; range: 
4-12) and 15 typically developing children (mean age: 9.5 years; range: 4-13). They 
measured muscle volume, muscle length, fascicle length and pennation angle and 
normalised volume and lengths by controlling for body mass and fibular length 
respectively. They found that the muscle was smaller and shorter in the paretic limb when 
compared to both the non-paretic limb and to the typically developing group. However, 
the altered morphology was not due to a decrease in fascicle length and so the authors 
suggested that the medial gastrocnemius deformity in spastic hemiplegic cerebral palsy is 
caused by lack of cross-sectional growth. Barber et al. (2011) used similar techniques to 
compare the medial gastrocnemius volume, fascicle length and pennation angle between 
younger typically developing children and children with spastic cerebral palsy (2-5 years) 
and found similar results.  
 
Oberhofer et al. (2010) used magnetic resonance imaging to compare the volumes and 
lengths of six lower limb muscles between five typically developing children (mean age 
10.2 years) and six children with cerebral palsy (four with spastic diplegia and two with 
hemiplegia; mean age 9.6 years). Volumes were normalised to body mass and lengths to 
the thigh or shank segment length (hip to knee joint centre or knee to ankle joint centre 
respectively). Muscle volumes in the case group were all smaller but significant reductions 
were only found in the biceps femoris, the combined vasti group, and the rectus femoris. 
All muscles in the case group were shorter with significance found in all muscles except 
the soleus and biceps femoris.  
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At this time, to the author’s knowledge, there are no studies in the literature that directly 
compare muscle fibre lengths or muscle pennation angles between typically developing 
subjects and subjects with cerebral palsy for multiple muscles of the lower limb. 
 
3.3 Methodology 
Ten adolescents with spastic diplegic cerebral palsy and ten typically developing control 
subjects were recruited for the study following the methods and selection criteria 
described in section 2.4. 
 
3.3.1 Ultrasound 
All subjects underwent an ultrasound scan of the lower limb muscles to record images of 
the fascicular architecture. The subject changed into shorts and lay prone on the 
examination couch. 2D, B-mode images were obtained bilaterally for the lower limb 
muscles listed in Table 3.2 using a Philips HD11 Scanner and L12-5 linear array probe 
(Philips Healthcare, Best, The Netherlands). Muscles were identified with the probe 
orientated in the transverse plane, the probe was then rotated to optimise viewing of the 
muscle fascicles and the image recorded. Image depths varied from 4-6cm as appropriate 
for each muscle.  
 
soleus (SOL) semimembranosus (SM) 
medial gastrocnemius (MG) biceps femoris long-head (BFLH) 
lateral gastrocnemius (LG) biceps femoris short-head (BFSH) 
tibialis posterior (TP) rectus femoris (RF) 
tibialis anterior – superficial compartment (TA-sup) vastus medialis (VM) 
tibialis anterior – deep compartment (TA-deep) vastus lateralis (VL) 
semitendinosus  (ST) vastus intermedius (VI) 
Table 3.2 – Lower limb muscles examined with 2D, B-mode ultrasound 
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Images were exported to a personal computer in bitmap format with a resolution of 
800x564 pixels. Measurement of fascicle length and pennation angle for each muscle was 
then carried out in Matlab (The MathworksTM Inc., MA, USA) (code in Appendix D). Pixel 




Figure 3.1 – Example ultrasound image showing the rectus femoris of Control01. Four lines 
were drawn to allow calculation of fascicle length and pennation angle:  
Line 1: yellow line drawn along the vertical scale of the image 
Line 2: green line drawn along the line of the muscle aponeurosis 
Line 3: red line drawn along the line of a muscle fibre 
Line 4: blue line drawn from the superficial to the deep aponeurosis and perpendicular to line 2 
 
Pixel size was calculated by dividing the image depth by the pixel length of line 1. 
Pennation angle was calculated using the dot product of line vectors 2 and 3. Muscle 
thickness was determined by calculating the length of line 4. Muscle fascicle length was 
then calculated by dividing muscle thickness by the sine of the pennation angle. Similar to 
the methodology of Shortland et al. (2002), muscle fascicle length was then normalised to 




3.3.2 Magnetic Resonance Imaging 
All subjects also underwent an MRI investigation of the pelvis and lower limbs to measure 
muscle volume. After completing the MRI safety questionnaire (Appendix E), data was 
collected using a 1.5T Philips Achieva MR system (Philips Healthcare, Best, The 
Netherlands) with the subject lying supine and feet first in the scanner. Image data was 
collected from the iliac crest to the distal calcaneum with a quadrature body coil using a 
three point Dixon sequence (TE/TR=4.6/13ms, echo time shift=1.53ms, 120o echo phase 
shift, 20o flip angle, 0.9x0.9mm in-plane voxel size, number of averages=2, 5mm slice 
thickness). Each scan took approximately 30 minutes. A Dixon sequence was chosen over 
the more conventional T1 weighted sequence to enable simultaneous collection of both 
volume data and fat content data which could be used as a measure of muscle quality if 
subsequently required. 
 
Volume measurements were performed using Osirix (v3.7.1; Rosset et al., 2004). The 
proximal and distal endpoints of each muscle belly were identified visually and regions of 
interest were outlined on every image slice manually using a tablet and stylus (Figure 3.2). 
The total volume was calculated as the sum of the outlined cross sectional areas 
multiplied by slice thickness. Volumes were collected for the muscles listed in Table 3.2 
and additionally from the adductor group (ADDS), gluteus maximus (GlutMax), gluteus 
medius (GlutMed), gluteus minimus (GlutMin), sartorius (SAR) and gracilis (GRA). A strong 
correlation between muscle volume and body mass has been reported in the literature 
(Malaiya et al., 2007; Fry et al., 2007; Noble et al., 2013) and so muscle volumes were 




Figure 3.2 – Example MRI image 
(a) Muscle delineation of the right thigh of a control subject 
 
red = quadriceps, green = hamstrings, yellow = adductors, 
blue = gracilis, purple = sartorius 
 
(b) Volume render of right BFLH 
 
(white line indicates location of slice 
shown in (a)) 
 
 
Percentage muscle deficit (PMD) of the case subject muscles were then calculated using 
Equation 3.1. 
 














PMDm,c  is percentage muscle deficit for muscle m for case subject c 
 

V m   is mean normalised muscle volume for muscle m from the typically  
  developing group 
 





Normalised muscle physiological cross-sectional area (PCSA) was then calculated using 
Equation 3.2: 
 
Equation 3.2  

PCSAm 






Vm  is normalised muscle volume for muscle m 
 

m   is muscle pennation angle for muscle m 
 

L f ,m  is the fascicle length for muscle m 
 
Data was tested for normality using the Shapiro-Wilk test with a significance threshold of 
0.05. Group differences were then compared with either independent samples T-Test or a 
non-parametric median test for two samples as appropriate with a significance threshold 
of 0.05. Control of type I errors was carried out using the Benjamini correction for multiple 
tests (Benjamini et al., 2001). All statistical analyses were performed using IBM SPSS 




It is hypothesised that the lower limb muscles of subjects with cerebral palsy will be 
smaller in volume than their typically developing peers. It is also expected that the two 
groups will have similar fascicle lengths and pennation angles leading to smaller 
physiological cross-sectional areas in the cerebral palsy group. Distal (shank) and 




Full magnetic resonance datasets were successfully collected from all of the typically 
developing subjects but only from 6/10 subjects with cerebral palsy. One subject became 
nauseous halfway through the scan and so only thigh images were obtained; one subject 
moved their left leg during the scan and so motion artefact rendered the images for this 
leg unusable; one subject had extensive metal bone plates in both lower limbs causing 
distortion in all the images; and one subject had a metal bone plate in their right thigh 
causing distortion in the thigh muscles of this leg. A reduced muscle volume dataset was 
therefore obtained from these subjects. 
 
Full ultrasound datasets were successfully collected from all of the typically developing 
subjects but only from 9/10 subjects with cerebral palsy due to time constraints after 
delays in gaining access to the hospital MRI scanner. A list of all previous surgery for the 
case subjects is given in Appendix F. 
 
3.4.1 Subject Data 
Subject data for age, height, mass and BMI can be seen in Figure 3.3 and Table 3.3. All 
data sets were found to be normally distributed using the Shapiro-Wilk Test with a 
threshold of 0.05. However, this test is less reliable for small sample sizes (such as those 
used here) and the appearance of skewedness on the box-plots for some variables gives a 
strong indication of non-normality. For this reason both parametric and non-parametric 
tests were performed to test for group differences. The outlier for age in the case group 
was not excluded as there is little change in musculo-skeletal maturation after 19 years of 
age (Tanner & Whitehouse, 1976). Outliers for height and body mass index were not 
excluded as muscle fibre lengths and muscle volumes were normalised to leg lengths and 
mass respectively. Both parametric and non-parametric tests showed there was no 
difference in age but the CP group were found to have significantly lower height, mass and 





Figure 3.3 – Box-plot group comparisons for age, height, mass and BMI. 
 
Box = inter-quartile range (IQR), horizontal line = median, whiskers = data range 







 n male/female age (years) height (m) mass (kg) BMI 
Controls 10 5/5 15.4 (3.2) 1.7 (0.1) 62.8 (14.4) 22.0 (3.1) 
Cases 10 6/4 14.3 (3.5) 1.5 (0.1) 43.1 (12.5) 18.3 (2.8) 
T-Test p-value 0.47 0.02* 0.01* 0.01* 
Mann-Whitney U Test p-value 0.44 0.03* 0.01* 0.01* 




Correlation analysis was carried out to test the suitability of the normalisation schemes 
adopted in the methodology. Data from the control and case subjects was analysed 
separately. The relationships of muscle volume with body mass, physiological cross-
sectional area with body mass, and fascicle length with leg length were tested with simple 











Controls 0.55 (0.16) 0.32 (0.23) 0.18 (0.14) 
Cases 0.68 (0.21) 0.45 (0.22) 0.05 (0.06) 
Table 3.4 – Regression analysis. The mean R2 (SD) value from 
simple linear regression of muscle volume with body mass, 
physiological cross-sectional area (PCSA) with body mass, and 
fascicle length with leg length. 
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3.4.2 Pennation Angle 
Muscle pennation data can be seen in Figure 3.4. No significant differences were found 
between the two groups. Data from the semitendinosus (ST) and vastus medialis (VM) are 
omitted as these muscles were typically found to have parallel fibre structures (very small 
or zero pennation angle) and so measurement of fascicle length was prone to high error 
using the ultrasound image methodology described above. 
 
 
TD n 20 20 20 19 15 20 20 20 20 20 20 
CP n 17 16 18 17 14 17 17 17 18 17 14 
p-value 0.84 0.04 0.24 0.34 0.12 0.10 0.28 0.40 0.61 0.90 0.13 
Figure 3.4 – Group differences in mean pennation between TD subjects and CP subjects. Underlining 
shows data was not normally distributed , error bars show ±1SE, DFs = dorsiflexors, PFs = plantarflexors 
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3.4.3 Fascicle Length 
Muscle fascicle data can be seen in Figure 3.5. Data was normalised to leg length to allow 
comparison across subjects (Fry et al., 2007). Data from the semitendinosus (ST) and 
vastus medialis (VM) are omitted as described above. There was a universal trend for 
shorter fascicle lengths in the case group especially for the rectus femoris (RF), vastus 
intermedius (VI) and semimembranosus (SM) muscles but only the difference in 
semimembranosus was found to be significant after applying the post-hoc correction for 
multiple tests (Benjamini et al., 2001). 
 
 
         
 
Figure 3.5 – Group differences in normalised mean fascicle length between TD & CP subjects. Fascicle 
lengths were normalised to leg length. Error bars show ±1SE. Underlining shows data was not normally 
distributed, * indicates significance, DFs = dorsiflexors, PFs = plantarflexors 
 
98 
3.4.4 Muscle Volume  
Normalised muscle volume data is shown in Figure 3.6. There was a trend for all measured 
muscles to be smaller in the cerebral palsy group compared to their typically developing 




Figure 3.6 – Group differences in normalised mean muscle volume between TD & CP subjects. Muscle 
volumes were normalised to body mass. Error bars show ±1SE. Underlining shows data was not normally 




Significant volume reductions were found in the gluteus minimus (GlutMin), rectus 
femoris (RF), biceps femoris long head (BFLH), semimembranosus (SM), tibialis anterior 
(TA) and all three calf muscles (LG, MG, SOL). Percentage muscle deficits for the muscles 
reduced in volume can be seen Figure 3.7. The mean deficit of the distal muscles was 32% 
(or 23% if including the tibialis posterior) compared to 16% for the proximal muscles. With 
the exception of sartorius (SAR) there was a trend for larger volume deficits in the 




Figure 3.7 – Percentage muscle volume deficits for muscles found to be smaller in the cerebral palsy 
group. Proximal muscles are shown in grey and distal muscles in green. Biarticular muscles are marked with 
red borders. Mean deficits for proximal and distal muscle groups are also shown. Error bars show ±1SE. 
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3.4.5 Muscle Physiological Cross-Sectional Area 
Normalised muscle PCSA data can be seen in Figure 3.8. The mean pennation angle and 
fascicle length from the two compartments of the tibialis anterior (TA) muscle were used 
to calculate tibialis anterior PCSA. There was a trend for increased PCSAs in all the thigh 
muscles and decreased PCSAs in all the shank muscles of the case group but after post-hoc 
correction for multiple tests (Benjamini et al., 2001), significant differences were only 




TD n 19 15 20 20 20 20 20 20 20 20 
CP n 12 10 12 13 11 14 16 15 13 15 
p-value 0.04 <0.01* 0.07 0.47 1.00 0.02 0.02 0.01* 0.67 0.10 
Figure 3.8 – Group differences in normalised mean muscle PCSA between TD & CP subjects. 
PCSAs were normalised to body mass. Error bars show ±1SE. Underlining shows data was not 




By design, there was no difference between the mean ages of the case and control groups 
but the mean height, mass and BMI of the case subjects were significantly reduced 
compared to their typically developing peers. This is an unexpected result as the large 
study of Day et al. (2007) found little difference between independently ambulant 
subjects with cerebral palsy when compared to growth charts of the general population, 
although they did find a reduction in growth for the more severely affected and hence 
non-ambulant individuals with cerebral palsy. However, reasonable relationships were 
found between body mass and both muscle volume and physiological cross-sectional area 
(Table 3.4) and so the normalisation schemes adopted for this data should enable fair 
comparisons between groups.  
 
3.5.1 Muscle Physiological Cross-Sectional Area 
Muscle PCSAs in the cerebral palsy group were found to be larger in the thigh and smaller 
in the calf than their typically developing peers. Statistically significant differences were 
only found in 2 of the 10 muscles tested however, but this is likely to be an effect of the 
small sample size and multiple test correction. 
 
As described in section 1.3, individuals with cerebral palsy often have weak muscles and 
so it was hypothesised that all muscle PCSAs would be smaller in the cerebral palsy group 
with larger deficits in the shank. A typical explanation for this is that as development of 
the long tracts of the spinal cord take place in utero and during the early years of life, and 
because the motor neurons of distal musculature connect to the cord in distal locations, 
the altered muscle development that occurs as a consequence of cerebral palsy 
neuropathy is more severe for the distal muscles (Gough & Shortland, 2012). The 
imbalance of PCSA reduction only being found in the shank muscles of the cerebral palsy 
group in this study supports this supposition. However, the increased PCSA of the thigh 
muscles is a surprising result, especially considering the volumes were found to be 
smaller. It is worth remembering that PCSA is the only muscle parameter that is directly 
proportional to the maximum tension that can be generated by a muscle (Lieber & Fridén, 
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2000). This result therefore implies that the subjects with cerebral palsy recruited for this 
study have, on average, stronger thigh muscles than their typically developing peers. This 
is contrary to the study of Wiley & Damiano (1998) who carried out a case/control 
comparison of lower limb muscle strength using a hand-held dynamometer for a group of 
ambulant children with diplegic or hemiplegic cerebral palsy, and found all muscles were 
weaker in the case group. However, the PCSA of a muscle gives a measurement of the 
maximum potential force that a muscle can develop, and the ability of the subjects with 
cerebral palsy to voluntarily recruit these muscles is likely to be compromised by other 
factors of the condition, as described in section 1.2, including incomplete muscle 
activation and spasticity. 
 
Based on the formula for calculating PCSA (Equation 3.2) it is clear that an increase in 
PCSA can be driven by an increase in muscle volume and/or a decrease in pennation angle 
and/or a decrease in fascicle length. Looking at the results of these three muscle 
parameters it should therefore be possible to determine which provides the principal 
contribution to this increase in PCSA at the thigh. 
 
3.5.2 Muscle Volume 
Muscle volumes were found to be smaller in subjects with cerebral palsy when compared 
to their typically developing peers and a greater reduction was found in the distal muscles. 
This is in agreement with the hypothesis and a number of studies in the literature (Malaiya 
et al., 2007; Fry, 2008; Oberhofer et al., 2010). Out of the 18 muscles measured only the 
tibialis posterior was found to be larger in the cerebral palsy group and so it was excluded 
from the analysis of mean muscle deficit in the distal muscles. As muscle volumes are 
smaller in the cerebral palsy group at both the thigh and shank level, the muscle volume 
parameter does not directly contribute to the increase in PCSA found in the thigh muscles 




3.5.3 Muscle Pennation Angle 
No differences in muscle pennation angle were found between the two groups. This is in 
agreement with the hypothesis and with the findings of Malaiya et al, (2007) who found 
no difference in pennation angle of the medial gastrocnemius (at resting ankle angle) 
between a typically developing group and in the paretic limb of a group of subjects with 
spastic hemiplegic cerebral palsy. There is also good agreement with Malaiya et al. (2007) 
on the magnitude of the medial gastrocnemius pennation angle (Figure 3.9), a likely result 












This study (imaging) 20,17 14 20 (3) 20 (3) 
Malaiya et al., 2007 (imaging) 15,16 9 17 (2) 16 (3) 
Ward et al., 2008 (cadaveric) 21 83 10 (4) - 
Friederich & Brand, 1990 (cadaveric) 1 50           7 - 
Wickiewicz, 1983 (cadaveric) 3 ? 17 (8) - 
Martin et al., 2001 (cadaveric) 5 73 33 (5) - 
Martin et al., 2001 (imaging) 9 76 19 (4) - 
Figure 3.9 – Mean pennation angles for the medial gastrocnemius from this study and other 
studies in the literature. 
 
However, there is a wide variation in this pennation angle when compared to the 
cadaveric studies discussed in section 3.2. This is likely to be due to a combination of 
effects including differences in methodology, changes in muscle morphology associated 
with age (Shortland, 2009) and the complications of muscle shrinkage linked with 
cadaveric techniques (Martin et al., 2001). Comparing the pennation angles for other 
muscles, this variation between studies is most striking (Figure 3.10) with a consistent 




Figure 3.10 – Pennation angles for ten lower limb muscles in typically developing human subjects 
measured in vivo using ultrasound (this study) and from cadaveric data of three previous studies. Tibialis 
anterior (TA) angle from this study is the mean value obtained from both the superficial and deep 
compartments. Error bars show ±1SE. No variance data was provided in Friederich & Brand (1990). 
 
There is currently no gold standard method for the measurement of human muscle 
pennation angle and these results highlight the difficulty in obtaining such data. All 
measurements must therefore be treated with caution and it is still not clear if the 
abnormalities of muscle growth associated with cerebral palsy affect this morphological 
parameter as any systematic changes in pennation angle may be masked by measurement 
variation. Despite finding no statistically significant changes in pennation angle between 
the groups, there was a general trend (5 out of 6) of higher pennation angles in the thigh 
muscles but not in the shank. This would lead to a slight decrease in PCSA and so for the 
results of this study, pennation angle opposes an increase in PCSA at the thigh. 
 
3.5.4 Muscle Fascicle Length 
By a process of elimination, the driving factor behind the increase in PCSA found in the 
thigh muscles of the subjects with cerebral palsy must therefore come from the 
differences in fascicle length. This would appear to agree with the data as there was a 
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universal trend for shorter fascicle lengths in the case group, especially at the thigh. For 
the data collected in this study, therefore, the stronger muscles found at the thigh in the 
cerebral palsy subjects are a result of the combination of decreased fascicle length and a 
limited volume reduction leading overall to an increase in PCSA. At the shank, the volume 
reduction dominates the calculation of PCSA leading to an overall reduction in PCSA. 
 
The trend of reduced fascicle lengths in the cerebral palsy group does not support the 
original hypothesis and it is also contrary to the results of Malaiya et al. (2007) who found 
no difference between their groups, despite the use of a similar normalisation scheme (leg 
length vs. fibular length). The regression analysis of Malaiya et al. (2007) however showed 
a weak relationship between fascicle length and fibular length for their typically 
developing data and an even poorer relationship for their cerebral palsy data. In this 
study, no relationship was found between leg length and fascicle length in either group 
(Table 3.4). In the literature there is a lack of consensus on the difference in fascicle 
lengths between typically developing controls and individuals with cerebral palsy. This 
calls into question the appropriateness of using a leg length or fibula length based 
normalisation scheme. However, the study of Mohagheghi et al. (2008) examined exactly 
this problem by comparing muscle fascicle lengths between typically developing controls 
and subjects with diplegic cerebral palsy. They used statistical methods to control for the 
confounding effect of the normalisation scheme and showed that the pathological group 
had shorter fascicles both with and without normalisation. Indeed, the same conclusion 
can be drawn from the data in this study by comparing absolute fascicle lengths (Figure 
3.11) and the normalised lengths shown above (Figure 3.5). Other than the difference in 
units, these two figures look remarkably similar, and the same result (shorter fascicles in 




Figure 3.11 – Mean fascicle lengths in the TD and CP groups. Error bars show ±1SE. 
 
3.5.5 Conclusions and Limitations 
Muscle morphological data (volume, fibre length, pennation angle) was collected using 2D 
ultrasound and magnetic resonance imaging for a number of lower limb muscles from ten 
typically developing adolescents and ten adolescents with cerebral palsy. Muscle volumes 
and fascicle lengths were found to be smaller in the case group with smaller volumes 
more prominent in the distal musculature. Physiological cross-sectional area was 
therefore found to be larger in the thigh and smaller in the shank for the case group. No 
difference between groups was found in pennation angle. 
 
There are a number of limitations in this study of muscle morphological data. Firstly, due 
to the time consuming nature of the data collection and processing it was only possible to 
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recruit a limited number of subjects and this reduces the statistical power of the 
subsequent analyses. General trends were seen in the data but after correction for 
multiple tests, many of the differences failed to reach statistical significance. Additionally, 
measurements were made on both lower limbs of each subject and the results analysed 
separately. This had the effect of increasing numbers but there will be a dependency 
between each limb pair that will not have been taken into account - a problem recently 
discussed by Sangeux et al. (2013). 
 
The first purpose of collecting this morphological data was to investigate the differences 
between typically developing individuals and individuals with cerebral palsy. The increase 
in thigh muscle physiological cross-sectional area between these cohorts was contrary to 
the accepted premise that cerebral palsy subjects have weaker muscles. If this is a genuine 
finding it is possible that, due to distal weakness and poorer motor control, individuals 
with cerebral palsy make more use of their proximal musculature for tasks such as walking 
and hence alter the morphology of these muscles to make them stronger (they are still 
smaller). The increase in thigh muscle PCSA in the case group appears to be driven by 
more marked shortening of the fascicle lengths in the thigh muscles. 
 
There is very little agreement between the pennation angles of resting muscles reported 
within the literature or between the literature and the values measured in this study. Plus, 
in individuals with abnormal muscle tone and spasticity as is common in cerebral palsy, it 
is arguable whether some muscles can ever be considered to be in a resting state. High 
variation, based on the standard error values, was also found in the measurement of 
muscle fascicle lengths in this study. As both of these parameters were calculated using 
the ultrasound technique described in section 3.3 their values and hence any errors are 
trigonometrically linked. There is low confidence therefore in the validity of these two 
parameters and subsequently to the derived PCSA data. Muscle volumes however were 
derived from MRI data and hence calculated independently from pennation and fascicle 
length. The muscle volumes measured in this study have now been published in 
combination with another magnetic resonance data set (Noble et al., 2013). 
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The second purpose of collecting these morphological parameters was to generate data 
for the parameterisation of musculo-skeletal models, as outlined in Table 3.1, for 
simulation analyses documented in later chapters. However, due to the uncertain validity 
of the pennation angle and fascicle length (and hence PCSA) data it was decided only to 
carry the muscle volume measurements forward. These will be used to generate 
normative ranges of maximum isometric muscle force for each cohort for use in sensitivity 
and validity analyses of simulated muscle activations. 
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4 The sensitivity of simulated muscle activations in the 
OpenSim model to changes in lower limb muscle volume in 
typically developing adolescents during walking 
 
Muscle volumes calculated from the MRI data collected in Chapter 3 were used to 
generate a normative range of lower limb muscle volumes in typically developing 
adolescents. These volumes were used to scale the strength of the gait2392 OpenSim 
generic musculo-skeletal model to create a number of models to represent this normative 
range. Muscle activations were simulated for each model over a single gait cycle to 
examine the sensitivity of simulated muscle activation to changes in muscle strength. In 
general, small increases in muscle activation were seen for decreases in muscle strength 
confirming that the model is insensitive to changes in muscle strength over a normative 
range. However, large increases in activation occurred in synergist and compensatory 
muscles when any muscle approached maximum activation.  
 
4.1. Introduction 
Static Optimisation and the Computed Muscle Control (as described in Chapter 2) are two 
alternative methods for the calculation of simulated muscle activations from a prescribed 
set of kinematics and kinetics. Such information, if insensitive to small changes in model 
parameters, would be valuable in the study of biomechanics, human movement and 
specifically gait analysis.  
 
Examples of human gait models available for and commonly used in OpenSim simulations 
are described in section 2.2.1. Many of these models are based on the work by Scott Delp 
(Delp, 1990) and use anatomical data from the cadaveric studies of Wickiewicz et al. 
(1983) and Friederich & Brand (1990) or more recently Ward et al. (2008) for muscle 
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parameterisation. Inevitably however, due to the availability of cadavers, all of these 
datasets are based on elderly adult subjects which results in models with a prescribed set 
of muscle parameters that may be unsuitable for use in simulations of movement of 
child/adolescent subjects – the typical population of interest in the treatment of cerebral 
palsy. When these models are scaled in size to match the stature of a specific subject, the 
only two muscle parameters which are also scaled are tendon slack length and optimal 
fibre length. The muscle parameter maximum isometric force is not scaled and as this is 
proportional to muscle physiological cross-sectional area and hence to muscle volume 
(Lieber & Fridén, 2000), it is likely that simulations of walking in non-adult populations 
that use these models will generate muscle activations that are unrepresentative for their 
group. 
 
It is unlikely that data on muscle morphology from cadavers of children or adolescents will 
ever become available in sufficient quantity and so parameterisation of these muscle 
models must rely on measurements from alternative techniques such as imaging. There 
are few complete imaging studies of the muscles of the lower limbs in children (Oberhofer 
et al., 2010). Certainly more work could be done to elucidate muscle growth in the lower 
limb during childhood, though there are significant challenges to delineating the 
architecture (fascicle length and pennation angle) of muscles due to the length of many of 
the fascicles in the lower limb (Noorkoiv et al., 2010) and of the variation in fascicle length 
with position in some muscles (Blazevich et al., 2006). Therefore, if the outputs of current 
models and techniques in musculo-skeletal simulation can be shown to be insensitive to 
small changes in muscle morphology then researchers can have confidence in using them 
in further investigations of younger populations and for research into cerebral palsy. 
 
A number of studies have investigated bespoke musculo-skeletal models based on MRI 
data (Correa et al., 2011; Scheys et al., 2005, 2008a, 2008b, 2008c). Focusing specifically 
on skeletal measures they found differences between the generic versus bespoke muscle 
moment-arms, muscle insertions, muscle-tendon lengths and hip joint centres which were 
shown to have significant effects on the output of simulations (Scheys et al., 2011). 
Although, based on potential induced accelerations, Correa et al. (2011) found no 
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difference in the prediction of muscle function between the two model types. It would 
appear therefore that these models require some bespoke skeletal elements if they are to 
provide the simulation fidelity necessary to be adopted into more routine use in 
orthopaedic/biomechanical research and clinical gait analysis. Whether this is also true for 
the muscle models however is still uncertain. 
 
To date, there have been few studies in the literature that examine the sensitivity of such 
simulations to changes in muscle model parameters. In his original work on the 
development of SIMM (Delp, 1990) Delp carried out some initial sensitivity tests of the 
muscle models he employed. To investigate the sensitivity of muscle actuator force to 
changes in tendon slack length and optimal fibre length he varied these two parameters 
and calculated the change in the joint angle at which each of four actuators (Gastroc - 
gastrocnemius, RF – rectus femoris, ST - semitendinosus, GRA - gracilis) developed peak 
force. Maximum and minimum joint angle changes for a 5% change in tendon slack length 
(he does not specify if lengthened or shortened) were 38° (Gastroc) and 6° (GRA) and for a 
5% change in optimal fibre length were 18° (ST) and 2° (Gastroc). Delp concluded that the 
angle of peak force was more sensitive to changes in tendon slack length for muscles with 
high ratios of tendon slack length to moment-arm length, and was more sensitive to 
changes in optimal fibre length for muscles with high ratios of fibre length to moment-arm 
length. Delp also carried out a series of isometric muscle model tests to look at the factors 
that affect the sensitivity of muscle force to changes in tendon length. The force of the 
baseline muscle (5cm fibres, 0° pennation, 30cm stiff tendon) was reduced by 48% 
following a decrease in tendon length by 2cm. He then repeated this tendon shortening in 
combination with other changes to the muscle model: decreasing the optimal fibre length 
by 1cm; increasing the tendon compliance to a nominal value; and increasing the 
pennation angle to 30°. For each of these changes, the corresponding muscle force 
reductions were 80%, 29% and 30% respectively. Delp therefore concluded that optimal 
fibre length was the most important parameter as regards muscle force sensitivity to 
changes in tendon length and that increases in tendon compliance and pennation angle 
reduced this sensitivity. 
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Correa & Pandy (2011) investigated a method of scaling the strength of the generic (adult) 
OpenSim gait model for use in children (7-13 years). For ten subjects they compared 
muscle forces simulated during normal walking from two models: a generic model with 
muscle strengths scaled by their own mass-strength scaling law, and a bespoke model 
with muscle strengths based on subject-specific MRI data. No differences were found 
between the muscle forces generated by the models and so they concluded that the use 
of mass-length scaling in the development of subject-specific musculo-skeletal models of 
children was appropriate. However, no comparison was made to the un-scaled generic 
model and so it was not clear that such scaling was necessary. 
 
More recently Van der Krogt et al., (2012) used a similar OpenSim model driven by 
experimental gait data and investigated its response to progressive muscle weakness. 
They decreased the maximum isometric force of the muscle actuators in increments of 
20% until the model was no longer able to follow the prescribed kinematics and examined 
the change in muscle force. They tested weakening all of the muscles together and also 
weakening selected muscle groups alone. Using this method they identified muscle groups 
that were robust (in terms of the maintenance of normal gait) to muscle weakness (hip 
and knee extensors) and muscle groups that were more sensitive to weakness 
(plantarflexors, hip abductors and hip flexors). They also observed that the weakening of a 
muscle not only resulted in its increased activation, as would be expected, but also an 
increase in the activation of synergist muscles as well as other muscles needed to 
compensate for these changes in synergist force. Compensatory strategies were therefore 
quite complex. However, there are two elements in this methodology that require 
comment. Firstly, the study used the gait2392 OpenSim lower limb and torso model scaled 
to six adolescent subjects (mean(SD) age: 15(1) years) but, as described above, this model 
is based on adult cadaver data and maximum isometric force is not scaled when the model 
is resized. The models used in this study therefore had muscle-tendon lengths, fibre 
lengths and segment masses of adolescent subjects but the muscle strengths of adults. 
Secondly, the arbitrary nature of weakening all muscles or functional muscle groups by 
20% is unlikely to be representative of actual muscle weakness that occurs in humans.  
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In the work described in this Chapter, an investigation was undertaken into the sensitivity 
of simulated muscle activations to changes in lower limb muscle volume in a model of 
human walking. A normative range of muscle volumes were calculated using the data 
collected from ten typically developing adolescent subjects, as described in the previous 
chapter. This data was used to alter the muscle strengths of the gait2392 OpenSim generic 
human walking model. Seven models were created to represent this range and muscle 
activations computed for each one to drive them to produce the same set of experimental 
kinematics and kinetics over a single gait cycle. Differences in the resulting simulated 
muscle activations were then compared and hence the sensitivity of the model to changes 
in muscle strength was demonstrated. 
 
4.2. Methodology 
4.2.1. Capturing Human Walking Data 
Ten adolescents with spastic diplegic cerebral palsy and ten typically developing control 
subjects were recruited for the study following the methods and selection criteria 
described in section 2.4. In addition to the muscle morphology data collected from the 
case and control groups, as described in Chapter 3, walking kinematic and kinetic data was 
also collected from all subjects using an opto-electrical motion capture system (Vicon MX 
system, T-series cameras, Oxford Metrics Group, Oxford, UK) and three strain-gauge AMTI 
OR6 force-plates (AMTI, MA, USA), following the methods described in Chapter 2. 
 
4.2.2. Setting up the Models 
As physiological cross-sectional area is directly proportional to the maximum tension that 
can be generated by a muscle (Lieber & Fridén, 2000) this parameter was to be used to 
scale the strength of the musculo-skeletal model for use in the sensitivity analysis. 
However, due to difficulties collecting architectural data (fascicle lengths and angles) as 
described in Chapter 3, and because muscle volume data was successfully collected on 
many more lower-limb muscles than was possible for PCSA due to the different imaging 
114 
modalities used, it was decided that muscle volume data would be used to scale the 
models as this made the most comprehensive use of the collected data. The normative 
range of muscle volume for each muscle was represented by seven data points calculated 
from the normalised muscle volume range of the control group data (Table 4.1).  
 
Data Point 1 2 3 4 5 6 7 








Percentile 0% 25% 33% 50% 67% 75% 100% 
ADDS 7.22 8.49 9.03 9.58 10.45 11.32 12.77 
BFLH 1.96 2.16 2.30 2.43 2.54 2.65 3.12 
BFSH 0.84 1.13 1.22 1.31 1.47 1.62 2.05 
GlutMax 8.41 9.19 9.89 10.59 11.31 12.02 13.63 
GlutMed 2.95 3.57 3.83 4.09 4.22 4.34 4.59 
GlutMin 0.93 1.00 1.11 1.22 1.29 1.36 1.61 
GRA 0.85 1.00 1.12 1.24 1.37 1.50 2.00 
LG 1.24 1.65 1.71 1.77 1.88 1.99 2.17 
MG 2.68 2.94 3.11 3.28 3.43 3.58 4.19 
RF 2.39 2.69 3.08 3.46 3.60 3.74 3.81 
SAR 1.41 1.73 1.86 1.99 2.26 2.54 2.97 
SM 2.26 2.51 2.62 2.72 2.84 2.97 3.51 
SOL 4.26 5.48 5.78 6.08 6.40 6.73 7.46 
ST 1.42 1.77 1.96 2.14 2.26 2.38 3.55 
TA 1.34 1.37 1.50 1.62 1.71 1.80 2.02 
TP 0.98 1.13 1.19 1.26 1.28 1.31 1.64 
VI 4.55 4.96 5.51 6.06 6.53 7.00 7.67 
VL 6.20 6.91 7.29 7.67 8.63 9.60 10.29 
VM 3.73 4.86 5.22 5.58 6.01 6.45 6.77 
Table 4.1 – Normative range of muscle volumes. Seven normalised muscle volume data points to 
represent the normative range of muscle volumes collected from the control group (cm
3
/kg) 
min = minimum, LIQR = lower limit of inter-quartile range, mid LIQR-med = mean value of LIQR and 
median, mid UIQR-med = mean value of UIQR and median, UIQR = upper limit of inter-quartile 
range, max = maximum, muscle codes as defined in Chapter 3. 
 
However, muscle volume is not one of the variables that can be proportionately scaled to 
a single OpenSim muscle actuator parameter, as shown in Table 3.1, and so a parameter 
conversion was necessary in order to enable appropriate scaling. This was carried out in 
two steps: firstly, the muscle actuator strength parameter, max_isometric_force, was 
converted to physiological cross-sectional area using the specific tension of 61N/cm2, used 
to create the original models (Delp, 1990); secondly, physiological cross-sectional area was 
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converted to volume using Equation 4.1, a rearranged version of Equation 3.2. Fascicle 
length and pennation values were taken from the muscle actuator parameters 
optimal_fiber_length and pennation respectively. The muscle volumes were then 
normalised to model body mass. 
 


























Vm   is normalised muscle volume for muscle m 
 mPCSA  is normalised muscle volume for muscle m 
 

m   is muscle pennation angle for muscle m 
 

L f ,m   is the fascicle length for muscle m 
 
Next it was necessary to select a baseline model from which to generate the range of 
sensitivity models. The gait2392 model was chosen and underwent scaling and marker 
adjustment (as described in Chapter 2) based on the control subject with mass closest to 
the control group median mass to avoid extremes of body size. Finally, seven versions of 
the baseline model were created with varied muscle strengths as determined by 
multiplying the max_isometric_force of each muscle actuator by the appropriate volume 









,   
 
where: imR ,   is volume Ratio for the mth muscle for the ith sensitivity model 
 imN ,  is Normative muscle volume for the mth muscle for the ith sensitivity model 
 mB   is Baseline model muscle actuator volume for the mth muscle 
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For muscle actuators for which there were no experimental data, the mean volume ratio 
of all measured muscles was used. The resulting seven models (Table 4.2) therefore 
represented a range of muscle strengths from weak to strong as defined by the control 
muscle volume data measured in Chapter 3.  
 
Percentile 0% 25% 38% 50% 63% 75% 100% 
Model code 5b 5 6 7 8 9 10 
R (vol. ratio) 0.82 0.96 1.03 1.11 1.18 1.26 1.44 
Description min v. weak weak median strong v. strong max 
Table 4.2 – Mean volume ratios (R) and descriptions of the seven sensitivity models 
 
An additional number of models were created to investigate the sensitivity of the 
simulations to the variation in hamstring, gastrocnemius or soleus muscle strength 
specifically. These models were copies of the median strength model (Model07 - Table 
4.2) with additional modification of the appropriate muscles as outlined in Table 4.3. 
 
 hamstrings medial & lateral gastrocnemius soleus 
Percentile 25% 38% 63% 75% 25% 38% 63% 75% 25% 38% 63% 75% 
Model code 11 12 13 14 15 16 17 18 19 20 21 22 

















Table 4.3 – Mean volume ratios (R) and descriptions of the additional sensitivity models 
 
4.2.3. Simulations and Analysis 
Using the gait data collected from the control subject chosen to create the baseline 
model, one walking trial was selected that contained three successive force-plate hits to 
ensure kinetic data was available over a whole gait cycle. Following the SimTrack method 
described in Chapter 2, marker trajectories and ground-reaction-force data from this gait 
cycle were input into OpenSim, and Inverse Kinematics, Residual Reduction and both 
Static Optimisation and Computed Muscle Control tools were run over this data range to 
calculate joint kinematics and two sets of muscle actuator activations for comparison. This 




Analysis was carried out using Matlab (The MathworksTM Inc., MA, USA). Sensitivity of the 
simulated muscle actuator activations to changes in muscle strength were then calculated 
using the following normalised root mean square error (RMSE) method (Equation 4.3). 
 
 Activation data for each muscle actuator was re-sampled to 201 data-points over 
the gait cycle. 
 RMSE between each instance of the model and the baseline model was calculated 
over the whole gait cycle for each muscle actuator for all muscle actuators in the 
lower limb on the side of the gait cycle selected (e.g. left or right). 
 RMSE values for each muscle actuator were then normalised by dividing by the 
mean activation of that muscle of the baseline model. Results were then reported 























where: NRMSE  is normalised root mean square error (%) 
 A  is simulated muscle actuator activation 
 
 subscripts: 
 s  =   sth sensitivity model (18 sensitivity models) 
 m  =   mth muscle actuator (43 muscle actuators) 
 n  =   nth data-point (201 data-points) 




The age, height, mass and mean muscle volume ratio (R) for all ten control subjects used 
to collate the normative muscle volume range for adolescents is shown in Table 4.4. The 
subject chosen to create the baseline model was Control08 as the mass (59.2kg) was 
closest to the control group median mass (60.1kg). Coincidentally, the height of Control08 
was equal to the control group median height indicating that Control08 was a suitable 
mid-range subject for both height and mass. Motion capture data of a right leg gait cycle 
with continuous force-plate data from this subject was chosen for the sensitivity analysis. 
 
Control 01 02 03 04 05 06 07 08 09 10 Gait2392 
Age (years) 12.4 10.6 18.6 14.3 18.6 11.9 14.0 16.5 17.4 12.4 - 
Height (m) 1.57 1.37 1.75 1.70 1.64 1.64 1.82 1.68 1.80 1.57 1.8 
Mass (kg) 47 39 68 83 58 56 61 59 83 75 75 
R (vol. ratio) 1.0 0.6 1.1 1.2 0.9 1.2 1.3 1.1 1.7 1.7 - 
Table 4.4 – Mean volume ratios (R) for all ten control subjects  
 
4.3.1. Scaling and Inverse Kinematics (IK) 
Scaling and Inverse Kinematics tools were run successfully to create the input joint angles 
for the subsequent simulations. A comparison between the kinematics created using the 
Vicon Plug-in-Gait model and the kinematics resulting from the OpenSim Inverse 
Kinematics tool can be seen in Figure 4.1. The two kinematic datasets are not expected to 
be identical due to the differences between the two models (Table 4.5: in particular Plug-
in-Gait ankle rotation and OpenSim subtalar_angle are not directly equivalent, however, 
this problem is overcome by locking the subtalar_angle at neutral, as explained in Chapter 
2). However, as a rough comparison it shows that appropriate joint angles have been 
input to the simulations for this walk. Some deviation can be seen between the two 
kinematic datasets in hip rotation which is likely to have been caused by skin movement 
under the thigh marker (THI). A portion of this movement will be interpreted by the Plug-
in-Gait model as thigh rotation but as the OpenSim Inverse Kinematics tool calculates 
rotations based on all the markers fixed to the thigh segment, erratic movement of one 
single marker will be smoothed out. Typically developing adult kinematics, as collected by 
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the Guy’s Hospital Gait Laboratory, is also shown in Figure 4.1. The kinematics can be seen 
to broadly lie within these normal limits.  
 
 
Figure 4.1 – Kinematic comparison between Vicon Plug-in-Gait and OpenSim. A comparison between the 
kinematics created using the Vicon Plug-in-Gait model (green curves) and the kinematics resulting from the 
OpenSim Inverse Kinematics tool (blue curves). The grey band shows the control limits for typically 
developing adults (Guy’s Hospital Gait Laboratory). 
Vertical axis shows joint angles measured in degrees, horizontal axis shows % gait cycle. 
Flex/Ext = flexion/extension, Abd/Add = abduction/adduction, post = posterior, ant = anterior, ext = external, 
int = internal, PF = plantarflexion, DF = dorsiflexion 
 
Vicon Plug-in-Gait Joint Angle OpenSim Coordinate 
pelvis1 (tilt) pelvis_tilt 
pelvis2 (obliquity) pelvis_list 
pelvis3 (rotation) pelvis_rotation 
hip1 (flexion) hip_flexion 
hip2 (abduction) hip_adduction 
hip3 (rotation) hip_rotation 
knee1 (flexion) knee_angle 
ankle1 (dorsiflexion) ankle_angle 
ankle3 (rotation) subtalar_angle 
Table 4.5 – Comparison joint angles between the Vicon 
Plug-in-Gait and OpenSim gait2392 models 
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4.3.2. Residual Reduction Algorithm (RRA) 
The Residual Reduction Algorithm tool was run twice on the simulation data to minimise 
mismatches between the recorded kinematics and kinetics and hence reduce the residual 
actuator forces that are necessary to ensure the simulation follows the prescribed 
kinematics. The magnitude of these six residual forces and moments over the gait cycle 
before and after running the Residual Reduction Algorithm tool are shown in Figure 4.2 







































































































(c) Before RRA (d) After RRA 
Figure 4.2 – Residual actuator forces and moments applied over the gait cycle to the model pelvis 
segment to minimise mismatch between the kinematics as calculated from the OpenSim Inverse Kinematics 
tool and the recorded ground-reaction-force. (a) and (b) show the residual forces (N) before and after 
running the Residual Reduction Algorithm (RRA). (c) and (d) show the residual moments (Nm) before and 




It is difficult to see any changes in the residual actuators from Figure 4.2, except the mean 
shift of Fy closer to zero, but the magnitudes of these residuals give us an insight into the 
likelihood that a biomechanical walking simulation will successfully run using this model 
and the kinematic/kinetic input datasets. 
 
The residual forces necessary to keep the kinematics and kinetics matched in the X 
(anterior/posterior) and Z (medial/lateral) directions are less than 5N and reasonably 
stable. The residual force in the Y (vertical) direction is more variable and larger, peaking 
at c.10N (2% bodyweight). The maximum residual moment is found around the Z (medial-
lateral) axis and peaks at c.17Nm. The residual acceptability thresholds recommended by 
the OpenSim developers were residual forces and moments below 10N and 50Nm 
respectively (Table 2.4). It is difficult to compare these values to typical gait kinetics as 
these residuals are global moments applied to the whole model at the pelvis segment 
rather than individual joint moments. The appropriateness of these thresholds was 
discussed in section 2.2.3 and 50Nm was considered too high. However, the purpose of 
this sensitivity analysis was to test the SimTrack method of movement simulation and 
therefore, irrespective of this concern, both these residual acceptability thresholds were 
adopted and hence all residuals were deemed acceptable. 
  
As described in section 2.2.3, outputs from the first run of the Residual Reduction 
Algorithm include suggested changes to the model mass (to reduce the Fy residual) and 
suggested changes to the position of the torso centre of mass (to reduce the Mx and Mz 
residuals). These changes were implemented before the second run of the residual 
reduction tool. However, the OpenSim software summarises each of these residuals using 
an arithmetic mean and, due to the cancellation of positive and negative values, this can 
give an overly generous and misleading impression of the success of residual reduction. 
This problem can be simply avoided by using the mean of the absolute residuals but this 




The difference between these two methods of summarising residuals can be seen in 
Figure 4.3. The visual inspection of Figure 4.2 described above showed only the Fy residual 
successfully reduced. This is more clearly represented by mean absolute calculation. 
 



















































Before RRA 2.66 -3.50 -0.67 -0.17 0.09 -0.36  0.3 4 -2 
After RRA 2.59 -0.46 -0.66 -0.03 0.08 -0.13  0.0 1 1 
Before RRA 2.70 4.83 0.85 3.78 3.39 7.77     
After RRA 2.63 3.81 0.84 3.80 3.41 7.82     
Figure 4.3 – Mean changes in residual actuator forces and moments after running the Residual 
Reduction Algorithm. The table shows the mean residual actuator forces and moments for the sensitivity 
analysis walking trial before and after running the Residual Reduction Algorithm (RRA) twice. Suggested 
model mass changes (∆mass) and torso centre of mass position changes in the anterior/posterior 
direction (∆CoMx) and medial/lateral direction (∆CoMz) for each run are also shown. The figure shows the 
change (increase positive, reduction negative) for each of the six residual actuators as calculated by 
OpenSim using a arithmetic mean over the gait cycle or as calculated using the arithmetic mean of the 
absolute value (mean abs) over the gait cycle. 
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4.3.3. Static Optimisation (SO) and Computed Muscle Control (CMC) 
Experimental kinematics and force-plate data during a right leg gait cycle from the 
baseline subject were used as input to both the Static Optimisation and the Computed 
Muscle Control tools in OpenSim to obtain simulated muscle actuator activations for each 
of the sensitivity models. Output kinematics from the Computed Muscle Control tool 
showed successful tracking of the input kinematics to within 1°. Output kinematics are not 
provided by the Static Optimisation tool. 
  
The reserve forces/moments and residuals moments shown in Figure 4.4 are generally 
within acceptable limits as outlined in section 2.2.3 – again these limits have been 
adopted despite concerns of their appropriateness in order to test the SimTrack 
methodology. Residuals for the other sensitivity models were similar except for the 
weakest model (5b) which had larger residuals and a second ankle_angle_r spike at 0.85s 
(but still within acceptable limits) and the strongest model (10) which had lower residual 
actuator magnitudes.  
 
Individual muscle actuator activations over the gait cycle for models 5b-10 from both 
Static Optimisation and Computed Muscle Control tools are shown in Figure 4.5. In the 
Computed Muscle Control data some unstable behaviour of the tibialis anterior actuator 
can be seen which appears to be propagating into other actuators, specifically toe flexors 
and plantarflexors. In addition, there are some unexpected peaks of high 
activity/saturation (even for the strong model) which suggests some form of problem has 
occurred running the Computed Muscle Control algorithm. This will be discussed in more 
detail in Chapter 5, where more than one set of input kinematics/ground-reaction-forces 
is available to allow a more detailed investigation into possible causes of the problem. For 
the rest of this chapter therefore, only actuator activations as calculated using the Static 
Optimisation tool will be discussed. 
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(a) CMC residuals/reserves 
 
(b) SO residuals/reserves 
Figure 4.4 – (a) CMC & (b) SO residual forces/moments & reserve moments for the baseline model (Model07) . 
Acceptable limits: reserve forces ±10N, reserve moments ±50Nm, residual hip flexion/adduction ±5.9 Nm, hip 
rotation 1.2Nm, knee flexion 3.6Nm, ankle flexion 11.3Nm. X ,Y. Z represent anterior/posterior, vertical and 




(a) CMC activations 
 
(b) SO activations 
Figure 4.5 – Muscle actuator sensitivity. (a) CMC and (b) SO simulated activations for 42 of the models’ 
right lower limb muscle actuators for each of the seven principal sensitivity models. 
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In the Static Optimisation data all actuators show an increase in activation with decreasing 
model strength. This is confirmed by Figure 4.6 which shows the mean normalised RMSE 
values calculated from all 43 right lower limb actuators for the six globally altered models 
(5b-10). A normalised RMSE value of 100% would indicate that the RMS difference 
between the new activation and the baseline activation was equivalent to the magnitude 
of the mean baseline activation. As would be expected, there is a general increase in 
muscle actuator activation for the weakened models and a general decrease in activation 
for the strengthened models.  
 
 
Figure 4.6 – Change in SO activations: mean normalised root mean square errors (NRMSE) for each of the 
six globally altered models (Models 5b-10) calculated from the mean NRMSE over all 43 right lower limb 
actuators. A positive value was assigned to models with a general increase in activation and negative to 
models with a general decrease in activation compared to the baseline model 
 
Changes in muscle actuator activation over the gait cycle for variation in the strength of 
the hamstrings (Models 11-14), gastrocnemius (Models 15-18), and soleus (Models 19-22) 









Figure 4.7 – Hamstring strength sensitivity. SO simulated muscle actuator activations for 42 of the models’ right 




Figure 4.8 – Gastrocnemius strength sensitivity. SO simulated muscle actuator activations for 42 of the models’ 





Figure 4.9 – Soleus strength sensitivity. SO simulated muscle actuator activations for 42 of the models’ right 
lower limb muscle actuators for each of the four sensitivity models 19-22 compared to the baseline Model07 
 
4.4. Discussion 
The gait2392 model was created using adult cadaveric data with modified muscle 
strengths to match experimental data of adult joint torques and is based on a subject of 
height 1.8m and mass 75kg. As muscle strengths are not altered when this generic model 
is scaled to match the stature of smaller subjects, muscle strengths in these scaled models 
were expected to be inappropriate (too large) for child or adolescent populations. Muscle 
volumes were collected from ten typically developing child/adolescent subjects 
(mean(SD): age 15.4(3.2)years, height 1.7(0.1)m, mass 62.8(14.4)kg) and compared to the 
volumes of the gait2392 model using a muscle volume ratio (Equation 4.2) in order to test 
this supposition. 
 
A mean volume ratio of less than one would imply that on average the subject has smaller 
muscle volumes than the generic gait2392 model. The mean and standard deviation of the 
mean muscle volume ratios for the control subjects (Table 4.4) were 1.18(0.34). Muscle 
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volumes in the child/adolescent group were therefore not generally smaller than the 
generic model. 
 
An inspection of the relationships between muscle volume and potential predictors was 
carried out using simple linear regression (Figure 4.10). The deviation in muscle volume 
(and hence strength) from the generic gait2392 model appears to be most correlated to 
differences in body mass, and to a smaller degree, to differences in height or BMI, with 
little correlation found with age. Due to the small sample size there was not enough data 
to perform a fuller analysis to develop a predictive equation for muscle volume based on 
anthropometric parameters. It is likely therefore that the muscle strengths of the gait2392 
model would be appropriate for child populations of typically developing subjects of 
similar weight to those used in this study, but maybe inappropriate for lighter children. It 
would also be useful for the OpenSim scaling tool to alter the max_isometric_force muscle 
parameters by the ratio of the subject mass/generic model mass.  
 
 
Figure 4.10 – Correlation of control group parameters against muscle volume. 
Correlation via linear regression of BMI, mass, height and age against the mean muscle 
volume ratio for each of the ten control subjects. BMI, height and mass of the un-
scaled gait2392 model are shown in red. 
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The mean muscle volume ratios for the seven principal sensitivity models (Table 4.2) were 
calculated from this normative range of adolescent data using muscle volumes normalised 
to body mass. As the baseline model, Control08, had a similar mass (59.2kg) to that of the 
gait2392 model (75kg) the mean volume ratios for the sensitivity models were closer to 
unity than for the individual control subjects. The strengths of the sensitivity models were 
therefore more similar in magnitude to the gait2392 model than they would have been by 
using other control subjects. 
 
 
Figure 4.11 – Correlation of case group parameters against muscle volume. 
Correlation via linear regression of BMI, mass, height and age against the mean muscle 
volume ratio for each of the ten case subjects. BMI, height and mass of the un-scaled 
gait2392 model are shown in red. 
 
Although not normally the case for the more ambulant individuals, subjects with cerebral 
palsy are often smaller and lighter than their typically developing peers (Day et al., 2007). 
This was shown to be true in the case and control data analysed in Chapter 3. The mean 
and standard deviation of mean muscle volume ratios for the case subjects were 0.7(0.2) 
with a range from 0.4 to 1.1. This shows that muscle volumes in this group are generally 
smaller than the generic model and so it would be ill advised to use this model in 
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simulations of cerebral palsy subjects without appropriate scaling of muscle strength. The 
simple linear regression analysis (Figure 4.11) shows the deviation in muscle volume from 
the generic gait2392 model appears to be most correlated to differences in body mass. 
Once again therefore it is suggested that the OpenSim scaling tool should alter the 
max_isometric_force muscle parameters by the ratio of the subject mass/generic model 
mass. 
 
4.4.1. Activation changes following global alterations of muscle strength 
Figure 4.5 shows the individual changes in muscle activation for each of the seven 
principal sensitivity models in which all muscle strengths were altered, and Figure 4.6 
summarises the changes for each model. As expected, both show a clear trend of higher 
activations for weaker models. In particular, high sensitivity is seen in medial 
gastrocnemius, soleus, gluteus medius, iliacus and psoas. In addition, there are a number 
of individual activations which require further comment. 
 
In the weakest model (Model05b) one muscle actuator, medial gastrocnemius, saturates 
into maximal activation. This can be seen to coincide with a slight increase in activation of 
the lateral gastrocnemius and a larger increase in activation of the slightly later acting 
soleus, both of which presumably have been recruited to compensate for the resulting 
plantarflexion insufficiency. There is also high activation and sensitivity in both the hip 
flexor actuators iliacus and psoas during pre-swing. High activity is not unexpected in this 
part of the gait cycle as this is a region of peak hip flexion but the reason for the increased 
sensitivity is less clear as these actuators were not disproportionately weakened 
compared to others. It is possible that the optimisation is complicated by muscle actuators 
operating outside of their optimum lengths but as the Static Optimisation tool does not 
output muscle fibre lengths this could not be verified. 
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4.4.2. Activation changes following localised alterations of muscle strength 
Changes in activation following alterations to hamstrings, gastrocnemius, and soleus 
strength are shown in Figure 4.7, Figure 4.8 and Figure 4.9 respectively. The changes in 
activations are much smaller and more localised to the specific muscle actuators that have 
been weakened when compared to Figure 4.5 and again, as would be expected, there is a 
clear trend for increased activation in the weaker models.  
 
Only the soleus is affected during soleus weakening (Figure 4.9). During hamstring 
weakening the most sensitive muscle actuator appears to be the semimembranosus 
(Figure 4.7) and during gastrocnemius weakening it is the medial side that appears slightly 
more sensitive (Figure 4.8). This is likely due to the cost function giving preference to the 
stronger muscles – in Model07 the semimembranosus is almost as strong as all the other 
hamstrings combined and the medial head of the gastrocnemius has twice the strength of 
the lateral head. Muscle weakness can therefore be resolved more “cheaply” by a small 
increase in activation of the larger muscle rather than a larger increase in activation of 
smaller ones. 
 
4.4.3. Sensitivity of muscle activation to changes in muscle strength 
To assess the sensitivity of the different muscle actuators in these simulations it is 
necessary to examine the individual root mean square activation differences from the 
baseline model. The ten most sensitive (largest RMSE) right lower limb actuators were 





Figure 4.12 – Sensitivity Analysis. Mean root mean square errors (RMSE) for the most sensitive muscle 
actuators from all eighteen sensitivity simulations. The ten most sensitive actuators were selected from each 
simulation and compiled. The count number is the number of times an actuator appeared in the top ten (i.e. 
count = 18, one of the top 10 most sensitive actuators in all 18 simulations). 
 
All = models 05b-10, Hams = models 11-14, Gastrocs = models 15-18, Soleus = models 19-22. 
 
It can be seen that muscle activation sensitivity to global changes in muscle strength is 
dominated by the plantarflexors (principally the medial gastrocnemius), the hip adductor 
gluteus medius, and the hip flexors iliacus and psoas. Predictably, muscle activation 
sensitivity to local changes in muscle strength are localised to the weakened areas. The 
semimembranosus was most affected during hamstring weakening, and the medial head 
was more affected during gastrocnemius weakening. A link in sensitivity between the 
plantarflexors and the hamstrings can also be seen with both muscle actuator groups 
being affected by weakness at either location, and again with the semimembranosus and 
medial gastrocnemius being most affected. It is likely that both of these muscle groups are 
linked via a knee flexion weakness compensatory mechanism. It is the change in activation 
of the medial hamstrings at late stance during gastrocnemius weakening that is most 
striking however, as they are more sensitive to this than when they are weakened directly. 
It is possible that this is a result of the Static Optimisation criterion. As the gastrocnemius 
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is already very active and the hamstrings quiet during this period of the gait cycle, 
minimising total muscle activation squared means it “costs” far less to compensate for 
gastrocnemius knee flexion weakness with an increase in hamstring activity than it does to 
increase gastrocnemius activity. 
 
4.5. Conclusions and Limitations 
A normative range of lower limb muscle volumes in typically developing adolescents were 
used to scale the strength of the gait2392 OpenSim generic musculo-skeletal model and 
muscle activations were simulated over a single gait cycle to examine the sensitivity of 
simulated muscle activation to changes in muscle strength. 
 
In general, small increases in muscle activation were seen for weakened muscles as well as 
in their synergists confirming that the model is insensitive to muscle strength changes 
over a normative range. However, larger increases in activation occurred in muscle 
actuators that approached maximum activation as well as in their synergist and 
compensatory muscles. This can be seen in Figure 4.5 where the medial gastrocnemius 
saturates into maximum activation in the weakest model. In such cases the model is very 
sensitive to changes in muscle strength and so simulated activations must be treated with 
caution. 
 
As the muscle models in the gait2392 model have been parameterised using data from 
cadaveric studies of elderly subjects, and because muscle strength is not scaled when the 
model is resized to match the stature of a new subject, it was expected that the muscle 
strengths of the gait2392 model would not be appropriate for use in simulations of gait in 
child/adolescent subjects. However, muscle volumes from an adolescent group of typically 
developing subjects were found to be similar (as determined by the muscle volume ratio 
R) to muscle volumes calculated from the model. However, a strong correlation was found 
between the muscle volume ratio (R) and body mass, implying that the muscle strength of 
the generic model will become less appropriate for use in simulations of lighter subjects 
(of any age). It is therefore recommended that the subject/gait2392model mass ratio is 
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used to scale the max_isometric_force parameters of this generic model if it is to be used 
in subject specific simulations. This may be especially relevant in the simulation of gait in 
subjects with cerebral palsy as they are often lighter than their typically developing peers. 
This is confirmed in the case and control subjects recruited for this study (Chapter 3). 
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5 The level of agreement of simulated muscle activations 
with activation profiles derived from experimental EMG 
in typically developing adolescents and adolescents with 
cerebral palsy during walking 
 
3D, multi-segment, musculo-skeletal models scaled to height, mass and muscle volume, 
were created for ten typically developing adolescents and ten adolescents with cerebral 
palsy. Each model’s muscle activations were allowed to vary in order to track the subject’s 
recorded walking pattern driven by an algorithm to minimise total muscle activation. The 
validity of a selection of simulated muscle activations were then determined, using a 
validity threshold based on intra- and inter-subject variability of activations determined 
from experimental electromyographic (EMG) data. Using this method, in the reduced set 
of nine actuators for which EMG data was available, all of the simulated muscle 
activations in both groups were found to be invalid. After allowing a generous 
optimisation of the simulated muscle activations in both amplitude and time, valid muscle 
activations were found in the control group for 5/9 actuators: semitendinosus, 
semimembranosus, biceps femoris long head, medial gastrocnemius, lateral 
gastrocnemius; and in the case group for only 3/9 actuators: semimembranosus, rectus 
femoris and medial gastrocnemius. 
 
5.1. Introduction 
The musculo-skeletal modelling software OpenSim is able to calculate muscle actuator 
activations that drive a model to follow a set of prescribed kinematics. In the work 
described in the previous chapter, the change in activation over a range of normative 
model strengths was used as a measure of model sensitivity. The simulations were found 
to be sufficiently robust to changes in actuator strength to allow bespoke model strengths 
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to be used. The possibility of using such computed modelling techniques in the analysis 
and clinical interpretation of biomechanical data is of interest to the clinician but it is 
important that appropriate validation studies are carried out to ensure the fidelity of the 
output of any such “black-box” simulations. What is the similarity between calculated 
muscle activation and experimental measurements of muscle action, i.e. how similar to 
real human muscle activations are these simulated activations? 
 
The early development of SIMM is documented in Delp (1990) but the validation analysis 
carried out in this work focused on comparing simulated to experimental joint torque data 
rather than looking at muscle activations. The combination of less advanced computing 
power and computationally heavy algorithms such as Dynamic Optimisation that were 
available at this time made such calculations less practical and hence limited work was 
carried out using these techniques. Anderson & Pandy (2001) used a dynamic optimisation 
method with a muscle metabolic energy cost function to calculate muscle actuator 
activations for a model similar to gait2392 (described in Chapter 2) during a walking task 
in five typically developing male adults. A qualitative comparison of simulated activations 
to experimental EMG (normalised to maximum voluntary contractions) was used to 
validate the model outputs and the two datasets were generally found to be consistent. 
 
Neptune et al. (2001) used a similar model, again based on Scott Delp’s work (Delp, 1990), 
to investigate the contributions of the ankle plantarflexors to human gait in five typically 
developing male adults. They solved the static indeterminacy problem (section 2.1.3) by 
using a simulated annealing optimisation algorithm to minimise differences in simulated 
and experimental kinematics and kinetics. Muscle actuator activations were constrained 
to ±25% of the gait cycle timings of Perry (1992) and so the brief qualitative comparison of 
the resulting simulated activations gave a predictably good match. This is an important 
result as it demonstrates that the model can be successfully driven to follow the desired 
movement pattern using near normal timing of muscle activations. 
 
Faster methods of calculating muscle activations have since become available which have 
led to an increased interest in these simulation techniques amongst researchers. Indeed, 
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the Computed Muscle Control algorithm, outlined by Thelen et al. (2003), when compared 
to a simulated annealing approach led to a reduction in computational time for a cycling 
simulation from 160 hours to 10 minutes. Validation of the resulting actuator activations is 
made by qualitative comparison to experimental EMG timings but as neither EMG 
collection nor processing methodologies are reported it is difficult to interpret these 
results. Some later work by Thelen & Anderson (2006) made use of a slightly modified 
Computed Muscle Control algorithm to simulate muscle activations during walking in ten 
typically developing adults using the gait2392 model and inputting experimental kinematic 
and kinetic data. This approach is very similar to one of the methodologies adopted in this 
chapter, but Thelen & Anderson (2006) validated their results principally by comparing the 
simulated kinematics and kinetics to the original experimental data and only gave a brief 
qualitative comparison of their actuator activations to EMG data published in Winter 
(1990). 
 
A year later Arnold et al. (2007) used muscle actuator activations during human walking 
calculated from the Computed Muscle Control algorithm as input to a perturbation 
analysis to examine muscle contributions to knee motion during the swing phase of six 
typically developing children. They refer to a comparison of simulated actuator activations 
to experimental surface EMG for the hamstrings, rectus femoris, gastrocnemius and 
tibialis anterior, finding similarities in most cases, but this data is not reported in the paper 
and only a comparison to the EMG timings of Perry (1992) is given. They also report that 
one or more actuators required constraint to eliminate inappropriate excitations but do 
not give any further details on which actuators or how this was carried out. 
 
Liu et al. (2008) also carried out a perturbation analysis using the gait2392 model looking 
at the change in muscle contributions to support and progression over a range of walking 
speeds in typically developing subjects. The simulated muscle activations averaged across 
all eight subjects were presented graphically alongside experimental surface EMG 
envelopes normalised to the peak EMG signal for each muscle across all walking speeds 
and averaged across all subjects. The authors made no comment on this comparison and 
described the EMG data as highly variable. Looking at their graphs (Figure 4 – Liu et al., 
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2008) there is generally a good agreement in both timing and magnitude between 
simulated activations and EMG except: timing of simulated plantarflexion action is 
delayed; simulated rectus femoris activity is low during early stance; and both rectus 
femoris and vastus medialis simulated activity is early in swing.  
 
Steele et al. (2010) carried out a similar approach and examined muscle contributions to 
support and progression during single support in crouch gait of nine subjects. Surface EMG 
data was collected from the medial hamstrings, biceps femoris long head, rectus femoris, 
gastrocnemius and tibialis anterior. Both EMG data and simulated actuator activations 
were normalised to the peak value of each muscle of each subject for comparison. The 
authors described the two data sets as exhibiting similar on-off patterns but highlighted 
excessive simulated rectus femoris activity during swing and reduced simulated biceps 
femoris activity during terminal swing (although this comment does not agree with their 
Figure 3 which shows a good match for biceps femoris activity and reduced 
semimembranosus activity in terminal swing). The authors also carried out an additional 
analysis looking at the sensitivity of the perturbation technique to mismatches between 
the simulated activations and experimental EMG. Simulated activations of ten actuators 
were constrained to better match the appropriate EMG and the perturbation analysis was 
repeated for one subject. Magnitudes of the muscle contributions to support and 
progression were altered but the directions stayed the same. The authors concluded that 
as these changes did not alter their conclusions it was therefore appropriate to have used 
un-constrained actuator activations in their principal analysis. This is a surprising 
argument as altered activations should lead to changes in the timing of muscle 
contributions. 
 
Lin et al. (2011) carried out an investigation into the differences of muscle force estimates 
from three different methods commonly reported in the literature: Static Optimisation, 
Computed Muscle Control, and Neuro-Musculo-Skeletal Tracking. Using an optical motion 
capture system and force-plates they collected walking and running data for a single 
healthy adult female subject whilst simultaneously recording surface EMG data from 
seven lower-limb muscles. The muscle forces estimated by the three different methods 
140 
for one walking trial and one running trial were then compared using correlation 
coefficients. The estimated forces were also qualitatively compared to the experimental 
EMG data. The authors concluded that the three methods produced similar muscle force 
estimations and these were consistent with the sequence and timing of the EMG data. 
However, they also concluded that Static Optimisation possessed several advantages in 
relation to accuracy, robustness and efficiency (terms the authors define) when compared 
to the other two methods. 
 
In response to the increased interest in using induced acceleration techniques to quantify 
muscle contributions during gait, Dorn et al. (2012) examined the sensitivity of these 
techniques to different ground contact models. They simulated the actuator activations 
for walking and running in fourteen typically developing adults using the gait2354 model 
and calculated each actuator’s contribution to each of the three components of ground-
reaction-force for a number of different ground contact models. Inconsistencies were 
found in the prediction of muscle function in the coronal plane. In addition, surface EMG 
was collected from the gluteus maximus, gluteus medius, medial hamstrings, vastus 
lateralis, medial gastrocnemius and soleus from one leg of each subject. No normalisation 
was carried out and actuator forces (rather that activation) were shown to be similar to 
EMG timings averaged across all subjects in a brief qualitative comparison. 
 
Many musculo-skeletal gait simulation papers are published in the literature each year 
using software and methods similar to the Computed Muscle Control and induced 
acceleration techniques found in OpenSim but few make comment on the success of 
these simulations in terms of minimising the recruitment of residual/reserve actuators 
and to date none have attempted to conduct a quantitative analysis of the level of 
agreement between simulated and experimentally derived muscle activations. Simulation 
of muscle activity from generic models is adequate to elucidate our understanding of 
generic factors of human gait, such as muscle function, but confidence in an individual 
patient’s simulation data from subject specific models is necessary if these techniques are 
to be developed further. There is an increased interest in the potential of implementing 
subject-specific musculo-skeletal simulations into the clinical gait analysis process and to 
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use them as an aid to treatment planning or as a method of virtually testing potential 
interventions. If this is to become a reality, then validation of these methods must be 
carried out. 
 
In the work described in this chapter, the validity of the muscle actuator activations 
generated by OpenSim was determined by a quantitative comparison with recorded 
surface EMG data during human walking for ten typically developing subjects and ten 
subjects with cerebral palsy. 
 
5.2. Methodology 
Ten adolescents with spastic diplegic cerebral palsy and ten typically developing control 
subjects were recruited for the study following the methods and selection criteria 
described in section 2.4. In addition to the collection of muscle morphology data (Chapter 
3), and the collection of walking kinematic and kinetic data (Chapter 4), EMG data was 
also collected for a standing pose and during walking using a Delsys Bagnoli-16 EMG 
system (Delsys Inc., MA, USA) as described in section 2.4.3. EMG data was also collected 
for a series of maximum voluntary contractions (section 2.4.4).  
 
5.2.1. Setting up the Models 
Subject mass and marker trajectories from the standing pose were used to create scaled 
and marker adjusted copies of the gait2392 model (section 2.2.2) for each of the twenty 
subjects. The strength of each model was then adjusted following a similar technique to 
that described in Chapter 4 but using subject specific muscle volume data. The 
max_isometric_force of each muscle actuator was multiplied by the appropriate muscle 
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where: smR ,   is the volume Ratio for the m
th muscle for the sth subject model 
 smS ,   is the Subject specific muscle volume 
 smM ,   is the subject scaled Model muscle actuator volume 
 
 subscripts: 
 m  =  mth muscle actuator (43 muscle actuators) 
 s  =  sth subject model (10 control and 10 case models) 
 
It was not possible to measure the volumes of all 92 muscles used in the gait2392 gait 
model and so for muscle actuators for which subject specific values were not available, 
the mean volume ratio of all measured muscles was used. 
 
5.2.2. Calculating Muscle Activations from Electromyography 
Experimental surface EMG (section 2.4.3) were collected from each subject during 
maximum voluntary contractions and during walking for the following muscles: soleus, 
lateral gastrocnemius, medial gastrocnemius, tibialis anterior, rectus femoris, vastus 
lateralis, semimembranosus and semitendinosus. Experimental muscle activations were 




     






 1. Rectification 2. Filtering 3. Activation Dynamics 4. Non-linearisation  
 
Figure 5.1 – Four step method for conversion of EMG signals to muscle activations as 
outlined by Buchanan et al. (2004). It is assumed that the raw EMG data has been collected 
after high pass filtering. Signals are then rectified and low pass filtered to produce an 
envelope. Normalisation to maximum voluntary contraction can be carried out at this stage. 
Two final processing stages then take into account activation dynamics and the non-linear 
relationship of muscle activation to EMG that represents the muscle twitch response 
mechanism.  
 
The raw EMG signals were sampled at 1080Hz after passing through a low pass (450Hz) 
analogue filter to prevent aliasing. A digital band-pass filter (20-400Hz) was applied using 
Matlab (The MathworksTM Inc., MA, USA) to remove DC offsets and low frequency 
artefacts. The following additional signal processing (steps 1-4 Figure 5.1) was also 
performed using Matlab: 
 
Step 1: rectification was carried out by taking the absolute value of the signal. 
 
Step 2: the signal envelope, e(t), was calculated using a low-pass Butterworth filter (2nd 
order, cut-off 6Hz) with zero phase shift. Signal envelopes were then normalised to 
maximum voluntary contraction data. 
 
Step 3: muscle activation dynamics can be modelled using a first order differential 
equation (Zajac, 1989) to convert the rectified EMG envelope e(t) to neural activation u(t). 
This is more conveniently done for sampled data using a second order, discretised, 
recursive filter (Equation 5.2) with coefficient values taken from Buchanan et al. (2004).  
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Equation 5.2  

u(t) e t  d 1u t 1 2u t 2  
 
where: )(tu   is neural activation 
 )(te   is rectified EMG envelope 
 α, β1, β2  are coefficients to define the second-order dynamics 
  α = 2.25 β1 = 1 β2 = 0.25 
 d = 40ms is the electromechanical delay 
 
Step 4: the non-linearity between neural activation and muscle force at high stimulation 
frequencies that corresponds to the muscle twitch mechanism approaching tetanus is not 
characterised by the neural activation term u(t) and hence it is necessary to introduce a 





eA u( t )
eA 1  
 
where: )(ta  is muscle activation 
 )(tu  is neural activation 
 A = -1 (non-linearisation curve factor) 
 
5.2.3. Simulations and Analysis 
Five gait cycles, each with three successive force-plate hits to ensure kinetic data was 
available over a whole gait cycle, were selected for each subject and kinematics and 
kinetics calculated using the Vicon Plug-in-Gait model (section 2.4.1). Following the 
SimTrack method described in Chapter 2, marker trajectories and ground-reaction-force 
data from each gait cycle were input into OpenSim, and Inverse Kinematics, Residual 
Reduction and both Static Optimisation and Computed Muscle Control tools were run to 
calculate joint kinematics and two sets of muscle actuator activations for comparison. 
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A number of checks were carried out to verify that each simulated gait cycle had run 
successfully before muscle activation validity analysis was carried out. In order to test 
SimTrack the recommended acceptability thresholds were adopted for this purpose 
despite concerns over their generosity (as discussed in section 2.2.3). 
 
 Check 1 – first kinematics check: OpenSim Inverse Kinematics was compared to the 
equivalent datasets calculated using the Vicon Plug-in-Gait model to ensure 
appropriate joint angles were input into the Static Optimisation and Computed 
Muscle Control tools. Simulations were rejected for gross deviations in joint angles 
(>10°) 
 
 Check 2 – second kinematics check: the resulting kinematics after the Computed 
Muscle Control tool was run were compared to the OpenSim Inverse Kinematics to 
ensure that the calculated muscle actuator activations successfully recreated the 
original motion. Simulations were rejected for changes in kinematics above 
recommended acceptability thresholds: >2° or >1cm (Table 2.5). 
 
 Check 3 – the magnitude of residual and reserve actuators were checked against 
acceptability thresholds (Table 2.5, Table 2.6): 
 
Residuals Reserve joint actuators (Nm/kg) 
Forces < 10N hip flex/ext  < 0.1 
Moments < 50Nm hip abd/add  < 0.1 
 hip rotation  < 0.02 
 knee flex/ext < 0.06 
 ankle flex/ext < 0.19 
 




Muscle activation validity was carried out using a root mean square error (RMSE) analysis 
comparing simulated muscle activity against muscle activations calculated from 
















where: E  is the root mean square Error of simulated muscle actuator activation to 
experimental muscle activation 
 A  is simulated muscle actuator activation 
 a  is muscle activation calculated from the experimental EMG 
 
 subscripts: 
 s = sth subject model (20 subject models) 
 t = tth gait cycle (five gait cycles) 
 m = mth muscle actuator (nine muscle actuators) 
 i = ith data-point (n data-points) 
 
One drawback of using a root mean square error analysis as a measure of curve similarity 
is that large differences can be found between two identical curves differing only by a 




Figure 5.2 – Drawback of the root mean square error measure. A hypothetical 
muscle activation (solid line) is shown alongside a copy (dotted line) shifted in 
time by 5%. The two curves are identical apart from this small temporal shift but 
the root mean square error normalised to the mean activation (NRMSE) 
indicates a 33% difference between the activations 
 
To overcome this problem the root mean square error was calculated within a 
minimisation algorithm that allowed both a time shift and gain compensation to be 
applied to the simulated muscle actuator activation. The time shift parameter was limited 
to ±0.1s based on the likelihood of mismatch between muscle model contraction 
dynamics and true human muscle twitch speed (Buchanan et al., 2004). 
 
The gain parameter was limited based on the likelihood of sub-maximal maximum 
voluntary contractions. This was examined by Stackhouse et al. (2005) who compared the 
forces exerted from maximum voluntary contractions to the maximum forces generated 
during electrical stimulation in a group of twelve children with spastic diplegic cerebral 
palsy and ten typically developing age matched controls. In the quadriceps and triceps 
surae respectively, maximum voluntary contraction forces were found to be reduced to 
70% and 90% in the control group and to 45% and 45% in the cerebral palsy group. The 
average of these four values (62.5%) was used as a basis to set the lower limit (0.6) of the 
gain compensation and the reciprocal value (1.7) was used for the upper limit. This range 
(0.6-1.7) was used for both groups in this analysis to allow comparison of the results. 
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This optimisation was implemented in Matlab (The MathworksTM Inc., MA, USA) using the 
least squares curve fitting algorithm (lsqcurvefit). An example can be seen in Figure 5.3. 
 
 
Figure 5.3 – An example comparison of simulated vs. experimental muscle 
activation for the right lateral gastrocnemius (lat_gas_r). The RMSE has been 
minimised by applying two transformations to the original simulated 
activation (green curve). The blue curve shows a shift in time by d (-96ms) 
and the dotted blue curve shows a subsequent increase in magnitude by 
x (1.69). The resultant RMSE (0.06) is then calculated between the adjusted 
simulated muscle activation (dotted blue curve) and the experimental 
activation (black curve) and normalised by the mean experimental muscle 
activation to give NRMSE=40.7%. The dashed black line marks the transition 
between the stance and swing phase of the gait cycle. 
 
Once the root mean square differences between simulated and experimental muscle 
activations have been calculated, the validity of the simulated muscle activations can be 
determined by comparing these values to a validity threshold – a value of RMSE above 
which the two curves are deemed too dissimilar. However, choice of a suitable validity 
threshold is difficult due to the inherent variability seen in experimental surface 
electromyography of human walking (Winter & Yack, 1987). Inter-subject variation in EMG 
will result from physical differences between subjects such as body size/shape, and from 
differences in walking kinematics, but additionally will also result from the methodology 
of collecting surface EMG. This is due to differences: in electrode placement, in muscle 
morphology, in the electrical impedance of the electrode-skin contact and in the 
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composition/conductivity of the tissue that lies between the motor unit action potential 
and the electrode at the skin surface (Blok et al., 2002). 
 
Many of these parameters will be fixed in a single individual and so intra-subject (stride-
to-stride) EMG variation should be smaller than that seen between subjects, but some 
variability will still be present even in subjects with a very consistent walking pattern 
(Winter & Yack, 1987; Agostini et al., 2010). Again, this can come about from changes in 
the electrical impedance of the electrode-skin contact as the subject moves but also from 
variation in muscle motor-unit recruitment pattern as there is evidence (Hodson-Tole & 
Wakeling, 2007) that the generally accepted Henneman “Size Principle” (Henneman et al., 
1965) recruitment mechanism, where smaller (usually slow) motor-units are recruited 
before larger (usually fast) motor-units, may not always be the case. Therefore the pattern 
of motor-unit recruitment in the same muscle may differ between repetitions of the same 
movement and hence lead to changes in the surface EMG signal as detected at the skin. 
 
It is unreasonable that the agreement between a simulated and experimentally derived 
muscle activation in an individual should be closer than the inherent variability of the 
individual’s EMG, but reasonable that this agreement should be closer than the inter-
subject variation of EMG within the group. It is proposed therefore than a RMSE validity 
threshold range can be determined using intra-subject EMG variance and inter-subject 
EMG variance as upper and lower bounds respectively. As the musculo-skeletal model is 
not hampered by the complications of EMG electrode contact or muscle motor-unit 
recruitment patterns, it can be assumed that the variance in an individual’s simulated 
muscle activations will be smaller than the intra-subject EMG variance, but to include this 
source of variation the lower bound will be adjusted to the sum of both (intra-subject 
simulated muscle activation variance + intra-subject EMG variance). 
 
The three variances were calculated using the root mean square error between the 
individual trial data and the mean data across all appropriate trials (Equation 5.5). 
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3,2,1 ,  
 
where: V  is the Variance of: 1: intra-subject experimental activation (EMG) 
   2: intra-subject simulated muscle activation 
   3: inter-subject experimental activation (EMG) 
 a  is the corresponding muscle activation (1, 2, 3) 
 
 subscripts: 
 m = mth muscle actuator (nine muscle actuators) 
 i = ith data-point (n data-points) 
 t = tth gait cycle  1 & 2: 5 gait cycles 
       3: 50 gait cycles 
 s = sth subject  1 & 2: individual subjects (10xTD, 10xCP) 
       3: grouped subjects (TD group, CP group) 
 
The lower bound of the RMSE validity range for each muscle for each subject was then 
calculated from the sum of the two intra-subject variances V1 and V2 (root of the sum of 







VVLB sm   
 
where: LB  is the Lower Bound of the RMSE validity range 
 
 subscripts: 
 m  =  mth muscle (nine muscle actuators) 
 s  =  sth subject (10xTD, 10xCP) 
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The invalidity ratio for each muscle for each subject was then calculated by dividing the 
RMSE of simulated muscle activation to experimental activation E, by the appropriate 











,   
 
where: R  is the invalidity Ratio 
 E  is the RMSE of simulated activation to experimental activation 
 LB  is the Lower Bound of the RMSE validity range 
 
 subscripts: 
 m = mth muscle actuator (nine muscle actuators) 
 s =  sth subject (10xTD, 10xCP) 
 
This parameter has been termed the invalidity ratio as R=1 would represent simulated 
muscle activations matching experimental activations as closely as the variance in the 
individual’s EMG, and R>1 would indicate a poorer match and hence a greater invalidity of 
the simulated activations. The upper bound of the RMSE validity (V3) for each muscle in 
the typically developing group and the cerebral palsy group were also normalised to the 
corresponding lower bound to give an upper threshold limit of the invalidity ratio. 
Simulated muscle activations for each muscle for each subject will therefore only be 
considered valid if their calculated invalidity ratios are close to unity and less than this 
upper threshold. An invalidity ratio close to or above the upper threshold will imply that 
the differences between the simulated and experimental muscle activations are as large 
as the group variation of experimental muscle activation and hence the bespoke nature of 
the musculo-skeletal model has failed as an individual’s muscle activations cannot be 




Previous researchers have commented on the similarity of simulated and experimentally 
derived muscle activations in typically developing subjects (section 5.1). It is expected 
therefore that the level of agreement in this group will lead to values of the invalidity ratio 
(R) of approximately one. However children with cerebral palsy are known to have 
difficulties in the selective activation of muscles during walking (section 1.2). This can lead 
to co-activation which generates greater overall muscular activation for the same net joint 
moment. Therefore, since the cost functions in both the Static Optimisation and the 
Computed Muscle Control algorithms are based on minimisation of total muscle 




5.3.1. Data Collection 
Table 5.1 gives a summary of the kinematic, kinetic and EMG data collected during 
walking, the EMG data collected during maximum voluntary contractions and the MRI 
data that was successfully collected from all ten control subjects and ten case subjects. 
 
 Controls Cases 
Number (n) 10 10 
Kinematics 10 10 
Kinetics 10 10 
EMG - walking 10 7 (+1 partial) 
EMG - MVC 10 7 (+1 partial) 
5 walking trials 7 3 
4 walking trials 2 3 
3 walking trials 1 3 
2 walking trials - 1 
Total walking trials 46 38 
Full MRI datasets 10 6 
gait2392 models 10 9 
Table 5.1 – Summary of data collection 
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Partial or no EMG data was collected from three case subjects due to a combination of 
tiredness, non-compliance and time constraints after the MRI data collection overran. A 
reduced number of walking trials were collected from three controls subjects due to 
inconsistencies in step length, and from seven case subjects due to a combination of 
obscured markers, incorrect leg hitting the force-plate and/or subject tiredness. A reduced 
set of muscle volumes were collected in four case subjects due to the reasons described in 
section 3.4. 
 
As expected, walking kinematics amongst the control group were more consistent and 
closer to typically developing limits than the case group (Figure 5.4). 
 
  
(a) control subjects (n=10) (b) case subjects (n=10) 
Figure 5.4 – Walking kinematics for all subjects over one gait cycle as calculated using the Conventional Gait 
Model. A separate colour band shows the mean joint angles (± 1SD) from all collected trials (max. 5) from each 
subject. The grey band shows the normal limits for typically developing adults (Guy’s Hospital Gait Laboratory). 
 
Vertical axis: joint angle (degrees), horizontal axis: gait cycle (%), Flex = flexion, Ext = extension, Ab = abduction, 
Add = adduction, Dors = dorsiflexion, Plan = plantarflexion, Int = internal, Ext = external, Var = varus, Val = valgus 
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5.3.2. Simulation and Data Quality 
Muscle volume ratios for all 20 subjects can be found in Appendix G. The most 
strengthened actuator was the vastus intermedius in Control10 with a muscle volume 
ratio of 2.9, and the most weakened actuator was the biceps femoris short head in Case05 
with a muscle volume ratio of 0.09. Subject scaled versions of the gait2392 OpenSim 
model were successfully created for all subjects except one. 
 
The static pose adopted by Case06, which involved both right internal thigh rotation and 
right external foot progression (Figure 5.5) could not be replicated by the model due to 
restrictions in degrees of freedom. Moving the model markers to match the experimental 
marker positions in an unmatched pose would have led to large errors in calculated 
kinematics and hence in any subsequently simulated muscle activations. No simulations 





Figure 5.5 – Standing pose for 
subject Case06. The combination of 
internal thigh rotation and external 
foot progression could not be 
replicated in the model 
 
Inverse Kinematics, Residual Reduction and the both Static Optimisation and Computed 
Muscle Control tools were run on the remaining 46 control trials and 36 case trials. A 
number of trials failed the four kinematic, reserve/residual and muscle activation checks 
as described in section 5.2.3. A large number of trials failed Check 2 and so the “OK” 
rather than “Good” category thresholds (Table 2.5) were adopted. Full check results are 
summarised in Table 5.2. 
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 Controls Cases 
 CMC SO CMC SO 
Planned number of gait cycle simulations (5 trials per subject) 50 50 
Remaining trials after collection 46 38 
Potential simulations from useable models 46 36 
Remaining trials after Check 1: OpenSim IK vs. Vicon Plug-in-Gait kinematics 46 36 
Remaining trials after Check 2: OpenSim CMC kinematics vs. OpenSim IK 45 n/a 34 n/a 
Remaining trials after Check 3: Residuals/Reserves 34 46 24 24 
Remaining trials after Check 4: Muscle activations 4 46 8 24 
Final number of simulations with viable EMG data for validity analysis 4 46 7 20 
Table 5.2 – Summary of the number of simulated gait cycle trials used in this study. Trials were eliminated 
following the simulation checks described in section 5.2.3.  




Figure 5.6 – An example trial from Case10 that failed Check 2, the kinematic matching between the kinematics 
as calculated by the OpenSim Inverse Kinematics tool (solid green curve) and the kinematics resulting from the 
muscle actuator action as calculated using the Computed Muscle Control tool (dotted blue curve). Gross 
deviations can be seen in pelvic tilt, hip flexion, hip adduction and in the position of the trunk (lumbar angles). 
The model has also undergone large global translations: upwards (pelvis-ty) by 200mm, laterally (pelvis-tz) by 
20mm and posteriorly by 250mm. The dotted black line marks the transition between stance and swing phase 
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All trials passed Check 1 giving similar kinematic tracking to that shown in figure 4.1. In the 
Computed Muscle Control dataset most trials passed Check 2 despite some minor 
deviations in the global position of the model with many simulations showing a vertical 
shift upwards by 1-2cm over the course of the gait cycle. However, as the ground-
reaction-force is applied to the model calcaneum segment, rather than the foot-ground 
contact point, a vertical translation should have no effect on the kinetics and so these 
trials were still acceptable. One control trial and two case trials failed Check 2 due to gross 
deviations in kinematic matching (Figure 5.6) 
 
It would seem likely that the failure of these simulations is caused by some mismatch 
between the experimental force-plate data and recorded motion.  
 
 
Figure 5.7 – Check 3 fail: residual/reserves. Example Computed Muscle Control residual/reserve data 
from Case10 trial that failed Check 2 shown in Figure 5.6. This trial also fails Check 3 as all three residual 
forces saturate at 20N and the residual moment about the z-axis saturates at 40Nm. Many of the joint 
moment reserve actuators also exceed acceptable levels. This trial was a right leg gait cycle. The vertical 
dotted black line marks the transition between the stance phase and swing phase. 
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Usually the trials that failed Check 2 also failed Check 3 (Figure 5.7) as the model applies 
unacceptably large residual forces/moments and reserve joint moments in an attempt to 
maintain kinematic tracking. 
 
Of the remaining simulations after Check 2, a further 11 control trials and 10 case trials 
failed Check 3 with residual forces/moments or reserve moments above acceptable 
thresholds (Figure 5.8). 
 
 
Figure 5.8 – Check 3 fail: residual/reserves. Example Computed Muscle Control residual/reserve data 
from Control05 that failed Check 3 – residual forces/moments and reserve moments. Excessive reserve 
joint torques can be seen on the bilateral ankle and knee. This trial was a right leg gait cycle. The vertical 
dotted black line marks the transition between the stance phase and swing phase 
 
Of the remaining simulations after Check 3, a further 30 control trials and 16 case trials 
failed Check 4 with muscle actuators exhibiting unusual activity. A small number of 
simulations exhibited activations with non-cyclical, high magnitude end effects (Figure 5.9) 
which are unlikely in a cyclical walking pattern, but the vast majority of the failures were 
due to unexpected mid-stance tibialis anterior activity combined with high 
activity/saturation in swing (Figure 5.10). 
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Figure 5.9 – Example Computed Muscle Control activations from Control02 that failed Check 4 due to 
discontinuities in muscle actuator activation. Non-cyclical, high activation, end effects can be seen on a 
number of actuators. This trial was a left leg gait cycle. The vertical dotted black line marks the transition 




Figure 5.10 – Example Computed Muscle Control activations from Control03 that failed Check 4 due to 
unusual tibialis anterior activation. Neither mid-stance activation nor such high activity in swing would be 
expected. The vertical dotted black line marks the transition between the stance phase and swing phase 
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The tibialis anterior is typically quiet during mid-stance (Agostini et al., 2010; Sutherland, 
2001; Winter & Yack, 1987) being active only during loading response (to control the 
lowering of the foot to be flat to the floor after heel strike) and during the swing phase (to 
lift up the foot and prevent tripping as the leg swings forward). Additionally, high 
activation during swing should be unnecessary as little effort is required to lift the freely 
hanging foot. High tibialis anterior activity/saturation has also resulted in recruitment of 
the lesser dorsiflexors (the toe extensors) and may also be responsible for other less 
obvious compensatory mechanisms. 
 
This is the same artefact as that identified in the sensitivity analysis (section 4.3.3) where 
the Computed Muscle Control algorithm calculated large changes in tibialis anterior 
activation for small changes in muscle strength for the same movement. Whereas before 
it was not clear whether this effect was due a specific problem with the data of the single 
trial or model used in the sensitivity analysis, it now appears to be a more general 
problem with the SimTrack workflow. In response to this, an investigation into possible 
causes of instability/high activations of the tibialis anterior actuator was carried out and 
the results are reported in the next section 5.3.3. 
 
In the Static Optimisation dataset all 46 control trials passed Checks 1, 3 and 4 (Check 2 
was not applicable to the data output by the Static Optimisation tool). Of the 36 case 
trials, 12 failed Check 3 exhibiting residual forces or reserve moments above acceptable 
thresholds (Figure 5.11). These trials also exhibited excessive residual forces during the 
second run of the Residual Reduction Algorithm and so it is likely that there were some 
mismatches between the experimental force-plate data and recorded motion. All the 




Figure 5.11 – Example Static Optimisation residual/reserve data from Case01 that failed Check 3 – 
residual forces/moments and reserve moments. Excessive vertical (Fy) residual forces and excessive 
reserve joint torques around the left hip can be seen. This trial was a right leg gait cycle. The vertical dotted 
black line marks the transition between the stance phase and swing phase 
 
5.3.3. Possible Causes of High Tibialis Anterior Activation 
There are a number of different mechanisms that may have been a cause of high tibialis 
anterior activation – these include: 
 
a) the joint may be stiff due to antagonistic action 
b) the foot segment may be inappropriately massive 
c) the muscle moment-arm may be underestimated in the model 
d) the strength of this muscle may be underestimated in the model 
e) a problem with the Computed Muscle Control algorithm 
 
Three of these mechanisms can be quickly disregarded: 
 
a) the main antagonists of the tibialis anterior are the gastrocnemeii and the soleus 
and Figure 4.5 shows all three are inactive during swing 
b) the foot mass was 1.25kg or 2.1% of bodyweight, close to the published 
anthropometric value of 1.5% (Winter, 2005) 
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c) The variation in tibialis anterior moment-arm length over one example gait cycle 
for the gait2392 model and for the scaled Control01 model is shown in Figure 5.12. 
For the 1.8m tall gait2392 model the moment-arm can be seen to range from 41-
43mm which is in agreement with published adult data (Miller et al., 2015). 
Assuming a linear scaling factor the 1.6m tall Control01 model therefore also 
shows an appropriate moment-arm range (32-37mm). However, it is interesting to 
note a mild oscillation on the ankle joint kinematics during mid-stance – this will be 
examined in more detail below. 
 
   
Figure 5.12 –The image shows muscle insertions for the calf muscle complex and tibialis anterior (red 
lines), the ankle axis of rotation (red dot) and tibialis anterior moment-arm (white arrow) of the gait2392 
model. The graph shows the ankle kinematics (as output from the Computed Muscle Control tool) for one 
trial of Control01 as well as the moment-arm length for both the generic gait2392 model and the scaled 
Control01 version. The vertical dotted black line marks the transition between the stance phase and swing 
phase 
 
The final two mechanisms that may have caused high tibialis anterior activation require 
more in-depth investigation. First it is necessary to examine the tibialis anterior muscle 
strength which is dependent on the muscle model (section 2.2.2). Many of the muscle 
parameters are the same for all muscles and so it is logical to examine the four 
parameters that are muscle specific: pennation_angle, max_isometric_force, 
optimal_fiber_length and tendon_slack_length. 
 
The tibialis anterior actuator pennation_angle is small (5 degrees) and so this is an unlikely 
cause of weakness as the force exerted by the active muscle fibres will be close to the line 
of action of the whole musculo-tendinous unit. The max_isometric_force parameter is the 
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maximum isometric force that can be exerted by the combined active action of the muscle 
fibres and is proportional to muscle volume (and hence PCSA). The sensitivity models were 
created from the generic gait2392 model by scaling each muscle’s max_isometric_force 
parameter by the appropriate volume ratio. For the baseline model (Model07) the mean 
volume ratio for all the muscles was 1.1 and so in general most values of 
max_isometric_force were altered only moderately. In fact only two muscles were 
weakened to less than 80% of their original value: biceps femoris short head (31%) and 
tibialis anterior (66%). This weakening is a likely cause of high tibialis anterior activation. 
The biceps femoris short head however, despite being more severely weakened, does not 
maximally activate. This is possibly because this muscle has a number of synergists 
available for compensation. 
 
Increasing the max_isometric_force of tibialis anterior will have a direct effect on the 
strength of the muscle actuator and should prevent saturation. Before testing this within 
the model however, it will be interesting to check if the current maximum strength of this 
actuator is being restricted by the values of optimal_fiber_length and 
tendon_slack_length. In the full muscle model (section 2.2.2) the interaction of these 
parameters to the net muscle force is complex due to their interaction with both the 
active muscle contraction force and the passive forces of muscle belly and tendon stretch. 
However, this complexity is somewhat reduced as the Static Optimisation algorithm used 
in the Computed Muscle Control tool uses a simplified version of the muscle model that 
ignores the muscle belly passive forces (the parallel elastic element) and considers the 
tendon inextensible. However, even with this simplified muscle model, if the muscle fibres 
are operating at a different length from optimum then their active force will be restricted.  
 
Looking at the active component of the muscle model (Figure 2.13) it can be seen that a 
muscle fibre operating too long or too short by half a resting fibre length will result in the 
maximum active force reducing to two thirds of the max_isometric_force. Changing the 
tendon_slack_length will change the length at which the muscle fibres operate and hence 
will change the operating strength of the muscle. 
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To investigate this interaction two more sensitivity models were created following the 
same protocol as described in Chapter 4 based on the control group muscle volumes. A 
baseline model (Model04) was scaled to the mean muscle volume of the control group 
(thus similar in strength to Model07) and muscle activations over the gait cycle used in the 
sensitivity analysis were simulated. The mean deviation of the operating fibre length of 
each muscle from their optimal fibre length was calculated and a second model was then 
created (Model04-TSL-Opt) with optimised tendon_slack_lengths to compensate 
appropriately. The simulation was re-run and muscle activations and operating muscle 
fibre lengths compared. In the un-optimised model, a number of actuators failed to 
operate at optimal length throughout the entire gait cycle, these included gluteus 
medius1, semimembranosus, all the adductors and tibialis anterior. These actuators 
therefore underwent the largest changes to their tendon slack lengths in the optimised 
model. In general, all corrections involved shortening of the tendon_slack_length to 
increase the operating length of the muscle fibres. This change should result in lower 
activation to achieve the same force as the muscle is operating at peak position on the 
active force curve and the tendon strain should increase for the same joint angle. The 




 Model04 Model04-TSL-Opt 
Figure 5.13 – Change in activation & operating fibre length after shortening the tendon slack 
length. Simulated right tibialis anterior actuator activation (green) and operating fibre length 
(blue) before (Model04) and after (Model04-TSL-Opt) optimising the fibre length by shortening 
the tendon slack length. OFL = optimum fibre length 
 
164 
Despite the fibre operating at optimal length the activation of the tibialis anterior in 
Model04-TSL-Opt has increased and, in general, most muscles increased their activation. 
This response of the model to changes in tendon_slack_length is contrary to expectations; 
however these results should be viewed with caution as large residual/reserve 
forces/moments were required to track the gait kinematics in the optimised model. A 
more detailed analysis of the model response to changes in both tendon_slack_length and 
optimal_fiber_length would therefore be warranted in future work as it would appear that 
simulated muscle activations are sensitive to these parameters. 
 
Finally, the maximum isometric force parameter (max_isometric_force) of the tibialis 
anterior actuator was increased to see if the dorsiflexor insufficiency could be eliminated. 
Model04, as described above, was again used as the baseline model and four additional 
models were created (Model04-TAx2,x3,x4,x5) with the bilateral tibialis anterior actuators 
given 2, 3, 4 and 5 times the max_isometric_force of Model04. Activation of the tibialis 
anterior and toe extensors progressively decreased as tibialis anterior strength increased 
and toe extension action was finally eliminated with Model04-TAx4. However, non-cyclical 
“end effects” and mid-stance tibialis anterior activation remained, and there were 
increases in activation of both heads of the gastrocnemius (Figure 5.14).  
 
 
Figure 5.14 – Changes in activation after increasing tibialis anterior strength. Simulated 
activations of the tibialis anterior, calf muscles and toe extensors for the baseline Model04 (blue) 
and the most strengthened Model04-TAx5 (green). 
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Dorsiflexion insufficiency was eliminated therefore by an increase in the maximum 
isometric strength of the tibialis anterior. Making use of such a un-physiologically strong 
tibialis anterior muscle is not a satisfactory solution as there are consequences for the 
activation profiles for other muscles in the model – most notably the antagonists. 
Additionally, maximal calf muscle activation during normal walking of typically developing 
subjects is unlikely to be valid. It would appear therefore that an underestimation of 
muscle strength on its own is not the primary cause of high tibialis anterior activation. 
 
The final mechanism to investigate that may have caused high tibialis anterior activation is 
the Computed Muscle Control algorithm. Mild oscillations on the ankle kinematics output 
from the algorithm were seen in Figure 5.12. If this noise was also present on the input 
kinematics then high muscle activations may have been necessary to cope with the 
subsequent high noise on the (double differentiated) desired joint accelerations. To 
prevent this problem occurring it is recommended that input kinematics be low pass 
filtered (e.g. cut off frequency 8Hz) to remove such noise from being amplified. Indeed, 
this was carried out and no such noise was present on kinematics generated in either of 
the previous SimTrack stages: Inverse Kinematics or the Residual Reduction Algorithm 
(Figure 5.15). 
 
However, noise or “ringing” can clearly be seen on the output kinematics from the 
Computed Muscle Control algorithm. This is quite mild on the ankle angle but becomes 
substantially more significant in the velocity and acceleration data. This ringing is only 
seen at the ankle (Figure 5.16) and the timing of the highest amplitude noise region 
corresponds to the unexpected mid-stance tibialis anterior activation. Indeed, of the four 
control trials that did not exhibit mid-stance tibialis anterior activation, the corresponding 
ankle acceleration ringing was noticeably reduced. The second and third noise regions 
occur during the pre-swing and early swing phases of the gait cycle which corresponds to 
the increased activation/saturation of the tibialis anterior seen in many of the Computed 









Figure 5.15 – Input and output ankle kinematics for a Control01 walking trial. No noise is visible on either 
the IK kinematics (input to RRA) or the RRA kinematics (input to CMC). However, mid-stance noise can be 
seen on the CMC output ankle angle which is greatly amplified on both the ankle velocity and acceleration. 




Figure 5.16 – Computed Muscle Control (CMC) output model coordinate accelerations for a Control01 




It would appear therefore that this ankle coordinate ringing is the cause of both the high 
tibialis anterior activation in early swing and the unexpected activation in mid-stance. It 
has already been shown that there was no corresponding noise on the input kinematics, 
and additionally no noise was found on the experimental ground-reaction-force data nor 
on joint moments as calculated using inverse dynamics. The ringing artefact therefore 
appears to be being generated within the Computed Muscle Control Algorithm.  
 
There are a number of parameters available to alter the set-up of the Computed Muscle 
Control algorithm but it is well known (Prentice, 2011) that ringing effects in numerical 
methods are sensitive to solution step-size. The CMC_time_window is the solution step 
parameter in the Computed Muscle Control algorithm and, as recommended by the 
OpenSim user-guide, it was set to 0.01s in these initial simulations. To investigate the 
effect of this parameter on ankle_angle acceleration ringing therefore, the Computed 
Muscle Control tool was run again on the same Control01 walking trial with three 
progressively smaller values of the CMC_time_window: 0.0075s, 0.005s and 0.001s. 
 
It can be seen in Figure 5.17 that tibialis anterior activation is very sensitive to the choice 
of the time window. As the time window is reduced, the ankle angle acceleration ringing 
initially increases and then reduces and the tibialis anterior activation responds 
accordingly with increased activation during ringing periods. For this single walking trial 
and within this limited range of time windows tested, the optimum value of 
CMC_time_window appears to be 0.005s. However, even for this simulation, the mid-





Figure 5.17 – Ankle angle accelerations (input – RRA, output – CMC) and tibialis anterior activations 
for a Control01 walking trial using four different values of the CMC_time_window parameter. 
RRA = residual reduction algorithm          CMC = computed muscle control 
 
Similar tests were run on other walking trials for Control01 and on other subjects but the 
results were variable: ankle angle acceleration ringing was often reduced leading to 
reductions in mid-stance/high activation of the tibialis anterior but mid-stance activation 
was rarely eliminated completely; and despite improvements at the ankle, changing the 
CMC_time_window resulted in increased acceleration ringing at other model coordinates 
in some trials. Using the definition of Lin et al. (2011), the algorithm therefore appears to 
have low robustness. It is also unfortunate that there are no results on the tibialis anterior 
in this paper. 
 
It would therefore appear that the low robustness, or sensitivity to changes in its input 
settings, of the Computed Muscle Control algorithm necessitates the use of trial specific 
set-up parameters. Such a task is impractical for the number of walking simulations 
investigated in this thesis. A number of papers (Anderson & Pandy, 2001; Lin et al., 2011) 
have indicated that muscle force estimates using Static Optimisation and Computed 
Muscle Control are practically equivalent, and therefore it seems prudent to only carry 
forward the Static Optimisation data into the subsequent validity analysis. 
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5.3.4. Validity Analysis 
After all the preceding simulation data quality checks, the OpenSim muscle actuator 
activation validity analysis was only carried out on the Static Optimisation data, using 
46/46 gait cycles from 10/10 control subjects and 20/36 gait cycles from 6/10 case 
subjects. Mean simulated muscle actuator activations from all these control trials and case 
trials are shown in Figure 5.18 and Figure 5.19 respectively.  
 
Individual trial activations, mean experimental activations, and normal EMG timings 
during adult walking are shown for the EMG muscles in Figure 5.20 and Figure 5.21 for the 
control and case groups respectively. 
 
Specific examples of the validity analysis for one control trial and one case trial can be 
seen in Figure 5.22 and Figure 5.23 respectively. Here the time shift and gain 





Figure 5.18 – Mean actuator activations (±1SD) from all 46 control subject gait cycle simulations. The 
vertical dotted black line marks the transition between the stance phase and swing phase. Trunk actuators 




Figure 5.19 – Mean actuator activations (±1SD) from all 20 case subject gait cycle simulations. The 
vertical dotted black line marks the transition between the stance phase and swing phase. Trunk actuators 




Figure 5.20 – Control subject simulated activations. Individual trial actuator activations (blue) and mean 
experimental muscle activation (black ±1SD) from all 46 control trials. No EMG was collected from bifemsh, 




Figure 5.21 – Case subject simulated activations. Individual trial actuator activations (blue) and mean 
experimental muscle activation (black ±1SD) from all 20 case trials. No EMG was collected from bifemsh, 












Figure 5.23 – Example validity analysis trial from Case02 for all EMG muscles (mean RMSE = 0.11 degrees) 
 
RMSE was calculated between the adjusted simulated muscle activations (dotted blue curves) and the 
experimental muscle activations (black curves). Adjustment of the original simulated activations (red curves) 
involved a time shift by d (blue curves) and then a change in magnitude by x. The dashed black line marks the 
transition between the stance and swing phase of the gait cycle. Grey horizontal bars show normal adult EMG 
timings from Sutherland (2001) 
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The variances of intra-subject experimental activations (V1), intra-subject simulated 
activations (V2) and inter-subject experimental activations (V3) were calculated using 
Equation 5.5. On average (across both groups) the V1 variances were 4.3 times higher than 
the corresponding V2 variances showing that there was generally higher variation in an 
individual’s EMG than in the their simulated muscle activations. All three variances (V1-3), 
lower and upper bounds of the RMSE validity range and the mean RMSE between 





V1: intra-subject experimental activation (EMG) variance 
V2: intra-subject simulated activation variance 
Lower Bound:  
Optimised RMSE between simulated activation and experimental activation (EMG) - Controls 
Optimised RMSE between simulated activation and experimental activation (EMG) - Cases 
Upper Bound (V3): inter-subject EMG variance 
Figure 5.24 – Variance of activation data 
Mean RMSE between simulated muscle actuator activations and experimental muscle activations (EMG) 
from all successfully simulated control (blue) and case (red) subject gait cycles. Variances (V1-3) are also 
shown with the lower and upper bounds of the RMSE validity range indicated by green bars.  
Error bars show ±1SE   EMG = electromyography 
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The mean invalidity ratios were calculated using Equation 5.7 for both the un-optimised 
and optimised simulated activations and the results are shown in Figure 5.25. 
 
 
  - optimised data     - un-optimised data 
 
Figure 5.25 – The invalidity ratio (R) 
 
Mean RMSE invalidity ratios for both groups from all successfully simulated gait cycles for all nine muscle actuators 
for which EMG data was collected. 
 
Mean RMSE invalidity ratios are shown for both optimised (black dots) and un-optimised (green dots) data 
following the optimisation procedure shown in Figure 5.3. Gain compensation was set to between 0.6-1.7 and the 
maximum time shift was set to ±0.1s. 
 
The underlying coloured regions (blue = control group, red = case group) show the RMSE validity range for each 
muscle. The block at the bottom shows the lower bound (R=1) as calculated from the sum of intra-subject 
experimental activation variance (V1) and intra-subject simulated activation variance (V2). The bar shows the upper 
bound as calculated from the group inter-subject experimental activation variance (V3). 
 
Simulated muscle activations are therefore only considered valid if the corresponding invalidity ratio lies below the 






Looking at Figure 5.18 and Figure 5.19 it can be seen that similar simulated muscle 
actuator activation patterns were found in both groups except for the rectus femoris and 
calf muscles (med_gas, lat_gas, soleus) which showed premature activity in the case 
group. Activations were also more consistent in the control group as can be seen from the 
tighter standard deviation bands. 
 
A good agreement can be seen between the experimental muscle activations of the 
control group and published timings of normal adult EMG (Figure 5.20). There is also a 
reasonable agreement between the peak experimental activations of the case group and 
published timings of normal adult EMG (Figure 5.21) except for the high activation of 
vastus lateralis (vas_lat) in mid-stance and prolonged early stance activity of the 
hamstrings (semiten, semimem, bifemlh). The experimental activations of the case group 
also show generally prolonged activity compared to the control group – a possible 
indication of increased tone that would be expected in these subjects. This can also be 
seen in the individual case-control comparison in Figure 5.22 and Figure 5.23. 
 
A visual comparison of simulated muscle actuator activity against the mean experimental 
activations (Figure 5.20 and Figure 5.21) can provide a qualitative indication of the validity 
of the simulated muscle activation. Looking at the differences in shape only (to mimic the 
time shift and gain compensations carried out in the RMSE optimisation) the least valid 
simulated actuator activations in the control group appear to be the rectus femoris which 
shows a lack of activity during loading response and the soleus with reduced activity 
during mid-stance. It is more difficult to make a visual assessment of the case group data 
due to the variability of the simulated activations but in general there is a good agreement 
in shape for all the muscle actuators except for the rectus femoris and late swing vastus 
lateralis. The semitendinosus, vastus lateralis, and tibialis anterior also show largely 




The effects of the time shift and gain compensation optimisation can be seen in Figure 
5.22 and Figure 5.23. The optimisation succeeds in closely matching many of the 
simulated activation curves to the experimental data. However, a poor match is found in 
the muscles which have low simulated activation levels due to the limit on the gain 
compensation. 
 
There are a number of difficulties associated with the use of a root mean square error 
analysis methodology for curve comparison. Although RMSE data can be intuitive as it has 
the same units as the parameter of interest (in this case muscle activation) comparison of 
magnitudes between muscles can be misleading. This is because a finite change in 
activation of a very active muscle is of less interest than the same finite change in 
activation of a less active muscle and yet the RMSE values will be the same. One solution 
to this problem is to normalise the RMSE data to the mean muscle activation (either 
experimental or simulated) to provide a measure that takes the activation level into 
account and so emphasise the more significant changes in muscle activation. However, 
despite this advantage, this normalisation method also introduces problems. Firstly, 
normalised RMSE is a dimensionless parameter which makes it less intuitive to interpret 
and, secondly, as the case group generally shows higher levels of experimental activation 
than the control group, such normalisation may confound genuine differences between 
the groups. The alternative normalisation method used in calculating the invalidity ratio 
(Equation 5.7) overcomes this problem as the RMSE is normalised to the variance in 
experimental activation rather than the magnitude of the experimental activation, and so 
differences in mean activation between the groups are ignored. 
 
Figure 5.24 shows the data variance in intra and inter-subject experimental activation (V1 
and V3) and simulated activation (V2) as well as the RMSE difference between the 
experimental and simulated data. On average the V1 variances are 4.3 times higher than 
the corresponding V2 variances showing that there was generally higher variation in an 
individual’s EMG than in the their simulated muscle activations for both the control group 
and the case group. This ratio is particularly high for the vastus lateralis in both groups due 
177 
to very low values of V2 (consistent simulated activations). Both intra and inter-subject 
experimental activation variance (V1 and V3) are higher in the case group which is to be 
expected in individuals with cerebral palsy (also clearly seen in Figure 5.21). The RMSE 
differences between simulated activations and experimental activations are higher in the 
case group but, due to the difficulties of interpreting RMSE data as discussed above, it is 
unclear whether this is due to poorer matching of simulated to experimental activations 
or rather due to the generally higher activity of the case muscle actuators. This should be 
revealed in the invalidity ratios. 
 
An invalidity ratio of R=1 represents a RMSE deviation between an individual’s simulated 
muscle activation and their experimental muscle activation of similar magnitude to the 
variance in that individual’s experimental muscle activation (EMG). Using a validity range 
of R < Upper Bound (V3) and looking at the un-optimised data in Figure 5.25 it can be seen 
that all simulated muscle activations in both groups were found to be either invalid or on 
the border of invalidity except for the rectus femoris in the case group. This is due to the 
high upper bound of this actuator as a result of a particularly high V3 and low V1 and V2 
(Figure 5.24). This was also the cause for a high upper bound for the vastus lateralis in the 
case group. However, on visual inspection of Figure 5.21, it is clear that the simulated 
muscle activations for the rectus femoris in the case group should also be considered 
invalid. 
 
Looking at the optimised data in Figure 5.25 and using the same validity threshold, 
consistently invalid simulated muscle activations were generated in the control group for 
the rectus femoris and soleus, with vastus lateralis and tibialis anterior being on the 
border of invalidity. Both rectus femoris and soleus were identified from Figure 5.20 as 
having poor shape matches to their experimental data. Vastus lateralis and tibialis 
anterior score poorly due to reduced amplitude of simulated activation compared to 
experimental data. 
 
In the case group consistently invalid simulated muscle activations were generated for the 
semitendinosus and tibialis anterior, with biceps femoris long head, vastus lateralis, soleus 
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and lateral gastrocnemius being on the border of invalidity. Again, three of these muscles, 
semitendinosus, vastus lateralis and tibialis anterior, were identified from Figure 5.20 as 
likely to be invalid due large deficiencies in activation amplitude compared to their 
experimental data. Biceps femoris long head and lateral gastrocnemius also exhibit 
deficiencies in activation amplitude compared to their experimental data and simulated 
activation of the soleus has a mismatched peak in late stance. It was expected that rectus 
femoris would also be calculated as invalid but, as explained above, it was not due to a 
high upper bound of the validity range. 
 
5.5. Conclusions and Limitations 
Musculo-skeletal models scaled to height, mass and muscle volume were created for ten 
typically developing adolescents and ten adolescents with cerebral palsy. Each model’s 
muscle activations were allowed to vary in order to track the subject’s recorded walking 
pattern and the validity of a selection of simulated muscle activations were then 
determined by comparison with activations derived from experimental EMG data. 
 
A problem with simulated muscle activations as calculated by the Computed Muscle 
Control algorithm was observed – specifically the high activation and mid-stance 
activation of the tibialis anterior actuator. These unlikely muscle activations correlated 
with instability (acceleration “ringing”) in the resulting model kinematics which was found 
to be very sensitive to the algorithm set-up parameters, and in particular to the time 
window used in the forward dynamics step. 
 
In addition to the testing of the sensitivity of muscle activations to changes in muscle 
strength (Chapter 4) and as part of the investigation into the instability of the Computed 
Muscle Control algorithm, some preliminary tests were performed looking at the 
sensitivity of muscle activations to changes in tendon slack length and (as the lengths are 
linked) to muscle fibre length. The relationship of these muscle model parameters to the 
net musculo-tendinous unit force is complex and a separate investigation would be 
needed to fully examine the sensitivity of muscle activations to changes in each of these 
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parameters. However, these initial tests resulted in large changes to muscle activations 
and so it is likely that muscle force and activation will show high sensitivity to changes in 
these parameters. This is in accordance with the brief sensitivity analysis carried out by 
Delp in his original work on the development of SIMM (Delp, 1990). As a result of this 
sensitivity of the Computed Muscle Control algorithm to a number of set-up parameters, 
the algorithm was classified as non-robust (Lin et al., 2011) and only simulated activation 
data as calculated using Static Optimisation was carried forward to the validity analysis. 
 
A good agreement between simulated and experimentally derived activations in typically 
developing subjects was hypothesised as previous researchers have commented on the 
similarity of such data (section 5.1). However, contrary to this hypothesis, using a validity 
threshold based on the variance of the group’s experimentally derived activations, all 
simulated muscle activations were found to deviate from experimentally derived 
activation patterns. After allowing a generous optimisation in both amplitude and time, 
the deviation of 5/9 of the simulated muscle actuators were reduced to acceptable levels: 
semitendinosus, semimembranosus, biceps femoris long head, medial gastrocnemius, 
lateral gastrocnemius. 
 
A poor agreement between simulated and experimentally derived activations in subjects 
with cerebral palsy was hypothesised as co-activation and poor selective activation 
associated with this group (section 1.2) are unlikely to result in activation patterns that 
would be predicted by algorithms based on the minimisation of total muscle activation. In 
agreement with this hypothesis, all of the muscle actuator activations tested in the 
cerebral palsy group in this study were found to deviate from experimentally derived 
activation patterns. After optimisation, an acceptable agreement between simulated and 
experimental activation was achieved for 3/9 of the simulated activations: 
semimembranosus, rectus femoris and medial gastrocnemius. 
 
Only walking trials that passed the simulation checks described in section 5.2.3 were used 
in this analysis and so it can be assumed that the simulated muscle activations and 
resultant joint torques successfully recreate the experimental kinematic and kinetic data 
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recorded during each walk. These simulated activations therefore are an alternate 
solution to walking than that actually employed by the subjects. Deviation from 
experimental activation is likely therefore to result from a number of other factors 
including mechanical differences between the bespoke musculo-skeletal models and the 
subjects’ bodies, non-physiological muscle models, and/or use of an inappropriate cost 
function to calculate the muscle force distribution to recreate experimental kinetic data. 
 
In conclusion, the muscle activations (and corresponding forces) as determined by the 
cost function in the Static Optimisation algorithm are generally invalid in comparison to 
the experimentally derived activations, and so muscle contributions to support and 
progression in walking as could be calculated from an induced acceleration analysis using 
these alternate solutions to human gait are unlikely to be correct. Reliably accurate and 
detailed knowledge of muscle function during walking, especially the differences between 
normal walking and pathological walking patterns, would be an invaluable aid to both 
treatment decision making and to improving the efficacy of intervention. However, this 
type of analysis has been carried out in many studies in the literature, none of which have 
attempted to conduct a quantitative analysis of the level of agreement between their 
simulated and experimentally derived muscle activations. If musculo-skeletal modelling 
techniques such as these are to be adopted into routine clinical gait analysis methods then 
clinicians need to have confidence in the data that they produce.  
 
There are a number of limitations in this validation technique that need to be considered. 
As stated in section 5.3.4, the intra-subject EMG variance (V1) was on average 4.3 times 
higher (3.3 controls, 5.3 cases) than the corresponding intra-subject simulated activation 
variance (V2). This is an interesting finding that raises the question of whether surface 
EMG has inherent features which essentially make it un-trackable (Hakanson, 2010). If 
true, this implies that surface EMG is not a good signal to use for the validation of 
simulated muscle activations. 
 
Possible alternative methods for validation could be to track the position of musculo-
tendinous junctions during walking (using portable ultrasound imaging techniques) and 
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compare these experimental datasets with simulated positions. Alternatively, fine-wire 
EMG may give more consistent signals than surface EMG as the wire electrodes are less 
prone to cross-talk (the detection of electrical activity from neighbouring muscles) and 
they do not suffer from the complications of signal transmission through soft tissue. 
However, as fine-wire EMG only detects very local electrical activity some variation will 
likely occur based on the local motor-unit recruitment strategy. In fact there is lack of 
consensus in the literature as to which modality is better as reliability can be affected by 
the intensity of contraction (Semciw et al., 2014) or the type of activity (Chapman et al., 
2010; Kadaba et al., 1985). 
 
Another limitation to this validation procedure is the inherent bias introduced by the 
dependence of the invalidity thresholds on the experimental and simulated muscle 
activations. As stated in section 5.4, both the experimental and simulated muscle 
activations were more consistent in the control group leading to smaller intra and inter-
subject variances (V1-3). An imbalance therefore exists between the invalidity thresholds of 





Cerebral palsy is a condition caused by a brain injury that typically occurs during the peri-
natal period. This primary injury is non-progressive but as important neurological 
development and growth occur after this period, progressive secondary abnormalities 
often result that can lead to reduced mobility and walking difficulties. Clinical gait analysis 
has for many years been used by clinicians working with this patient group. A subject’s 
walking pattern can be defined by their kinematics, kinetics and spatio-temporal 
parameters and the deviations identified by comparison to unaffected individuals. 
However, these techniques are essentially a pattern recognition tool that relies on the 
experience of the interpreting clinician to find clinical meaning. 
 
It has been suggested therefore that incorporating musculo-skeletal modelling methods 
within the gait analysis process may provide a more objective analysis of the causes of 
walking difficulties. For example, the energy cost or mechanical disadvantage of a 
deformity can be calculated, and the efficacy of potential interventions evaluated in the 
virtual environment as an aid to treatment decision making. However, there are currently 
a number of limitations to these techniques and so there is a need for evaluation and 
validation of such methods. 
 
This programme of work therefore included a validity analysis of muscle activations 
generated using musculo-skeletal modelling simulations of human walking. Validity was 




6.1. Review of Work 
This programme of work set out with the following set of aims: 
 
1. To measure and compare muscle morphology between typically developing 
adolescents and independently ambulant adolescents with cerebral palsy. 
 
2. To evaluate the sensitivity of simulated muscle activations in the OpenSim model 
to changes in lower limb muscle volumes in typically developing adolescents 
during walking. 
 
3. To evaluate the validity of simulated muscle activations in both subject groups by 
comparison to EMG data. 
 
Findings of this programme of work were: 
 
1. Muscle volumes and fibre lengths were found to be smaller in the case group with 
smaller volumes more prominent in the distal musculature. Physiological cross-
sectional area was found to be larger in the thigh and smaller in the shank for the 
case group and no difference between groups was found in pennation angle. A 
high variation in reported muscle pennation was noted from the literature. 
 
2. In general the model was insensitive to changes in muscle strength with only small 
increases in muscle activation resulting from decreases in muscle strength over a 
normative range. However, large increases in activation occurred in synergist and 
compensatory muscles when any muscle approached maximum activation. 
 
3. All simulated muscle actuator activations that were tested were found to be 
invalid. After a generous optimisation process which allowed limited change to the 
activations in both amplitude and time, valid simulated activations were found in 
the control group for semitendinosus, semimembranosus, biceps femoris long 
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head, and both heads of the gastrocnemius; and in the case group for 
semimembranosus, rectus femoris and lateral gastrocnemius. 
 
To the author’s knowledge, this is the first study to carry out a quantitative validation of 
simulated muscle activations during walking in typically developing individuals and 
individuals with cerebral palsy. 
 
6.2. Clinical Implications 
Muscle volumes were found to be smaller in the cerebral palsy group in 18/19 of the 
muscles measured when normalised to body mass. Significant volume reductions were 
found in the gluteus minimus, rectus femoris, biceps femoris long head, 
semimembranosus, tibialis anterior and all three calf muscles. Mean percentage muscle 
volume deficits were 32% for the distal muscles compared to 16% for the proximal 
muscles. With the exception of sartorius there was a trend for larger volume deficits in the 
biarticular muscles compared to their monoarticular neighbours. This volume data has 
now been published (Noble et al., 2013) as part of a larger study of muscle morphology. 
 
Despite finding smaller muscle volumes in the cerebral palsy group, and contrary to the 
accepted premise that cerebral palsy subjects have weaker muscles, muscle physiological 
cross-sectional areas were found to be larger in the thigh muscles (principally the 
quadriceps) of the case group compared to their typically developing peers. If this is a 
genuine finding it is possible that, due to distal weakness and poorer motor control, 
individuals with cerebral palsy make more use of their proximal musculature for tasks 
such as walking and hence alter the morphology of these muscles to make them stronger. 
 
6.3. Methodological Findings 
The increase in thigh muscle physiological cross-sectional area in the case group appears 
to be driven by more marked shortening of the fascicle lengths in the thigh muscles. 
However, this is uncertain as a poor relationship was found between fascicle lengths and 
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leg length and so the trend for shorter fascicle lengths in the thigh may be an artefact of 
the normalisation scheme. Additionally, the high variation in reported muscle pennation 
that exists in the literature highlights the difficulty in measuring these muscle parameters. 
 
Muscle volume is proportional to physiological cross-sectional area which is the only 
muscle parameter directly proportional to the maximum tension that can be generated by 
a muscle. In the OpenSim gait2392 model, simulated muscle activations were shown to be 
insensitive to changes in muscle strength over a normative range (82-144% of the generic 
model strength) based on the muscle volumes of the control group. However, in the 
weakest sensitivity model some muscles were shown to approach maximum activation, a 
state where sensitivity to changes in muscle strength increased. Therefore, as the subjects 
in the case group were shown to have smaller and hence weaker muscles than the control 
subjects (40-110% of the generic model strength compared to 63-167%) then it is likely 
that simulations of muscle activation using models scaled to the muscle volumes of this 
patient group may encounter sensitivity complications caused by muscle activation 
saturation. This questions the suitability of using these models in the analysis of subjects 
with cerebral palsy. 
 
The validity of nine simulated muscle actuator activations were evaluated by comparison 
to experimental activations derived from EMG data. All simulated activations were found 
to be invalid. Although there are many possible limitations in the musculo-skeletal 
modelling process that may have resulted in these discrepancies in experimentally derived 
versus simulated activation, the principal cause is likely to be the optimisation procedure 
used to overcome the static indeterminacy problem of calculating muscle forces from 
joint torques. This is carried out in the OpenSim Static Optimisation algorithm by 
minimizing the cost function ∑(activation)2 – Equation 2.16. As confirmed by the results of 
this study, this function was expected to be inappropriate for individuals with cerebral 
palsy due to muscle abnormalities such as spasticity and co-contraction which will work 
against the principles of this cost function. Based on the results of this study it would also 
appear that this cost function is also inappropriate for use in typically developing subjects. 
If musculo-skeletal modelling techniques, such as those used in this programme of work 
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and in the literature, are to be used in the simulation of muscle activity in individuals with 
neurological conditions such as cerebral palsy, then there is a need for alternative 
optimisations that incorporate the neurological aspects of these conditions. It may be 
appropriate to call such techniques neuro-musculo-skeletal modelling. However, due to 
the variety of cerebral injuries that exist in this group, a generic solution may not be 
possible. If this is the case, then alternate, hybrid solutions may be necessary that 
combine bespoke measurements of muscle morphology with EMG-driven simulation 
techniques (Lloyd & Besier, 2003; Shao et al., 2009). 
 
As simulated muscle activations were found to be invalid, this data could not be used in 
any further techniques, such as induced acceleration analysis, to evaluate muscle 
contributions to support and progression during walking. 
 
6.4. Conclusion 
Musculo-skeletal modelling techniques were used to test the sensitivity of simulated 
muscle activations to changes in model muscle strength and to test the validity of 
simulated muscle activations against experimentally derived activations in typically 
developing subjects and subjects with cerebral palsy. If bespoke muscle strengths are used 
for this group then sensitivity is likely to be high and simulated muscle activations were 
shown to be invalid. There is also a lack of consensus in the literature between studies 
using these techniques to calculate muscle contributions in gait. Other studies have also 
shown variation in the output of such modelling techniques dependent on a number of 
factors including the number of degrees of freedom in a model and the modelling of the 
foot-ground interaction. Additionally, in this programme of work, the Computed Muscle 
Control algorithm was shown to be non-robust – specifically in relation to ankle 
acceleration “ringing” effects which were sensitive to the forward dynamics time window. 
Therefore, at present, it would be inappropriate to use these simulated muscle activations 
in further analyses such as induced acceleration analyses to evaluate muscle function. 
Further work is necessary to develop and evaluate these modelling methodologies in 
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order to gain confidence in the outputs of such “black box” techniques. It is hoped that 
these methods will then prove a valuable tool for use in the clinical setting. 
 
6.5. Future Work 
As described above, a poor relationship was found between fascicle lengths and leg length 
in this study suggesting that the shorter fascicle lengths found in the cerebral palsy group 
may have been an artefact of the normalisation scheme. It would be interesting to re-
normalise the fascicle length data by muscle length, a commonly reported normalisation 
method, to see if the difference in fascicle length between the groups, and the more 
marked shortening in the thigh muscles, remains. 
 
Simulated muscle activations in the OpenSim gait2392 model were shown to be 
insensitive to changes in muscle strengths over a normative range. It would also be 
interesting to examine the sensitivity of model outputs to changes in other muscle model 
parameters such as tendon_slack_length. Imaging data similar to that collected in this 
study could be used for example to determine a normative range of optimum fibre lengths 
and passive stiffnesses – both parameters that have direct effects on the force that a 
muscle can generate, and that could be altered in pathological muscle.  
 
In this study simulated muscle activations were found to be invalid in both typically 
developing adolescents and adolescents with cerebral palsy. Although this may have been 
the result of a number of limitations in the musculo-skeletal model, i.e. incorrect bony 
geometry, muscle attachments, muscle moment-arms, and/or un-physiological muscle 
models, the principal cause is likely to be the optimisation procedure used to calculate 
muscle forces from joint torques. It is also likely that different cost functions will be 
necessary to accurately emulate muscle recruitment patterns employed by typically 
developing subjects and subjects with a neurological condition. Investigations examining 
different optimisation cost functions and the validity of the resulting simulated muscle 
activations would therefore be warranted. 
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Such studies would contribute to one part of the more general question: do we need 
personalised models? It is intuitive that a more personalised model will have the potential 
to produce more accurate data, but unless techniques are developed to speed-
up/automate the conversion of imaging data to musculo-skeletal models then the heavy 
work load of this process currently prevents its use outside the research environment. 
However, work has been carried out looking at the differences in simulation outputs from 
bespoke verses generic models, specifically muscles’ lines of action and bony geometry. 
More studies of this nature may provide the necessary knowledge to create quasi-bespoke 
models that incorporate enough elements of an individual’s unique musculo-skeletal 
make-up to ensure accurate simulation, but few enough elements to enable them to be 
used practicably in a routine clinical setting. 
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Appendix D – Matlab Code for the Calculation of Fibre Lengths 
 
%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%% 
% APLFibreLength.m  
% calculates the fibre length and pennation angle from  
% a 2D ultrasound image and saves to a txt file – 
% Create a blank txt file with tab deliminated columns headers in the 
% target directory first 
% Headers are: 
% ImageNumber ImageDepth(cm) MuscleThickness(mm) FibreLength(mm) 
% Pennation(degs) a1 b1 a2 b2 u1 v1 u2 v2 r1 s1 r2 s2 sx sy 
% explanation of a1, b1 etc given below 





% User selects Ultrasound Image 
[file,path]=uigetfile('*.bmp','Select Ultrasound Image File '); 
imagenumber = str2num(file(length(file)-6:length(file)-4)); 
  
% Image is loaded 
USImage=imread([path,file]); 
image(USImage); 
% user input image depth 
N = inputdlg('Enter the image depth (cm):','Image Depth'); 
image_depth = str2num(str2mat(N)); 
  
% User draws a line along a muscle fibre by clicking on the image 
button = 'No'; 
while strcmp(button,'Yes') ~= 1 
    close 
    image(USImage); 
    [Px Py Pz] = size(USImage); 
    truesize([1*Px 1*Py]); 
    hold on 
    h=msgbox('Click two points to draw a line along the length of a 
muscle fibre'); 
    uiwait(h); 
    [u1(1),v1(1)]=ginput(1);         
    plot([u1-10 u1+10],[v1 v1],'r'); 
    plot([u1 u1],[v1-10 v1+10],'r'); 
    [u2(1),v2(1)]=ginput(1); 
    plot([u2-10 u2+10],[v2 v2],'r'); 
    plot([u2 u2],[v2-10 v2+10],'r'); 
    plot([u2 u1],[v2 v1],'r'); 
  
    % User marks line of action of muscle to calculate pennation angle 
    h=msgbox('Now draw a line along the aponeurosis:                                  
Deep aponeurosis: MG,LG,VL,RF                                                     
Superficial aponeurosis: SOL,VI,BFLH,BFSH,SM                                       
Central aponeurosis: TA                                                           
Pennation is zero in VM,ST'); 
    uiwait(h); 
    [r1(1),s1(1)]=ginput(1);         
    plot([r1-10 r1+10],[s1 s1],'g'); 
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    plot([r1 r1],[s1-10 s1+10],'g'); 
    [r2(1),s2(1)]=ginput(1); 
    plot([r2-10 r2+10],[s2 s2],'g'); 
    plot([r2 r2],[s2-10 s2+10],'g'); 
    plot([r2 r1],[s2 s1],'g'); 
     
    % User measures the thickness of a muscle 
    h=msgbox('Now draw a line to measure the thickness of the muscle                   
ie the perpendicular distance between superficial and deep aponeuroses'); 
    uiwait(h); 
    [a1(1),b1(1)]=ginput(1);         
    plot([a1-10 a1+10],[b1 b1],'b'); 
    plot([a1 a1],[b1-10 b1+10],'b'); 
    [a2(1),b2(1)]=ginput(1); 
    plot([a2-10 a2+10],[b2 b2],'b'); 
    plot([a2 a2],[b2-10 b2+10],'b'); 
    plot([a2 a1],[b2 b1],'b'); 
     
    button = questdlg('Are you happy with this selection?'); 
end 
  
%load US image depth info for various image depths 
depth_info; 
  



















% create vectors from points for pennation calc below 
UV = [u2-u1,v2-v1]; 
RS = [r2-r1,s2-s1]; 
  
% calculate pennation angle (angle between muscle fibre and aponeurosis) 
NB in radians 
% a.b = ABCos(Theta) so (Theta) = acos(a.b/AB) 
pennationRadians = (acos(dot(UV,RS)/(norm(UV)*norm(RS)))); 
if pennationRadians > (pi/2) 
    pennationRadians = (pi) - pennationRadians; 
end 
  
% avoid divide by zero issues if pennation <1 deg (or (2*pi)/360 radians) 
if pennationRadians < (2*pi)/360 




% calculate muscle fibre length using trigonometry 
% length = thickness / sin(pennationRadians) 
thickness = ((a2-a1)^2+(b2-b1)^2)^0.5; 
fibrelength = thickness /sin(pennationRadians)  
  
% convert radians to degrees for output 
pennation = (360/(2*pi))*pennationRadians 
  
% OUTPUT RESULTS 
% data columns are: 
% image number 
% image depth (cm) 
% muscle thickness (mm) 
% fibrelength (mm) 
% pennation (degs) 
% a1 - 1st muscle thickness point x (mm) 
% b1 - 1st muscle thickness point y (mm) 
% a2 - 2nd muscle thickness point x (mm) 
% b2 - 2nd muscle thickness point y (mm) 
% u1 - 1st fibre point x (mm) 
% v1 - 1st fibre point y (mm) 
% u2 - 2nd fibre point x (mm) 
% v2 - 2nd fibre point y (mm) 
% r1 - 1st muscle line of action point x (mm) 
% s1 - 1st muscle line of action point y (mm) 
% r2 - 2nd muscle line of action point x (mm) 
% s2 - 2nd muscle line of action point y (mm) 
% sx - pixel size x (mm) 
% sy - pixel size y (mm) 
  
% assign results to results variable 
results = [imagenumber image_depth thickness fibrelength pennation a1 b1 
a2 b2 u1 v1 u2 v2 r1 s1 r2 s2 sx sy]; 
  
% append data to results file 
resultsfile = 'FibreLengths.txt'; 
fid=fopen([path,resultsfile],'a+'); 
fprintf(fid, '\n'); 
fprintf(fid, '%1.0f\t' , results(1)); 
fprintf(fid, '%1.0f\t' , results(2)); 
% write results to file 
for i = 3:length(results) 
    fprintf(fid, '%1.1f\t' , results(i)); 
end 
fclose(fid); 









Appendix F – Case Group Previous Surgery 
 







L calf & hamstring lengthening 
 
Botulinum toxin L gastrocnemius 
 
Botulinum toxin L gastrocnemius & serial casting 
Case03 2010 L calf & hamstring lengthening 







Bilateral ankle serial casting, R foot correction of equino-varus 
deformity, R tibialis posterior, toe flexor & Achilles tendon lengthening, 
plantarflexor release & first metatarsal extension osteotomy 
 






R Achilles tendon lengthening, bilateral medial/lateral hamstring 
lengthening & R gastrocnemius slide 
 






Bilateral psoas release, rectus femoris transfer, hamstring lengthening, 
gastrocnemius slide & femoral de-rotation 
 










Bilateral distal hamstring lengthening, R gastrocnemius slide & L Achilles 
tendon lengthening 
 
Bilateral ankle serial casting 
 
Botulinum toxin L calf - 4 courses 
 






L distal hamstring lengthening, L gastrocnemius recession & L medial 
displacement calcaneal osteotomy 
 
Botulinum toxin bilateral gastrocnemius 
Case10 2009 




Appendix G – Muscle Volume Ratios 
 
 Control Subjects 
 Co1 Co2 Co3 Co4 Co5 Co6 Co7 Co8 Co9 Co10 
add_brev_l 1.09 0.70 1.30 1.32 1.00 1.32 1.31 1.20 2.03 2.06 
add_brev_r 1.11 0.70 1.29 1.25 0.98 1.43 1.34 1.12 2.07 2.04 
add_long_l 1.09 0.70 1.30 1.32 1.00 1.32 1.31 1.20 2.03 2.06 
add_long_r 1.11 0.70 1.29 1.25 0.98 1.43 1.34 1.12 2.07 2.04 
add_mag1_l 1.09 0.70 1.30 1.32 1.00 1.32 1.31 1.20 2.03 2.06 
add_mag1_r 1.11 0.70 1.29 1.25 0.98 1.43 1.34 1.12 2.07 2.04 
add_mag2_l 1.09 0.70 1.30 1.32 1.00 1.32 1.31 1.20 2.03 2.06 
add_mag2_r 1.11 0.70 1.29 1.25 0.98 1.43 1.34 1.12 2.07 2.04 
add_mag3_l 1.09 0.70 1.30 1.32 1.00 1.32 1.31 1.20 2.03 2.06 
add_mag3_r 1.11 0.70 1.29 1.25 0.98 1.43 1.34 1.12 2.07 2.04 
bifemlh_l 0.95 0.55 0.83 1.08 0.75 0.76 1.13 0.91 1.25 1.26 
bifemlh_r 0.90 0.56 0.84 1.00 0.78 0.93 1.20 0.89 1.39 1.24 
bifemsh_l 0.25 0.18 0.27 0.28 0.28 0.37 0.41 0.25 0.52 0.75 
bifemsh_r 0.31 0.18 0.26 0.28 0.25 0.36 0.46 0.30 0.55 0.49 
ercspn_l 1.02 0.63 1.10 1.24 0.93 1.18 1.29 1.07 1.67 1.67 
ercspn_r 1.02 0.63 1.10 1.24 0.93 1.18 1.29 1.07 1.67 1.67 
ext_dig_l 1.02 0.63 1.10 1.24 0.93 1.18 1.29 1.07 1.67 1.67 
ext_dig_r 1.02 0.63 1.10 1.24 0.93 1.18 1.29 1.07 1.67 1.67 
ext_hal_l 1.02 0.63 1.10 1.24 0.93 1.18 1.29 1.07 1.67 1.67 
ext_hal_r 1.02 0.63 1.10 1.24 0.93 1.18 1.29 1.07 1.67 1.67 
extobl_l 1.02 0.63 1.10 1.24 0.93 1.18 1.29 1.07 1.67 1.67 
extobl_r 1.02 0.63 1.10 1.24 0.93 1.18 1.29 1.07 1.67 1.67 
flex_dig_l 1.02 0.63 1.10 1.24 0.93 1.18 1.29 1.07 1.67 1.67 
flex_dig_r 1.02 0.63 1.10 1.24 0.93 1.18 1.29 1.07 1.67 1.67 
flex_hal_l 1.02 0.63 1.10 1.24 0.93 1.18 1.29 1.07 1.67 1.67 
flex_hal_r 1.02 0.63 1.10 1.24 0.93 1.18 1.29 1.07 1.67 1.67 
gem_l 1.02 0.63 1.10 1.24 0.93 1.18 1.29 1.07 1.67 1.67 
gem_r 1.02 0.63 1.10 1.24 0.93 1.18 1.29 1.07 1.67 1.67 
glut_max1_l 1.19 0.74 1.25 1.47 1.13 1.57 1.56 1.10 2.17 1.87 
glut_max1_r 1.24 0.80 1.39 1.54 1.23 1.70 1.57 1.26 2.18 2.03 
glut_max2_l 1.19 0.74 1.25 1.47 1.13 1.57 1.56 1.10 2.17 1.87 
glut_max2_r 1.24 0.80 1.39 1.54 1.23 1.70 1.57 1.26 2.18 2.03 
glut_max3_l 1.19 0.74 1.25 1.47 1.13 1.57 1.56 1.10 2.17 1.87 
glut_max3_r 1.24 0.80 1.39 1.54 1.23 1.70 1.57 1.26 2.18 2.03 
glut_med1_l 0.94 0.55 1.17 1.07 0.87 1.03 1.28 1.12 1.54 1.51 
glut_med1_r 0.91 0.53 1.31 1.10 0.90 1.04 1.21 1.03 1.39 1.44 
glut_med2_l 0.94 0.55 1.17 1.07 0.87 1.03 1.28 1.12 1.54 1.51 
glut_med2_r 0.91 0.53 1.31 1.10 0.90 1.04 1.21 1.03 1.39 1.44 
glut_med3_l 0.94 0.55 1.17 1.07 0.87 1.03 1.28 1.12 1.54 1.51 
glut_med3_r 0.91 0.53 1.31 1.10 0.90 1.04 1.21 1.03 1.39 1.44 
glut_min1_l 0.81 0.48 1.11 0.93 0.70 0.89 1.11 0.87 1.12 1.55 
glut_min1_r 0.99 0.49 1.24 1.08 0.72 0.98 1.06 0.89 1.22 1.58 
glut_min2_l 0.81 0.48 1.11 0.93 0.70 0.89 1.11 0.87 1.12 1.55 
glut_min2_r 0.99 0.49 1.24 1.08 0.72 0.98 1.06 0.89 1.22 1.58 
glut_min3_l 0.81 0.48 1.11 0.93 0.70 0.89 1.11 0.87 1.12 1.55 
glut_min3_r 0.99 0.49 1.24 1.08 0.72 0.98 1.06 0.89 1.22 1.58 
209 
grac_l 1.07 0.47 0.62 0.85 0.56 0.88 0.78 0.73 1.20 1.53 
grac_r 0.95 0.53 0.61 0.79 0.62 0.92 0.88 0.72 1.33 1.33 
iliacus_l 1.02 0.63 1.10 1.24 0.93 1.18 1.29 1.07 1.67 1.67 
iliacus_r 1.02 0.63 1.10 1.24 0.93 1.18 1.29 1.07 1.67 1.67 
intobl_l 1.02 0.63 1.10 1.24 0.93 1.18 1.29 1.07 1.67 1.67 
intobl_r 1.02 0.63 1.10 1.24 0.93 1.18 1.29 1.07 1.67 1.67 
lat_gas_l 0.84 0.64 1.67 1.75 1.25 1.23 1.53 1.75 2.47 2.22 
lat_gas_r 0.96 0.69 1.61 2.34 1.40 1.29 1.59 1.59 2.45 2.26 
med_gas_l 0.90 0.62 1.20 1.35 1.15 1.27 1.30 1.44 2.14 1.63 
med_gas_r 0.94 0.67 1.26 1.51 1.07 1.21 1.33 1.57 2.18 1.69 
pect_l 1.02 0.63 1.10 1.24 0.93 1.18 1.29 1.07 1.67 1.67 
pect_r 1.02 0.63 1.10 1.24 0.93 1.18 1.29 1.07 1.67 1.67 
per_brev_l 1.02 0.63 1.10 1.24 0.93 1.18 1.29 1.07 1.67 1.67 
per_brev_r 1.02 0.63 1.10 1.24 0.93 1.18 1.29 1.07 1.67 1.67 
per_long_l 1.02 0.63 1.10 1.24 0.93 1.18 1.29 1.07 1.67 1.67 
per_long_r 1.02 0.63 1.10 1.24 0.93 1.18 1.29 1.07 1.67 1.67 
per_tert_l 1.02 0.63 1.10 1.24 0.93 1.18 1.29 1.07 1.67 1.67 
per_tert_r 1.02 0.63 1.10 1.24 0.93 1.18 1.29 1.07 1.67 1.67 
peri_l 1.02 0.63 1.10 1.24 0.93 1.18 1.29 1.07 1.67 1.67 
peri_r 1.02 0.63 1.10 1.24 0.93 1.18 1.29 1.07 1.67 1.67 
psoas_l 1.02 0.63 1.10 1.24 0.93 1.18 1.29 1.07 1.67 1.67 
psoas_r 1.02 0.63 1.10 1.24 0.93 1.18 1.29 1.07 1.67 1.67 
quad_fem_l 1.02 0.63 1.10 1.24 0.93 1.18 1.29 1.07 1.67 1.67 
quad_fem_r 1.02 0.63 1.10 1.24 0.93 1.18 1.29 1.07 1.67 1.67 
rect_fem_l 0.83 0.61 0.74 0.97 0.67 0.91 1.04 0.91 1.39 1.28 
rect_fem_r 0.79 0.55 0.74 0.89 0.64 0.90 1.07 0.89 1.43 1.31 
sar_l 0.93 0.50 0.97 0.98 0.77 1.22 0.94 0.62 1.64 1.46 
sar_r 0.88 0.50 1.02 0.96 0.77 1.26 0.92 0.64 1.57 1.37 
semimem_l 0.94 0.59 0.88 1.12 0.79 0.90 0.93 0.90 1.37 1.42 
semimem_r 0.97 0.61 0.87 1.19 0.83 0.99 0.96 0.93 1.41 1.37 
semiten_l 1.28 0.61 0.70 1.06 0.70 0.99 1.06 0.76 1.45 1.98 
semiten_r 1.20 0.57 0.73 1.06 0.71 0.90 1.11 0.87 1.23 1.65 
soleus_l 0.72 0.53 1.31 1.44 1.10 1.26 1.22 1.14 1.70 1.25 
soleus_r 0.67 0.49 1.23 1.36 1.13 1.32 1.38 1.39 1.60 1.37 
tfl_l 1.02 0.63 1.10 1.24 0.93 1.18 1.29 1.07 1.67 1.67 
tfl_r 1.02 0.63 1.10 1.24 0.93 1.18 1.29 1.07 1.67 1.67 
tib_ant_l 0.65 0.41 0.67 0.79 0.54 0.59 0.75 0.52 1.05 0.97 
tib_ant_r 0.66 0.42 0.67 0.73 0.53 0.68 0.69 0.57 1.02 0.92 
tib_post_l 0.90 0.55 0.83 1.17 0.70 0.92 1.25 0.85 1.06 1.16 
tib_post_r 0.74 0.60 1.01 1.15 0.73 0.82 1.18 1.03 0.92 1.18 
vas_int_l 1.70 0.98 1.72 1.98 1.52 1.85 2.38 1.91 2.57 2.78 
vas_int_r 1.72 0.98 1.74 1.88 1.40 2.07 2.42 1.77 2.57 2.90 
vas_lat_l 1.81 1.16 1.76 1.97 1.53 2.09 2.20 1.48 2.38 2.76 
vas_lat_r 1.80 1.09 1.62 1.99 1.62 2.32 2.26 1.67 2.61 2.81 
vas_med_l 1.74 1.13 1.75 1.58 1.56 1.77 2.03 1.45 2.52 2.50 
vas_med_r 1.65 1.04 1.71 1.68 1.49 2.06 2.14 1.43 2.57 2.49 




 Case Subjects 
 Ca1 Ca2 Ca3 Ca4 Ca5 Ca6 Ca7 Ca8 Ca9 Ca10 
add_brev_l 0.44 1.38 0.72 0.52 0.51 0.83 0.53 0.55 0.90 1.16 
add_brev_r 0.44 1.58 0.75 0.47 0.47 0.67 0.53 0.62 1.06 0.89 
add_long_l 0.44 1.38 0.72 0.52 0.51 0.83 0.53 0.55 0.90 1.16 
add_long_r 0.44 1.58 0.75 0.47 0.47 0.67 0.53 0.62 1.06 0.89 
add_mag1_l 0.44 1.38 0.72 0.52 0.51 0.83 0.53 0.55 0.90 1.16 
add_mag1_r 0.44 1.58 0.75 0.47 0.47 0.67 0.53 0.62 1.06 0.89 
add_mag2_l 0.44 1.38 0.72 0.52 0.51 0.83 0.53 0.55 0.90 1.16 
add_mag2_r 0.44 1.58 0.75 0.47 0.47 0.67 0.53 0.62 1.06 0.89 
add_mag3_l 0.44 1.38 0.72 0.52 0.51 0.83 0.53 0.55 0.90 1.16 
add_mag3_r 0.44 1.58 0.75 0.47 0.47 0.67 0.53 0.62 1.06 0.89 
bifemlh_l 0.44 0.96 0.72 0.33 0.35 0.40 0.52 0.27 0.56 0.63 
bifemlh_r 0.44 1.09 0.50 0.29 0.32 0.38 0.64 0.41 0.71 0.89 
bifemsh_l 0.44 0.30 0.72 0.10 0.12 0.28 0.32 0.18 0.25 0.29 
bifemsh_r 0.44 0.36 0.21 0.10 0.09 0.24 0.30 0.20 0.24 0.27 
ercspn_l 0.44 1.10 0.72 0.40 0.44 0.72 0.53 0.46 0.80 0.89 
ercspn_r 0.44 1.10 0.72 0.40 0.44 0.72 0.53 0.46 0.80 0.89 
ext_dig_l 0.44 1.10 0.72 0.40 0.44 0.72 0.53 0.46 0.80 0.89 
ext_dig_r 0.44 1.10 0.72 0.40 0.44 0.72 0.53 0.46 0.80 0.89 
ext_hal_l 0.44 1.10 0.72 0.40 0.44 0.72 0.53 0.46 0.80 0.89 
ext_hal_r 0.44 1.10 0.72 0.40 0.44 0.72 0.53 0.46 0.80 0.89 
extobl_l 0.44 1.10 0.72 0.40 0.44 0.72 0.53 0.46 0.80 0.89 
extobl_r 0.44 1.10 0.72 0.40 0.44 0.72 0.53 0.46 0.80 0.89 
flex_dig_l 0.44 1.10 0.72 0.40 0.44 0.72 0.53 0.46 0.80 0.89 
flex_dig_r 0.44 1.10 0.72 0.40 0.44 0.72 0.53 0.46 0.80 0.89 
flex_hal_l 0.44 1.10 0.72 0.40 0.44 0.72 0.53 0.46 0.80 0.89 
flex_hal_r 0.44 1.10 0.72 0.40 0.44 0.72 0.53 0.46 0.80 0.89 
gem_l 0.44 1.10 0.72 0.40 0.44 0.72 0.53 0.46 0.80 0.89 
gem_r 0.44 1.10 0.72 0.40 0.44 0.72 0.53 0.46 0.80 0.89 
glut_max1_l 0.44 1.33 0.72 0.45 0.62 0.87 1.04 0.49 1.13 1.30 
glut_max1_r 0.44 1.75 0.89 0.44 0.62 0.83 1.32 0.58 1.23 0.89 
glut_max2_l 0.44 1.33 0.72 0.45 0.62 0.87 1.04 0.49 1.13 1.30 
glut_max2_r 0.44 1.75 0.89 0.44 0.62 0.83 1.32 0.58 1.23 0.89 
glut_max3_l 0.44 1.33 0.72 0.45 0.62 0.87 1.04 0.49 1.13 1.30 
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